var title_f34_57_35728="Medial ankle ligaments";
var content_f34_57_35728=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Medial ankle ligaments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 412px; height: 416px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The deltoid ligament, located on the medial side of the ankle, is a broad band of connective tissue that has four separate divisions connecting the distal tibia with the talus, calcaneus, and the navicular bones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35728=[""].join("\n");
var outline_f34_57_35728=null;
var title_f34_57_35729="African trypanosomiasis epidemic areas";
var content_f34_57_35729=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Epidemic areas for African trypanosomiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Regions with African trypanosomiasis epidemics.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From the Centers for Disease Control and Prevention (CDC)",
"     <a href=\"file://www.cdc.gov\">",
"      file://www.cdc.gov",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35729=[""].join("\n");
var outline_f34_57_35729=null;
var title_f34_57_35730="Cerv interstit brachyther";
var content_f34_57_35730=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cervical interstitial brachytherapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 312px; height: 422px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Syed-type interstitial implant used for cervical brachytherapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kristin Bradley, MD and Derek McHaffie, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35730=[""].join("\n");
var outline_f34_57_35730=null;
var title_f34_57_35731="Migraine headaches in adults";
var content_f34_57_35731=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Migraine headaches in adults (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?34/57/35731/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35731/contributors\" id=\"au1611\">",
"       Zahid H Bajwa, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35731/contributors\" id=\"au4358\">",
"       R Joshua Wootton, MDiv, PhD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?34/57/35731/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35731/contributors\" id=\"se7359\">",
"       Jerry W Swanson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?34/57/35731/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35731/contributors\" id=\"de6967\">",
"       John F Dashe, MD, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/57/35731?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      MIGRAINE HEADACHE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Headaches can be quite debilitating, although the vast majority are",
"     <strong>",
"      not",
"     </strong>",
"     due to life-threatening disorders. Approximately 90 percent of headaches are caused by one of three syndromes (",
"     <a class=\"graphic graphic_table graphicRef76857 \" href=\"mobipreview.htm?41/59/42939\">",
"      table 1",
"     </a>",
"     ):",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Migraine headache",
"      </li>",
"      <li>",
"       Tension-type headaches",
"      </li>",
"      <li>",
"       Cluster headaches",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     This article discusses migraine headaches in adults. Other types of headaches are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/51/16179?source=see_link\">",
"      \"Patient information: Headache causes and diagnosis in adults (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/59/42931?source=see_link\">",
"      \"Patient information: Headache treatment in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      MIGRAINE HEADACHE SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Between 12 and 16 percent of people in the United States experience migraine headaches, making it the second most common type of headache.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;The pain of a migraine headache usually begins gradually, intensifies over minutes to one or more hours, and resolves gradually at the end of the attack. The headache is typically dull, deep, and steady when mild to moderate in severity; it becomes throbbing or pulsatile when severe.",
"    </p>",
"    <p>",
"     Migraine headaches are worsened by light, sneezing, straining, constant motion, moving the head rapidly, or physical activity. Many migraine sufferers try to get relief by lying down in a darkened, quiet room. In 60 to 70 percent of people, the pain occurs on only one side of the head. In adults, a migraine headache usually lasts a few hours, although it can last from four to 72 hours.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Other symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;Migraine headaches are often accompanied by nausea and vomiting, as well as sensitivity to light and noise. Between 10 and 20 percent of people with migraines also experience nasal stuffiness and runny nose, or teary eyes.",
"    </p>",
"    <p>",
"     The symptoms of a migraine attack may be severe and alarming, but in most cases there are no lasting health effects when the attack ends.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Aura",
"     </span>",
"     &nbsp;&mdash;&nbsp;About 20 percent of people with migraines experience symptoms before the headache; this is called an aura. The aura may include flashing lights or bright spots, zigzag lines, changes in vision, or numbness or tingling in the fingers of one hand, lips, tongue, or lower face. You may have one or more of these aura symptoms.",
"    </p>",
"    <p>",
"     Auras may also involve other senses and can occasionally cause temporary muscle weakness or changes in speech; these symptoms can be frightening.",
"    </p>",
"    <p>",
"     Aura symptoms typically last five to 20 minutes and rarely last more than 60 minutes. The headache occurs soon after the aura stops. Muscle-related auras may last longer.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      MIGRAINE HEADACHE TRIGGERS",
"     </span>",
"    </p>",
"    <p>",
"     Migraines can be triggered by stress, worry, menstrual periods, birth control pills, physical exertion, fatigue, lack of sleep, hunger, head trauma, and certain foods or drinks that contain chemicals such as nitrites, glutamate, aspartate, tyramine. A partial list of potential triggers appears in the table (",
"     <a class=\"graphic graphic_table graphicRef68062 \" href=\"mobipreview.htm?24/25/24988\">",
"      table 2",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Certain medications and chemicals can also trigger a migraine, including nitroglycerin (used to treat chest pain), estrogens, hydralazine (used to treat high blood pressure), perfumes, smoke, and organic solvents with a strong odor.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Headache diary",
"     </span>",
"     &nbsp;&mdash;&nbsp;People who have frequent or severe headaches may benefit from keeping a headache diary over the course of one month. This can be used to determine what triggers the migraines and what makes them better. &nbsp;A sample diary is included here (",
"     <a class=\"graphic graphic_figure graphicRef59359 \" href=\"mobipreview.htm?16/47/17136\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      MIGRAINE HEADACHE TREATMENT TYPES",
"     </span>",
"    </p>",
"    <p>",
"     Migraine headache treatment depends upon the frequency, severity, and symptoms of your headache.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Acute treatment refers to medicines you can take when you have a headache to relieve the pain immediately.",
"      </li>",
"      <li>",
"       Preventive treatment refers to medicines you can take on a regular (usually daily) basis to prevent headaches in the future.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Acute treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;The pain of migraines can be tough to get rid of. Treatment is most likely to work if you take it at the first sign of an attack (eg, at the first sign of aura if one occurs, or when pain begins).",
"    </p>",
"    <p>",
"     In some people, an aura occurs before the migraine (see",
"     <a class=\"local\" href=\"#H5\">",
"      'Aura'",
"     </a>",
"     above). Therefore, an aura can serve as a reliable warning that a migraine headache is on the way, and should be the signal to take migraine medication. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=see_link\">",
"      \"Acute treatment of migraine in adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Pain relievers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mild migraine attacks may respond to pain relievers, some of which are available without a prescription. These drugs include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Aspirin",
"      </li>",
"      <li>",
"       Acetaminophen (sold as Tylenol&reg;)",
"      </li>",
"      <li>",
"       Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (sold as Motrin&reg; or Advil&reg;), indomethacin, or naproxen (sold as Naprosyn&reg; or Aleve&reg;).",
"      </li>",
"      <li>",
"       Indomethacin is a prescription medicine that comes in a rectal suppository, which may be useful for people who have nausea during their headaches.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Pain relievers are also available in combination with caffeine, which enhances their antimigraine effect. As an example, some pain relievers contain a combination of acetaminophen, aspirin, and caffeine.",
"    </p>",
"    <p>",
"     Pain relievers are often recommended first for mild to moderate migraine attacks. However, they should not be used too often because overuse can lead to medication-overuse headaches or chronic daily headaches. If you respond to a pain reliever, continue taking it with each attack, as long as you do not take it more than once or twice per week.",
"    </p>",
"    <p>",
"     People with gastritis (inflammation of the stomach), ulcers, kidney disease, and bleeding conditions should not take products containing aspirin or NSAIDs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Anti-nausea medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have nausea and vomiting with a migraine, you can take an anti-nausea medicine by injection or rectal suppository. In some cases, antimigraine drugs can be taken in combination with drugs that alleviate nausea and vomiting, such as metoclopramide or prochlorperazine. Anti-nausea medications given by mouth are usually used in combination with other medications to treat acute migraine. However, anti-nausea medications can be given alone in the hospital by intravenous and intramuscular administration to treat acute migraine headache.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Triptans",
"     </span>",
"     &nbsp;&mdash;&nbsp;If a pain reliever does not control your migraine pain, most healthcare providers will recommend a treatment that is migraine-specific. This includes a class of medications called triptans. Examples of triptans are sumatriptan (also sold as Imitrex&reg;), zolmitriptan (sold as Zomig&reg;), naratriptan (sold as Amerge&reg;), rizatriptan (sold as Maxalt&reg;), almotriptan (sold as Axert&reg;), eletriptan (sold as Relpax&reg;) and frovatriptan (sold as Frova&reg;).",
"    </p>",
"    <p>",
"     Triptans can be used at home or",
"     <span class=\"nowrap\">",
"      work/school,",
"     </span>",
"     and are all available in an oral (pill) form. Sumatriptan and zolmitriptan are available as nasal sprays, and sumatriptan is available as an injection.",
"    </p>",
"    <p>",
"     People with familial hemiplegic migraine, basilar migraine, uncontrolled high blood pressure, vascular disease (including ischemic stroke and coronary artery disease), Prinzmetal's angina, pregnancy, and severe kidney or liver disease should not take triptans in most cases.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Sumatriptan &mdash; Sumatriptan is available in many different formulas, including a tablet, nasal spray, and injection. Over 70 percent of people get pain relief within one hour of injecting sumatriptan; by two hours, 90 percent of people notice improvement. Your healthcare provider can help to decide which formula (pill, nasal spray, or shot) is best for you.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Common side effects of injectable sumatriptan include pain at the injection site, dizziness, a feeling of warmth, and tingling in the arms or legs. Most of these reactions occur soon after the injection and resolve within 30 minutes. These drugs are safe for most patients.",
"    </p>",
"    <p>",
"     Sumatriptan nasal spray begins to work faster than the pill form and has fewer side effects than the injection. The most common side effect of the nasal spray is an unpleasant taste.",
"    </p>",
"    <p>",
"     A tablet that contains a combination of sumatriptan-naproxen (sold as Treximet&reg;) appears to be more effective than each medication taken alone. It is not known if taking the two medications separately would be as effective as the combination tablet.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Ergots",
"     </span>",
"     &nbsp;&mdash;&nbsp;Ergotamine is an older, migraine-specific drug. It is often combined with caffeine. Ergots are not usually as effective as triptans and are more likely to cause side effects. Ergots are sometimes recommended for people with migraines of a long duration (greater than 48 hours) or that frequently recur. People with high blood pressure, coronary artery disease, or kidney or liver disease should not use ergotamines.",
"    </p>",
"    <p>",
"     Dihydroergotamine is related to ergotamine, and can be taken by nasal spray for mild or moderate migraine attacks. It can also be given by injection for severe attacks.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Other medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Other medications for migraine are not as well studied or are less effective. A small percentage of people with migraine headaches do not respond to routine acute treatments and may require additional treatment for pain.",
"    </p>",
"    <p>",
"     Dexamethasone is a glucocorticoid (steroid) medication that can be given by injection, along with another acute migraine treatment, to reduce the risk of a migraine coming back. Dexamethasone injections may be given in an emergency department or clinic.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Preventive treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Preventive treatment effectively controls migraine headaches in most people, although the benefits of this treatment may not be evident for three to four weeks. In some cases, both acute treatment and preventive treatment are necessary to adequately control migraines. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42889?source=see_link\">",
"      \"Preventive treatment of migraine in adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Beta blockers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beta blockers were originally developed to treat high blood pressure. In addition, beta blockers reduce the frequency of migraine attacks in 60 to 80 percent of people. Commonly used beta blockers include propranolol, nadolol, atenolol, and metoprolol. Beta blockers may cause depression in some people or impotence in some men.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Antidepressant medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tricyclic antidepressants (TCAs) and certain other antidepressant medications are often recommended for migraine prevention. These include amitriptyline, nortriptyline, and doxepin. Of these, amitriptyline has proven benefit for migraine prevention, while there is less data for the other tricyclics.",
"    </p>",
"    <p>",
"     Side effects are common with tricyclic antidepressants. Most of these drugs cause drowsiness, particularly amitriptyline and doxepin. Therefore, these drugs are usually taken at bedtime and started at a low dose. Additional side effects of tricyclics can include dry mouth, constipation, palpitations, weight gain, blurred vision, and urinary retention. Confusion can occur, particularly in older adults.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      Anti-seizure medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;The anti-seizure medications valproate (also called divalproex or Depakote&reg;), gabapentin, and topiramate (sold as Topamax&reg;) are sometimes used to prevent migraines.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Valproate is an anti-seizure drug that seems to work as well as beta blockers for preventing migraine, and may be better tolerated. However, valproate can cause weight gain and hair loss. Women who are pregnant or sexually active and not using birth control (pills, condoms, etc) should not take valproate.",
"      </li>",
"      <li>",
"       Gabapentin was effective for reducing migraine headache frequency in a small clinical trial. Potential side effects include lightheadedness, drowsiness, dizziness, and balance problems.",
"      </li>",
"      <li>",
"       Topiramate is an anti-seizure drug that can help to prevent migraine. It can cause mild to moderate side effects that may include abnormal sensations (often tingling), fatigue, nausea, changes in taste, loss of appetite, diarrhea, and weight loss. More severe side effects can occur, including difficulty with thinking and concentration.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Calcium channel blockers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Calcium channel blockers were developed to treat high blood pressure. Calcium channel blockers are widely used for migraine prevention. Examples of calcium channel blockers include verapamil and nifedipine extended-release. Verapamil is frequently used as a first choice for preventive migraine therapy because it is easy to use and has few side effects.",
"    </p>",
"    <p>",
"     Calcium channel blockers may lose their effectiveness over time, but this can sometimes be remedied by taking a higher dose of the drug or switching to a similar drug.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h3\">",
"      Herbal therapies",
"     </span>",
"     &nbsp;&mdash;&nbsp;Herbal therapies have been evaluated for the treatment of migraine headache, including feverfew and butterbur. Of these, feverfew has been the most widely studied. Some studies have found it to be effective for migraine prevention, although most experts agree that the benefits are still unproven. Neither treatment is recommended.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Avoiding medication overuse",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is essential to use antimigraine medications according to the prescription and clinician's instructions. Overuse of certain medications for migraine, including over-the-counter drugs such as acetaminophen and nonsteroidal antiinflammatory drugs, or prescription drugs such as triptans, can lead to medication-overuse headaches (also called rebound headaches) and to a pattern of daily headaches that require increasing quantities of drugs for relief.",
"    </p>",
"    <p>",
"     A vicious cycle occurs when frequent headaches cause you to take medications, which then cause rebound headaches as the medications wear off, causing you to take more medication, and so on. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/59/42931?source=see_link\">",
"      \"Patient information: Headache treatment in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Speak with a healthcare provider if your migraine treatment does not relieve your headaches or if you are having unpleasant medication side effects. Switching to another drug or switching from acute treatment to preventive treatment may be helpful.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      MENSTRUAL MIGRAINES",
"     </span>",
"    </p>",
"    <p>",
"     Migraines occur about three times more commonly in women than in men. Estrogen has a variable effect on the frequency and severity of a woman's migraines; some women who take birth control pills (which contain estrogen) or hormone replacement therapy experience worsening headaches, while others improve. Similarly, some women have more frequent or severe headaches during pregnancy while others have improvement. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/38/35433?source=see_link\">",
"      \"Estrogen-associated migraine\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Menstrual migraines are migraine headaches that occur around the beginning of a woman's menstrual period (usually two days before to three days after the period begins). Women with menstrual migraine may also have migraines at other times during the month. Most often, there is no migraine aura associated with menstrual migraines, even if the woman usually has aura at other times.",
"    </p>",
"    <p>",
"     Menstrual migraines are thought to be triggered by the normal decrease in estrogen levels that occurs before the menstrual period begins. Menstrual migraines tend to be longer lasting, more severe, and more resistant to treatment than other types of migraine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Initial treatment of acute menstrual migraine is the same as treatment for migraine occurring at any other time. (See",
"     <a class=\"local\" href=\"#H9\">",
"      'Acute treatment'",
"     </a>",
"     above.)",
"    </p>",
"    <p>",
"     Preventive therapies for menstrual migraine can be either nonspecific (those that do not address the hormonal trigger) or specific (hormone-based treatments). (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/38/35433?source=see_link&amp;anchor=H9#H9\">",
"      \"Estrogen-associated migraine\", section on 'Preventive therapies'",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     With nonspecific strategies, success requires accurate anticipation of menses for scheduling interventions; therefore, women with irregular cycles are not good candidates for these options. Coexisting problems, such as dysmenorrhea, menorrhagia, endometriosis, as well as contraception needs may influence choice of preventive therapy.",
"    </p>",
"    <p>",
"     A preventive treatment may be useful for women who have menstrual migraines on a predictable schedule. This treatment strategy is called \"mini-prophylaxis\".",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Nonsteroidal antiinflammatory drugs (NSAIDs) such as ibuprofen or naproxen are one option for mini-prophylaxis of menstrual migraine.",
"      </li>",
"      <li>",
"       Triptans such as frovatriptan, sumatriptan, or naratriptan are another option. Typically, long-acting triptans are dosed twice daily beginning two days before anticipated menses and continued for five days.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Hormonal treatments may be recommended to prevent menstrual migraines. One approach is to use estrogen-progestin contraceptive pills in an extended cycle; another choice is menstrually-targeted supplemental estrogen. These treatments work by preventing a rapid decline in the level of estrogen in the body before the menstrual period, which is believed to trigger the migraine. However, some experts avoid treatment with estrogen-progestin contraceptives for women who have a menstrual migraine with aura. Others consider the use of such treatment only for healthy women younger than age 35 who do not have focal neurologic signs and who do not smoke.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H24\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287491087\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5515710\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/31/3570?source=see_link\">",
"      Patient information: Headache (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5515718\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/51/16179?source=see_link\">",
"      Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/59/42931?source=see_link\">",
"      Patient information: Headache treatment in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=see_link\">",
"      Acute treatment of migraine in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44743?source=see_link\">",
"      Basilar-type migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/61/7128?source=see_link\">",
"      Chronic migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/38/35433?source=see_link\">",
"      Estrogen-associated migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34615?source=see_link\">",
"      Evaluation of headache in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3624?source=see_link\">",
"      Headache syndromes other than migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=see_link\">",
"      Headache, migraine, and stroke",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42889?source=see_link\">",
"      Preventive treatment of migraine in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/migraine.html\">",
"      www.nlm.nih.gov/medlineplus/migraine.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Neurological Disorders and Stroke",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ninds.nih.gov/disorders/migraine/migraine.htm\">",
"      www.ninds.nih.gov/disorders/migraine/migraine.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Headache Society",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.achenet.org/resources/information_for_patients/\">",
"      www.achenet.org/resources/information_for_patients/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?34/57/35731/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 16, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/57/35731?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35731/abstract/1\">",
"      Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35731/abstract/2\">",
"      Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004; :CD003225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35731/abstract/3\">",
"      Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med 2002; 346:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35731/abstract/4\">",
"      Silberstein SD, Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology 2000; 54:1553.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f34_57_35731=[""].join("\n");
var outline_f34_57_35731=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           MIGRAINE HEADACHE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           MIGRAINE HEADACHE SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           MIGRAINE HEADACHE TRIGGERS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           MIGRAINE HEADACHE TREATMENT TYPES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           MENSTRUAL MIGRAINES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H24\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/47/17136\" title=\"figure 1\">",
"           Headache diary PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/59/42939\" title=\"table 1\">",
"           Headache syndromes PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/25/24988\" title=\"table 2\">",
"           Headache triggers PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f34_57_35732="Trichomycosis axillaris";
var content_f34_57_35732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Trichomycosis axillaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tan concretions are present on the hair shafts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35732=[""].join("\n");
var outline_f34_57_35732=null;
var title_f34_57_35733="Pathogenesis cluster headache";
var content_f34_57_35733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of cluster headache",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 563px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIzAfsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKTIzjIoJAGSRQAtFRG4gBwZowf94Uvnw/89Y/++hSuh2ZJRTUkR/uOrfQ5p1MQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUhIAJJwB3rNutbsrfI8zzW9Ixn9elTKSjuyoxctkadFcrd+JJnyLWNY1/vNyf8Ky5727uf9dPIw9M4H5CsJYqC21N44WT30O3nvLe3/wBdNGh9C3P5VmzeIrJCQnmye6rgfrXI7DThGSaxlipvZG0cLFbs35fEzn/VWwHuzZqjNr1/IflkWMeiqP61SWAntUi25rN1akupoqdOPQcdTv263Mv4HFQPNPIcyTSMfdiasrbGni2qbSe7KvFbIz9pJyetKErQ+zUfZqXIx86KGyl8ur32elEHtRyC5yh5ZHSjMg5DsPxrRFvntSNbe1PkYc6KcN7dw/6u4lA9Nxx+VTrrGoL0uGP1AP8ASnNbe1Rtb0e+tmL3Hui5F4ju1/1iROPoQavQ+JoSP31vIp/2CG/wrCNvTDB7VarVI9SXRpy6HXQa3YS/8tth9HGKvxSxyruidXX1U5rz9oiKYAyMGUkEdCDitFipLdGbwsX8LPRqK4m11q+tyAZPNUdpOf161qQeJkOBPbsPUo2f0raOJg99DGWGmttToqKp2mpWl1gRTLuP8J4P5VcrdNPVGDTWjCiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACimyOsaM8jBVAySegrAv/EaqSlnHv7b36fgKidSMPiZcKcp/CjdnmjgjMkzqiDuaw77xHGmVs4zI399uB+XWueurq4vJN1xIznsOw+gpI4S1cc8TKWkDrhhox1mPur26uyfPmdlP8OcD8qhWMntVvykiQvKyoo6sxwBWZd+JdHtAR9pEzj+GIbs/j0/WslTlPU2dSMNC4sJ9KmS3JrnD43tt2IrKVh6s4H+NOufHVvFD8llJ5rHC7mG0H3rVYeXYyeIj3OkkjjhjMkzrGg6sxwBWPd+JdKtThZHnb0iXP6nFcpLLd6zceZdSMwzwOy/QVq2uhR7MkZNbxw6W5hLEN7FweN7AHm0ucewX/Gpn8baYUC2yTSTkcIy7cfU/4VlXGjRKD8tc9qVl9mmSVB91h+VX7GJHtpG9e63qt6xEUhgT+7Fx+vWqQj1Vjk3lz/39atXS4xIgOOtbMVqMcitFFLZGbk3uzlVm1e25S9uPoXJH61OfGOqWqpFKsMrE43smCPy4rfubUbTxXJa/aAAsByOaTin0GpNdS9JretT/ADJcFQeyoo/pQmra9HyLpj/vIp/pU2jr51uh9q3oLFWXkUcsewcz7mPB4r1WDH2i2gmUdTgqf04/Sta18a6a6/6XFPbMBzldy/mP8KSfTUC9K57VtNXYxApOnFjVSSOkm8ZaYP8AUxzyj1CgD9TVNvGttu5spsf7wrktBgUyyQOM7Dx9K6EWMJ/gFL2UR+1kacPi7TZD+8SeL3Kgj9DWpZ6np96Qttcxu56KTg/ka5WTR0ccLis+fRypylS6EXsUq0lueitB7VE9v7Vwdrreq6SyqJPOhHHly/MPwPUV1el+LLC7AS7U20p/vcqfx/xrGVBo2jXTLLwVGYiO1au+1kAKTREHphwc0jQAjK4IrF0zZVTJMdW7TUry0IEcpZB/A/IqWSDFV2i9qizi7ou6lozoLHxBBMwS4XyG/vE5X/61bSsrqGUhlPQg5Brz94j6VJZ3dzYvugkIGclTyD+FbwxLWkznnhk9YHe0Vjadr0FwQlwPJk9T90/j2rZHNdkZxmrxOSUJQdpBRRRVEhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRQSACScCgAqlqOowWEZMrZk/hjHU1l6r4gVN0Vjhm6eYeg+nrXNuzzSM8jFnY5JJ5NctXEpaQ3OqlhnLWWxa1DUri/b962Ix0RegqqkZJqWKLJq7DCAK47ObuzruoKyIIbf2rJ13xDBpu6C0UT3Y4I/hT6/4VD4q8Qrbg2OnSK1w3EkinPlj0Hv8Ayrm9PsdxBIyTXZSoLdnJVrvZEFyL/VpvMvZmf0XsPoKtW+hLjJXNdDYaf0yK2VtVVOldSVjlbucemkIh5UVQ1+wRbNyowVGfyrsbuELnArmvEL4tXH975fzoAm0KMGNDjsK6y2jBQVhaNEFhjA9BXSwJhRQBRvIOOBWBf2QlBBHWuvmQEc1Se2Dk8UAZWkwFSMit1Y+BUdvbbDWhEgI6UAULiPKGuW1mDeGXFdvNENprDu7MSPQBlaPCYolUjHFdRarhKz7e12YxWnCAq80ANnA21g6igKtW5cOAKxNRcBWJNAHM6ZHt1mYf7IP611dvGDjNcpp8wOtS4P8ACBXXWx4oAvwxKRjFV7q1AyRVu3p9yMpQBy2o2yspBHNc7fQiONiOMCuwu1BJrmdeXEZA6k4oAq2tj5sKkk9BUn9nTxNut5HRvVTitjS4P3KkitmG1BHSgDmbfWtasGG6Vp0H8Mo3Z/Hr+tb+m+LbS4KpfRNbSH+Icr/iKlubFSpyorFvNJR87VwaiVOMi41JRO3RY5oxJC6ujDIZTkGopIfauBtLm+0SbdbOTHn5o25Vvwrt9G1a31eDdF8kyj54j1H+IrlqUeXU6adbmGSRe1XdM1a4sCEb97B/cJ6fSiSP2qtJHx0rDWDvE6NJq0jtLK7hvIRJA2R3HdT6GrFcBbzy2kwlgcqw/I+xrrNJ1eK+ARv3c4HKnofpXZSrqej3OOrQcNVsadFFFdBzhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU2R1jRnkYKijJJ7UAJLIkUbSSMFRRkk9q4/WdYe+Yxw5S3Hbu31/wpNc1Rr+TZFlbdTwP7x9TWfGma4K1dz92Ox30aCj70txqpmrUMOe1SQw+1c94l14xO1hpzfvekkg/h9h7+9Z06Tky6lVRRZ1fxDb6c5gt1+0XI4Kg/Kv1P8ASsG7vdT1FG8+VliP/LNPlX/6/wCNO0nS1AEkgyx5ra8kBcADFd8KcYnDOpKRwtpbmPUJEbqfmFdnpUSgLxWLrdqYpVuIhyhz9RWpo1ysiqwPWtDM6eBAAKmbpUNq4K1ZYcUAZl8PkJridek3yRR+sg/Su5vvuNXA60P+JhBngbj/ACoA6nSBiNM10kBXaK5SwlCxJz2rRF6FHWgDbk2mogQtZA1Dc2AatJPuoAvhs1Ij4qmkmKlEgxQBaZwRzVWRVzmmvJxxVW4kKqaALG9AccU4OOxrmpb8rcBM4J6VqW0pYAmgC3Ovy5rmNYSaZtsTbQevFdV99Kz57U7sgUAcYLI2N7E67ju4bPrXXWDb1FRvab+q81btICmOKANGEYGaJ2+U0DhaguHwuKAM26PzGuY1Uma9hiHOWyfwrobp8BjWBY/6RrDv/DGuPxNAHSWMWI1GK2LdOBxVC0XpWtbjAoAbLENtZk0Y3Gtmc5HFZF22wk0AZt7bpIpBFc6xl028W5tmKshyPf2ropZ1Y9axNYdRCx/GgDt7HW9OvoY2W6iWRgMoxxg9xzV14wRkcg+leXWFg0tmoI5IzUtvcarojhrWZjCOsTcofw/wrnlQvsbxr23O/mixVY7kYMpIYHII7VDoHiG21geS6+TeAcxk8N7qf6VoXEOORXJOm4s7IVFJHQaFqwu1EFwQLgDg/wB8f41tV53yrBlJDA5BHaur0LVhdqILggXAHB/v/wD166KFe/uy3OavQt70djZooorrOUKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5XxLqXnv9lgP7tD859T6fhWn4h1L7HD5UJ/fyDr/dHrXIxrk1x4mr9hHZhqX22OijyaupGqIWchVHUk4Aqpe3cGmWbXNycKOAB1Y+grjru7vtek/ekx22fliU8fj6ms6VFy1NKtZR0NrxH4rtbS2kh09jLMw2mRB8qe+e/wCFchpTLJcByc5Oc1sDRlWPBGawJ4H0q9HUW7H/AL5P+Fd0IKKsjhlNyd2d9ZqCi1fEQK1jaNciSIAnmt2JgRVEmVf2wdGUiuYhL6bfeWeI2Py/4V212gI4rm9ctBNGTjkdD6UAbthc5C81rb8pXDeHrx3DRSn54zg12Fs+6MZoAivD8prgvFRZZYBDzMXyv4V3l8PkNcncWhuNUV2HyquB+dAGdZ3Oo7ArQJ9QTWhBHfzffwg9hXRWlkoQYUVO8IjFAGbZ23koNxJPqavxsBVO7uFhUsTwKSGYOAwPBoA1M0hkPrUMb5GKeAPWgCVX9arXT5pzyAcCqssmaAOe1OXy7+D/AHv6V0+ntujWuO1R9+sQLnpk109nJ5aLQB0MAGKeyA1RhuAQOatLMCOtADxEvpSFABxSeb702SYYoAY74qncvxRNNVKWTdQBS1KUJCxJwO9Z/h5GLO5HLnNM1aRrmZLaM/ePP0ra0m28sDigDZtFwtaEQqvCuABVvIRM0ANcc1SvIQ6mnSXIDHmmLP5jYzQBzGpWcoJKEjHpXM3pugwWfDRhhkgc4r0ue23jpWNe6YrZO3mgCvp7RtAhjxjFXmiWVCGAIrKtbdrZyFztz09K3bRMrzQBymq6Y9vKJ7YlHU7gV4INdX4Y1tdVgNvc4W9jHI6bx6j+tJeQBkPHFcjfLLpd/Hd2x2vG24f4VE4KasXCbizv7iLaarqzRyK6Eq6nII7Gr1ncRalp8N1Dyki5x6HuPwNVpo8E15042Z6MJXOu0bUVv7bJwJk4df61oVwOn3b2N2kycgcMPUdxXdwyrNEkkZyjDINdtCrzqz3RxV6XI7rZj6KKK3MAooooAKKKKACiiigAooooAKKKKACiiigAooooAKgvblLS2eaU/Ko6ep9KnrkvE98Z7n7LGf3cR592/wDrVlVqezjc0pU/aSsZVxNJd3LzSnLMc/T2q1bxYGTUVtFkiqfjC9NhojrGcSzny1I7ep/L+dcNODkzvqSUUclrd+2tavtjObWI7Yx2Pq3410Gn2qxxKAK5rRYQhUmuzsiCBXpJWVkea227seLYFelYuuaatxbOpXnFdUqjbxVK8jDKeKYjhNCuWt2aGU/PGdp9x2NdfbXWQOa5HV7J11NWiJRmBGRVu0GpIwUqjL68igDrWfetUbuPchGKfa79o39aknHFAHIE/Y9XRhwsnB+tdrYv+7B9a4jxAfLuYWHQSCuq0u6UwJk9qANSVfMGDVb7JGrbsc1IbmNRnIqnc6jGoPzUAaCSKoxUF3KMGsK41hE/iH51nz60XHybm/3RmgCzrsoW2kOeimjRrpJLVMsM4FYlzDf6lwIykf8AtHrTotAvUX5LgqPQUAdWJ1H8Q/Oka9RRy4rnF0W/xg3LYqSPQbg/fuJD+NAGrLqUCfecVm3euxgFYgWJ9OalTw8vVyWP+0c1bg0iKMg7R+VAHJv9qNyLySNtvTHcCugsNWikQfMPoa2PsaFdu3is260GKViyjB+lAF6G9jP3XFXI7v8A2q5h9FuIeYZmHseaYU1GDqofHocUAdf9q4prXGa5NdSnjOJUkX6ipl1Ze7igDeeQt1NUL+7WGM81QbU1P8Y/Os2a5+3XawJyucsfagDS0eJpp2ncct0z2FdXaqFArJ06IIgxWuhwKAL6OBiorq5wpwarNLgdaz7652oxJ6UAVtR1DyTxyxOAB3NX9HZ2AaXG6uZ00m9vGnb7qnC5/nXS2hwwAoA30YEUNCrjpUETcCrcbUAZ81iuc4pI49nGK1SARUTQ5NAFF49ymud1m1EkbKRXWOu1cViako5OKAKPw+u2imudNlJ2n95F7HuP5flXW3EWRXnlpcpYa/b3DtsRZBuOOx4P6V6Lb3drfRGS0mSZPVT0+o7VzVoa3OmjPSxlTJg1ueFtQ2sbOU8HmMnse4rOuouvFUQWjkDKSGU5BHY1yRk6cro65RVSNmejUVV026F5ZRzDqRhh6HvVqvTTTV0eY007MKKKKYgooooAKKKKACiiigAooooAKKKKACiiigCpqtz9ksJZgQGAwufU9K4eIF3LEkknJNbXiu68yeO1Q/LH8zfU9P0/nWbaJyK8+vLnnbsd9CPJC/cknuINPs2uLlwsa/mT6D3rzjxNfXmtTJcJ8kcWdkXbB9fer/iG+bWNW8iFs2kB2rjox7tV61sVWMDFdVKnyq5zVanM7I5fTdSCOEmBRx2autsL1WUbWqvcaRbzffjU/hSW2mx2x/d5A9M1sYnRwXY24JqRmD1zt3cGBARmrWnXyzRghqAJru0WRwSOlSRQ4AGKsIQ/epQFWgCIR4qvckAGrEsoA4rH1K9SJTlhQBzvid1CqT0Dqf1qSLU4ooARIvT1qncRPq0w4YQKf++jWrZaBBGA2wA/SgDPk1a4m+WBGwe54qW2sL25GZpWAPZeK6O202KP7qDPvWhHbADoBQBzlvoUYOX+Y+/NacGnRxjhR+Va6wgdqk8sDtQBnLbgDgU/yaunAppZaAK6w+1TLb04SIO4oN0gHUUAKLenC3FRfbE9aa16o70AWPIX0pphUVUOor60n24N3oAstApqJ7VT2FMW7BPWpknB70AVJLFD1QH8Kpz6VA/WNfyrdVlb0oMYagDln0a2zzEv5VkanYtp9wl1bJlRw6j0rupIAe1Urm1DKQwyKAMnTL2OaNSjZBrUE3FczeabPZTGayzjqY+xqS11hT8snyOOobigDfkkOOTWDrl2fKZI+XbgAU281iPG1DuY9AKNNs5LqXzp1wew9BQAzTIrtI1VAiL6dTXQ6esvmDfVu0sgFAAq8tvs5xQA6IYqwsgHWoc4Wqc1wFbBNAG3Gwank4NZdlcZI9Kus+aACcZFYepnarE1u5yvNZuoW4mUj1oA4Nrdru6dsEIp4z3NQQ3Fzot+tzasQQfmXsw9DXZLYCNCAKw9ZscqeKNw2O20+9i1TTo7qD7rjkd1PcVUuEwxrkfBupNp2oG1mJ+zznHP8LdjXb3ada8+vDlZ6FCpzIveFrzyrprdz8kv3f8AerrK85R2ilWRDhlIIPvXoFnOtzaxTL0dc/j3rXCzuuV9DHFQs+ZdSaiiius5QooooAKKKKACiiigAooooAKKKKACmyOscbO5wqgkn2p1Y/ie58jTvLU/NMdv4d6mcuWLZUI80lE5eR2uLh5XOWdiTVXxJenTdEldCRLJ+7QjsT3/ACzVu2XmuY8ezF72ytQflVS5HuTj+lcFCPNLU768uWOhU8N2uRvYV1ccaqBmszRYwkKgelarjAr0TzhWjUiqtwgVSak80A4zTiBIpBoA5zUbqIKUbdn2UmsKy1VbW7ZGJEZOVJGPwrtJrKM9RWZe6LDcKcqPyoAsWWpI6gqw/OrpugR1ribvSrrTyWtJG2j+E8inWutEDZcfI46hjigDp76/SGJmLYwOtYNvHLqs/mOCIAeAe9Vo2fWLpY0P7hTliO/tXX2lusSBUGAKAI7WzWMAKOlaUVvxk06GLFWQOOKAGKgHapAABzUUsixjk1Qur8AHacUAaTTIveq0l2nOCOK5q51NnlMVtumnP8EYLEfgKt2Og67drjbFaI3JaQ73/IdPzoAuT6gB3ArOn1mKM/vJVX8a3bXwHG+Df31zOe6qfLU/lz+tblj4U0izx5dnCWH8TLuP5nmgDz8az5uPs8VxOT/zzjZv5CrEces3QzbaRc4PeUiP+Zr1GK3hjACIo+gp52joKAPM4tC8RTfegtoP96bP8hVxPCetSD5721T6Rs39RXoGRTg+KAPPj4J1Q8nVY8+0B/8AiqY3g3V0X93qMbn0aIj+tei76UN6igDyufw74ggfcFilx/clx+hH9ary3V9ZkrfWdxFj+PYSv5jIr1z5W6io5II36qKAPLLfVlcZjkVvoc1oQaoM4aum1bwtpuoZMluqSdpI/kYfiK5LU/COpWRL2Ewu4h/yzk+V8ezdD+NAGzDdRyDqKkZVccVxKXskEvlSq8Ew/wCWcgwfw9a1rLVedrmgDVntwQeKwdU0qKbLbBu9cV0cNwkq8EU2eIMMigDz2zhW1vmjmAHPBx2rstOVDjZjFZ+saWs67lGHHINVNHvXgn8mbhhQB3NugAGKmYVUtJg6jmrZYYoAqzfLWHqp+RjWzdNmsTVDmE0ASaFcmWNcnJFdGv3BXG+F24b/AHj/ADrrVf5KABpcHFJuzVaZ8HNEUm40AWCoIrL1KIOp4rUDDFVLsZUmgDhNRg8tyRxzXoGmzm80m2nblmQZ+o4NcZrSkk4HArb8F6pBNp6WJO2ePcQD0cZzxWFeN4m9CVpGlIME10/hK5328lux5jO5fof/AK/86524XDVZ8PzGDVYcdHOw/j/9fFcVKXJUR2VY89NncUUUV6h5gUUUUAFFFFABRRRQAUUUUAFFFFABXIeKbjzdQEQ6RLg/U8/4V19ef3cv2i/mkP8AE5P4ZrlxUrRS7nVhY3k32J7VelcF4plMniqcHogVR+Q/xr0C2rzbxCxXxPeFv+en9KnDLUrEvQ6jSiBGtacx+Sub029UKBmtb7SHXANdhxmVq9xLbMJFBKjrir2m36XEakNk0y5QSxkMMg1zdjKbHUnt8/ITuX6elAHdAhhSmMEVXtJA6KavKPloAzLuAMpBGRXD+KbNFRWQAMGA/OvQ7lflrifEA8y4ijHVpB+nNAGp4etEhtk2qBxXRwR4FZ2lRbYEGK2EGBQAoGKiurhYYySealY7VJrmPEF75SHGSxOFUdSfSgCvqurMG2pl5GOFReST7CruleF77VCJNUmaCA8+TGfmP1bt9BWr4R8PCFVurxQ13IMnPOwf3RXbQwhFAAoAzNI0Wy02Ly7S3jiHcgcn6nvWsqqo4FOAApO9ACk0znPNPyFHJrn9d8UabpRKzThpR/yyj+Zvx9PxqZzjCLlJ2SKhCU5KMVds3sgdTTGlVetcFqmveJJokex0v7NBIQqSSEMTkgDvgdR61w+qX+rzXMkN/c3DSBijJu4yDggAcflXjYnPKNB2UZP5WX4nuYXh+viFdzivnd/h/mey3et6dbAma8gTHUFxn8qzpfGOix/8vgb/AHUY/wBK8gWzuWtJbpYz5ETrE7ZGQxzgY69jUBDq+0hg/p3rjfEsVvSf3/8AAO5cLSe1Vfd/wT2IeN9F/wCfiT/v03+FTweMtFlbAvAh/wBtGUfmRXjIklTByw+oqeG5LsFkh8zP90c10UeIsNN2mnH8fy/yOWvw1iqa5oNS/B/j/me52+q2dyf9HuYZf9xw38qtCXPQ14jDZJcRia1cnB7cEGtK01nWtO4S5aRB/DMN/wCvX9a92E41IqUHdM8CcJU5OE1Zo9c30E7uoridH8bQTOsWpxfZpDx5gOUP9R+tdlbypNGrxuro3IZTkEexqiCjq2i2mpwGO5hSRT6jkfQ15/rXh280gmW3D3VoOo6yIP8A2YfrXrKqCKimhV1IYCgDyPTdQwFZXyp966S1u1lUc0zxR4TZ3e70rEc3V4uiyf4H3rlbG+eCYxyh0dTtZHGCp9DQB2E0YYZFc/q9kSfNTh15Brbs7hZYwc0XkQaM4oAytF1LcAjnDDgiuhim3gc1wtwDa6grjgMcGupspN8YIPJoAu3Ddqx9UYC2cn0q7cSbFLHoKw9cul+wPt6kUAP8MncoI7811ycrXMeGYtlun0rqIh8tAFK++UZqvbygnrVjUh8hrFtZSszqT0NAHQo2RmoL18IajjmwvJrP1G74IBoAx9bk2wPj77HaKz5LeXTxBNESskeGBHrVpB9t1FB1SLk/WtPUoQ9uRjoKAOgtrlb6whuU6SKCR6HuPzojcxyo6/eUgj6isjwfKW02WA/8spDj6Hn+ea1m6mvKqx5ZNHq0pc0Uz0WNw8auOjAEU6qOhyGXSbZj1C7fyOP6Ver1Iu6TPLkrNoKKKKYgooooAKKKKACiiigAooooAq6pP9m0+eUHBC8H3PArhIh82a6jxbOEso4QfmkfP4D/AOviuahHFefiZXnbsd+GjaF+5Z8xLeB5ZmCRoCzE9hXmPiC6a/1OW8ghARiPlzzxxmuo8c3hjtLeyQkNM258f3R2/P8AlWRY2fmRgYrow8LLmMMRO75TFtr9VYBiUPo3FbVnfKCDvBH1q5/Y0bj50B/CoH8OwEnbGAfbiug5yS41WJF+8o+prlrm98zU0nCt5S/KWxxXTReG48521d/saJIim3IoAk0i6WSFCrCt+BtwFclFpUttMDbOVXuvUV1FiGWMb+tADr3hDXE3OJdbRf7qk/ma7DUH+U4ri0P/ABUMmT/AP5mgDsbNcIo9BV4dKpWhG0VczQBV1GfyojzXPaDAdZ8SB2GYbQbyPVz0/IZNW/EdxtURr95v5VpfDO2X+zpbgDmad2z7A4H8qAO0tofLUcVbBoAwBQDzQAMKr3M8dvC8srqkaDLMxwAKsO1eZeO9Wl1DUzplu3+jQkeZtP339D7D+dADdd8V3mqTPbaTuhtvumXo7/T0H61zGqaTNFbrMgL4yX7n610Gn2qwRjA5q5XNjMNHFUZUZO1zqwWKlhK8a8Vdo5i31m3j07RLdkl32V208hAGCpKnA568HritQ+K7W4uIJL37bI0NxcyRvnmNZAAgGGBIGOVyBjvUl3pFncks8Wxz/EnB/wAKzZfDSk/urlh7Mua+YqZZmFHSnaS0/C1tH6H1VPNcurq9W8Xr+N76r1NC78UabcXkkkkN28b3FrM2MIx8tCrHIbIOSCOfxFF/4ugcSvZveJcmyFsswUI24S78/fJA28dSaxJfD8yf8vEWPfIp1l4avr6QragSAcFhkKPxNYOjmbuvZ7+nX5+Z0KvlSs/abW79Pl5G9N4ytZdRE8iXbwrfNOisBlImjKkDng5OcdPeorHxNptk1tHD9s+zxWv2di0Q3P8AvC/G2QFeo5B/A1asfh4xUNfXuD/diT+p/wAK6Cw8GaPa4zbmdh/FKxP6cD9K66OBzGpK9S0fX5dvRHJXzDLKceWneXp8+/qzz20ihu7y8uWaaGOWQtF+8O8Aknk9/r3q3HcNbzrDdOJ4JOElIwQfQ16bHpVhEMJZW4/7ZisnxdpdtJ4dvWht4UljTzVZUAI28/yBr1lgVg6HPSfvR19erTW2vTseO8wljq/JWXuSsv8AD0TT303fc424tLeXOCBTtK1G/wBBm32jmW2z80DH5T9PQ+9d3aadpuo6dbXDWcA86NZPlXaeQD2qKXwrp0gIRZYs/wB2Qn+ea9WMlJKS6njyi4txfQ2dA1m11i0861Ygjh42+8h9D/jWlJyOK4eLwvd6XeLeaPeAyL1jlGA49CRXYRys0as67GIGVznB9KYh2MnBFcn4w8MLfA3dmAl4g/CQeh/x7V1gOTStggg0AeUaRcujNHIrI6Ha6N1U+ldDuDxZp/i3R23G/skBuEHzL/z0X0+vpWbp92k9sjIflYcZ6j2oAx9di6kdetaeiSeZbg98VV1lcoTU2gLiAUAaN0qyxFWANcTrlu8E6qrN5LMPlzxmu8eI7a5zxBamSBmA5X5vyoA0/D4xbLnrXQx/drmvD8waJPcCukQjFAFe9Tctcxfk206y/wAPRq62UblrF1G3WRWVxkHigCmt8jL96sq/ugCcck8Ae9VLqC6sZCFQyw/wkdRUmiWr314J5hiND8o9TQBtaHp/k2+5uXbkn3pQCftUbckNkfQ10EMSrEABWJq6G3uUnX7jfI49vWgCt4Qk2317D6qG/I//AF66GQc1zXhYY8QXIHTyj/MV1Eorz8SvfPQwz9w6jwnLv094z/yzfj6H/JrbrmvBzc3Sf7p/nXS11UHemjlrq1RhRRRWxiFFFFABRRRQAUUUUAFIOtLTHcRxs7dFBJoA5LxNP52pmNeREu38epqnCnIqIyGa4klblmJJq1CvevKb55NnqJckUjhfFzmbxMkXaONV/Pn+tbGnxKsS1j+K1MXilnboyIR+WP6VsWUoMS16VP4UedU+JmkirjpTtoz0qKOQetWEwasgkjQHtUrQBqYpC0yW7Ef3jQBJ9mVe1RPhOBSi8DrwaoXl2sYJY0AMvpAEbJrhZbkL4jHPVMfrWjquqTXTmGyUn1c9BWLc6FOkRufMc3A+YMe/tQB6DYS7olOa0VbIrkfDOoedCobg9x6GumjegDJ1q3VVmkHLsOprc+F7D/hHIF/iVnB+u41S1GIyRHjNVPAl/wD2fqlzp052rKxlhJ7k/eH9aAPT8jFNPFMRsgEU/qKAKWrXJtNOuZxyYomcfgCa8k0NGnkknlO53YsxPcmvU/E6sfD+pbBlvs7/APoJrzDw448oigDbHFFFFABUU8oiTJ6noKlJwM1b8KWY1DUpbuUbobY4QHu/r+H9aALGkeGzNi41TODysIOMf73+FdPHHHCgSJFRF4CqMAVI57CoJpo7eJpZ5FjjUZZmOAKAJxiq99qNnp8Ye8njhB6bjyfoOprkNS8WT3TtDo0ZROnnuMk/Qf41zepNZ2UZvNd1COIE8yXMoGT6Ak/pVQhKbUYq7YHZTeN9NVyI47qUD+JUAB/Miqt34wsbi0mhNtdgSIycqvcY9a4ix8T+FbqZYbfWLFpG4AaQLn88c10otYsfdGKuvhqtH3a0HG/dNfmEZ63iWfDfi2ytdGtLe5E4eJNhYJkcH610tj4i0u7IEV5EGPG1zsJ/PFef6NaxSWjq6glJXX9amn0qJwdoxXBgXfDU79l+R149JYmpbu/zPUw4YcUnevKbe71TSGBtLh/LH/LNvmU/gen4V2XhvxVBqkotrlPs92furnKv9D6+1dRyHTAEU48inAAimNxQBBOokQq1cDrli2k6gLiPizuWw/oknY/Q9PrXoBGaz9Y0+PUdPntZRlJFx9D2NAHEzQm6jKjr0rS0y0MSgYrN0eR0YxXH+uiYxSf7w7/jwa6aHBUEUAI0Y2Vj6lDlWGODW7IRiqF4m5DQByejzfZ7t4G42tx9K7G3kDKOa4vWIGt50uU7HDfStjSr7zI15oA6M8is+9XNSpcjFUtRuliiZ2PAoAwdYuBGpRclzwAOtV9NnurSBVFoSB1Oea0NIszdSG6mGWc/KD2Fb/2VVj+6KAMvT9aWQ7HBRx1VuCKmvyLmFgD1rI8RRpE0ToMS7uCKtWs6tbZZsNjkGgBnhSMnXLtuyxEfqP8ACumlHFZHhOPJvp8cFlQH1xkn+YrYl6V5+Id5nfh1aJreEGxeTr6pn9a6quR8JtjUnHrEf5iuurow38MwxP8AECiiiug5wooooAKKKKACiiigAPSs3xBN5GlS46vhB+NaVcz4tuNzxWynp87fXtWVaXLBs1ox5ppGFbjrWhCBjiqUA6VoQrXnwO+bOR8f2Z32t4vQDyyf1H9axLPUlijw7Dj1rrvHzINB8uQZEsir9Op/pXG6fo1q4D7Nx9yTXo0vhPPq/EbGn6ktzJiPkeordRiq5rOsbNIABGoH0rRk4j6VoZiibPes3Wmf7OzRn5gOKrnUkjuDHLlSehPQ0+5uI5IT8wOaAG6Jd/aIFOeauXVsJl5rmfDtwFuZ48/dkIxXZW+HWgDMgsI4vurzTpoAylWHFa4iGaV7YMvSgDzy7hfSL/zowfIY5YenvXVabeJcRKysDRqlgJY2VlzXLqZ9InyoZrfPIH8NAHfIBImDWHrOlGT548q6ncrLwQexFWtLv0njVlYEGtgFZU5oApeHfFUkGy01sFHHyrcY+R/r6Gu5hmiljDIwIIyCDXCXVgjk8DnqMVmrZXNmxOnXc9oe6odyH/gJ4/KgD0yVElieNwGRwVI9Qa8g1Gwn8Oau8Uik2zMTFJ2Zf8R3rbi1rXbXh3trpB3ZTG36ZFTTeJ7W8ga21vTZfLbqUw4HvxyKAKdvOkyAqRUtUzpSGM3fh26+2W4PzQ5+dP8AH6dfrTrS6WVcHhhwQeCDQBPNnymx6V0fgTaNBG3G/wA19/1z/hiufPIpllcXulyyNYSJsk5aOQZXPrQB3l1NHBE8krBEUZLHoBXnmr3s2vXnVksEPyJ03f7RqS7kvtSkB1C43RjkRINqj8O/41IiKigKMCgDN1i9t9A0O81CdcxW0RkKjgsR0A9ycD8a+XvEF9rfih7zXb5J57aKRY3kVT5VvuztQdh0OPXFfQvxegkuPhzrKQqWYIjkD+6sisx/IGvFPB/jG18P+B9e0x7OC7vr25t5Yo7q3WaHam/duBPX5hjiv0jgugqeFqYulDmqcyj6R0v6bv7jjxLvJRexnW/w98X3DTLB4b1WRoH8qULbMdj4B2njg4IP413vwT8W3sGrHwxqzyMhDC38w/NE69Y+e2AeOxHvWfr/AI+0e/8AFPxC1GBbv7Pr1gLa03RgMHBi++M8D5D69q5b4UQST/EHRliUkrKXb2UKSTX0OYUqmPy6t9eglaPMtNU+W+7fR6dOplBqM1yn0to3yvfp6XLH88VpVm6b8upakno6N+YrSr8LwP8ABS7Nr7m0e7j/AOO33UX98UxsiBxgisLUrLy28yPIIOQR2rfqK4jEkZBrrOM6XwVrbapppW4bN1Adjn+8Ozf59K6T71eVeGbhtM8SxqTiOfMTZ/MfqBXqEb8UAOZaYV4qQnPNITxQBwPiW3+xa+sq8Jdpz/vr/iP5Vo6fLviFP8dxA6UtyB81vKj59s4P6E1naVL8uKANhulRsu5cUobIpcgA0AY2oWwdWDDIPauWMj6Zc7Gz5RPyn09q7S6IOa53V44mRxIAQRQBYh1FCgJ5+lZt9cvqV7HaxZ2k5b6ViWMV1OzJbE7M4ya6TRtPms2LfIzt94nOaAOisIgiqoHAGK0JBiOq9opABIqaZvlIoA5bVYhPqVsrfd3E1cvraIxFtoDAdRSX0Ba6jkU8qc0t9KBFg+lIC54ZGNI4GAZWq9J0qt4eTbosJ/vFm/8AHjVmbpXnVviZ6VH4UaPhT/kKN/1zP8xXX1x/hX/kKH/rmf6V2FdWF+A5cV8YUUUV0HOFFFFABRRRQAUUUUARXc6WttJNJ91Bn6+1cJJK91cSTSnLsea0/GWrQxzR2PmDcvzuP5Vk2jpIuUIIrz8RU5p8q6Hfh6fLHmfUtwJzVyMYqGHpU4pRRUndnLfEhSdHgcZws4z+INY2gOHgFdX4ttvtfh+8QDLKu8fhz/jXC+HbgKNhNdlF3icdZWkdpbgECrhgDR1m20g4rVgkytamRgajpSz5DKDmsCfQZgSI7iVFPYHP867yXbg5rNu2UZoA4K50ibTD9otpGLjlsnO6un8P6l9pt1aqur30EcDK7D8a5bTdZWynmAVzCzZVgpI96APVI5wwqzG+a4zTvEFvPgbxmuhtL1HAKsCKAL88QcVi31grg8VuJMrL1pkiqeeKAOGksprOYvbErzyvY1r6Zq2cJKCrj1rSuolIPFZxtE3ZxzQBtxzq4FOZVcVlISgAqwk+B1oAnaAHtVG7sFdTxg1bN0AOtNFwHGKAOWnimsboT2khhuV+7IO/sR3FdhocOneIrFrue0jW8J2TFeGVx6EVi6rCGQkdaZ4UvpNOXWZkXeIoBPtJwCRkY/QUAT+W9teXNnK29oH2hv7wIyD+RFPqnNfJHHc6pqs8NusmHkd2CogwABk/hWJaeP8AwtdXK28OtWvmMcDflAT/ALxAH610UsJXrxcqUHJLdpN2+4Tkluzp6juZ0treWeU4jjUux9gM1j+MfEdp4X0KbUbwhiPlhiB5lc9FH8yfQVzXgnVNQ8e2F7ca1a2kehTR/ZxaAMXkcYLPu449MfzGT00MuqzoPGTVqSdm+/kl1f4eZLmk+XqVtH8cXXjjVpNM0HTRFpaj/S7u7G4+WeNoQcbm5AyT3OOK4Hxv8KNV0y8ln0GF7/TmJZUTmWIf3SOrfUZr3vS9KsNJheLTLOC1jdtzLCgUE4Azx7AVdr1cPxE8uxDll0OWna3K9b+bfftbRdiHR51771Pkyz8E+JrudYotC1FWPeWBo1/76YAV6r4K8Gap4J1TRrrylvJr2R4L7yoywtoyuVw3b5h8x9gB7934R06PTbvX1jv4bprjUJLp4o2BMBcD5W5znAB7VN43h1Gfw3dx6Hcm31L5WhcMFzhgSMn1Ga9PMeKcRjqiwj5VTlo2018S3d9Ule+na+xEKCiubqXLX5dcvR/eRG/IYrRrGtJ3m1rckLyO1sCyxKWwc89Oo960pbkQ4+0RTQj1kjK1+d4TRTj2lL87/qerjdZQfeMfwVv0JJZFiQsxwBT7a11K7QSW9kxiPIZiFyPxqsDHd3tlFuDRPMob3Geldb4l1SXSLSFoEVnlk8sbs4XgnPH0rrOM4LWYLq2njkuLaSFkcEMRxwfWvUYTuQMOhrmdN8RWupIbXUERJXGCp5R/pn+RrodNmhntke2cNF0BHtxQBcB4pGPFK3AqJSWfFAGX4riEnh7UAf8Anix/IZrlNJYmNDnqAa6rxhcC38P3rHvEyj6kYH865PT8RRRoeqqAfyoA3oz8vNMnmCA81QmvNi4BrKu75jnnigC7d3YGeea5y8lkv7j7PBk5+8w7CkEk19N5cGdv8T9hXSaTYxW0YCr9T3NADtK0tLeFVA7VqRwKp6VDJewwnazAH0zVeTVoFz89AGszqi8Vl3t/HHncwrGv9fUgpB87nsKz4NPub9vMu2ZVP8IoA1xq1u74LD86qandK6/I2RQ2h2oThOfXNVdO015NYgtwd0JbJyegHJpN2VxpXdjutPi8jTLaPHKxjP1xTZuhq3KMDA6VTmrzJu7uenBW0NPwkM6lIT2iP8xXXVyfhAf8TCU9vKP8xXWV2Yb+GceJ/iBRRRXQc4UUUUAFFFFABWD4w1ltI09TCyLczEqjPyFABLNjvgDpW9XmXxolxa2kS8OwOD9fl/rWGJm6dNyRpSjzTSZ5neaw99fyXN3KXlkfJLkncBwMgewrpdC1xEUERBUXqyMSPyNcDJbPE0OfMRGdtzoDnHrWpZzvEyMtxIdy5V87gR6H0r52FSSd2exyq1j1/Tr2O4jDI3WtJWyMivLNCuGZBNZXckM2dssUhDKW9R7Gu50fUWlgXzyok6FRxXoUq3NuYTh2NzG4YIyD1FeW67p76JrLIufIf54z7en4dK9SjO4Zqlr2kxavYmGTCyL80b/3T/hXdSlys5aseZHHWN+Cgya2LS9DMBurhJJLm2u5bUwyeZGxQ8cZHvW5olvclw82B6AGus5DsGyyZFYmpxTurLHwT3retfugGrEkMZGcCgDhrfw4HbfcEyN6mrv9hwquBGMV0+1F9KcBGR2oA4S98NQvkouxuxHFZoGo6VLzuliHp1r0p7dHHGKoXNiG4K5FAHNWHiJGIWQ4b0PWtqLUo5B8ris++0CCc5MYDetZ/wDYlxCf3UzY9DzQB0hmDDqKhklVFJPSsq2tL1Ww7Aj2rSW2dkw/WgDJvdWCMVjBZuyqMms9tTv+SlsxHuQK6q00uIMSVGTVqWwRV4QflQBwr61d70jeFoSxwGfpXSaa7NACzZPrTNV0+OSFgVqroDN5JVuxI/KgDVu2BhbPpVCwZY9F12ZuA4jtwT3JJz+jCn6rOsUBycDqa6DQ9GC6ZZrdgN8xuHjYdXPTP+6OPrQB454ptdN8U+JZdG1rVfslrY2cc1ta/ao7UXkzsc/vXVlUhegIJPOO9ZkHwYs7xDBDPqFlq39o+SNPu3iZ3t0WFpSrL8rOFm3jHBUZxW5490nxBDfX2teB5djSOYbi0EaOJURiUYK4IJBLe/TFeXQ3vxCutVtJQNZN9b3T3cUskJUpKwVWYsw6YVRgnGBiv07JKk6mDi8LXjCMVqm9U0tbq1rN6t6uz0a2OKqlze8rnpfw60qy1GbVLLV4jqJ0C+lsrN7o7wsQY4+X7u7jrjPQdq9MykagDCqBgD0rj/hn4d1K3sriEOk+p3c7XV/dH7gdu3HX/HPavTbXwrZxqDdvLcydyzFRn2A/+vXw2dYqOIxc3TleCenbza8m7v5nTTjaOphCRCeGH506t2fwvpjLiOFom7MjnI/M4rn9SsbjRXUyuZrNjgSY5U+jf415Roc7oEOmWniXxKLO7eW+eSGW8gZSFhJT5cHGDkcnk/hXX6F4ch1u0mudSy8EqtHHHnAx0Lfzrhjc6VF4s1mK2hnXVpbWKaeVj8jxj5V289R34r2TSUFpplrEowEjUfpXbjXJVYz1vyx3tf4V26dutrX1Jjsef+AbJdEutE0o6pa6pNY2k9lNPbsCA6vu2EZOGUMoIPPfvXZalr9hZXItrpXZyNzBYywUHucVwlnb6LofxUnttPvZnvryabULu3kXCRGRBgocDOSOeT+FWPFV5FNqpa3cPsjCOV6bsnA/U/nXHWv9arSd/elzaq1+aMZbdrt2tp2OzEa06T/u/lKSOkudI0zVBHeaZKsMmQ6yRcqSPUVd8QWEmp6S0ZKrOMOh6gMOfyrz/T9RuLCfzrZs5+/GeBIP6H3rvdL1q11C13Rvg9GRuGQ+hFI5Tzh15kjkQBgdrIw6Edq6jwbqsVkDYzERoXLw9hz1X6g5/CsnXjE+tztCQR8obH97nP6YqtLGsiYIBB6g96APWo5VkQEc0xpEiyx4FeVxXlzbJst7u4iXsFkyB+ear3N5LMpF1e3Mq91eXA/IYoA6TxdqsepPHZWzB4UcPMw6cdF/OstJAgyTzWMt6iAJAhbHACjinLb314eWESHsOtAFm91KGEHe2W9BWM94bqYecxSLP3V71v2ehQphpBvb1atGLSbf+4o/CgDLs9RsoY1SPCj0IxW7Y3ccyYRhzUM2i27rgoKzJtMmsjvtGOO6mgDXvdIjvcFyeOmDVE+GI89WI9CaZY68Y2Ec4KsODmt6DU43XIIoAq2Gg29vz5Y3etXZIUjGOKSS+yPlrLudQ/equcknFAEt2wVTim+FY/P1Sab+GJMZ9z/k1n6nchEIzzXQ+DrUwaQZ3Hz3Db/wHA/qfxrOq7RNKSvI1ZapT9TVyU8VRlOTXnTPRgbXg8f6VcH/AGB/Ouqrm/By8XT/AO6B+tdJXdh1+7Rw4h/vGFFFFbmAUUUUAFFFFABXM+PdBj1vR8ltk9sfNRsZyB1U/XFdNTJoxLC8bdHUqfxqKkFOLi+pUJcskzx+40a3lTAQIQ24EdjjrXPT+GGTfIhVZ0bcoHAYV3Eyrb3Jin+Vw+z8amCI3DCvElSUtz2bnl4jbzZVjcW8/wDEjrwx9c9jWrZamW04m7h+0LG2N6H54j745xXbXOhWt4Vd4hvXow4NU7rwxbtMJ4UMFwBjfHxn6jvUKhOOqJckzLtNXtmZPK1CdGx913OB+P8AjXUpdz28MUqXMdzG44DkKx+hrnl8P3RlGVt5AP7y8EehpBGNIz5tqWtyfmibnb9D0IrSMpR3IaTKnipPLv11CEH7Pcdcj7rjqD/OrGkXiuoGRV7/AES4jlW1dZIJQN9rJx+Knsa57UNMutJAubffLZHndjlPZh2r08PXU1yvc4a1FxfMtjtYJQQCDUk05C4zXI6frIKgMa011BHH3hXUc5Hq+pzWpDBSV74oi1uMwLIXAB96qazdR/ZWyR0zXOaBpxuR5k2WViSqnoBQB3NlrUcrYVwfpWvFOJFz2rnLSwijxtAH0rZgIRMCgCw8keecVG5j9qz7/cQShIrBlvL+3LfuzKB0KnFAHVhowKaZox0IrhJtevZLhbdbdkkbpuIx9a0rW0vWw8txjPOAKAOsimGeKs7ty81j2Z2ABjk1cNwqjrQBFfqCpFZKKlqrHgZ5qbUNRRc85qtpNjca5ehEysCnLv2Uf40N2BK5Lptg2qXkTS5EIkBA/vbSCfw6D8RXU+IL37Do15PG2JETavsx4H6kVMmnzWtw0dnABEVVEkLDCADnI6k5JPvmsLxjEtvo+oxJyBJCST1JyuTSUrlOLRQsoxDaRIOgUZrPuGm1G+SxtRlnOCewHcmi7visEcEALTPhQBycmun8P6dHodo1xeYa8lHzH+6P7o/rTJNnSrWHS7KO2gXCr1Pdj3Jq6H3d6xbq8uY1ElxbSRRHo5HH4+n41Na3YYjBoA11GfpTZ7aO5t5IJ1DxupUg9xSwPuFTjHSgDw3VGi03x3daFNYJ9qNgZo7/AD87xh+I8Y6d8569q9rgP+iRZ/uD+VedfEn+1H8a6HBYaabi1ltpjNPHEzMhXBClhwB6Dqea9B00P/Z1sJlKyeUoYHqDjmuvFLSm7WvFdb9WvltsTHqeVfFC3sLXxxoU4tJG1TU4ZLVZs/uykfz7SM/eJbg4qvC4khVlAAI6AYxXS/F64i0y08Pam9nFcPDq0ERdxzEj5DMpx14AqrL4avJby7Fg8LbW3iF22tg+nbGc1lVg+WNZp2atdu92uy6JJxVvn1N5S5oRjfa/Tz/HqYZbnpTigJDdGHQ9x+NWJtF1mInzNNuOOu1d38s1EmnasxwNNvM/9cW/wrC6M7MIwExgjjoKc8oxjOKnTQNak6WEw/3sD+dX7bwXq04Bm8mD2d8n9M0XQWZzkx3E/OcVEqRA5PJ967aPwTaQ/wDIR1VEPdVwv6k/0rTsvB2hSx7opZLkDgsswP8AKlzofIzg4Zo0AAAFXIb0KOMV258IaIW2AOH9PN5pJPBOlsuFa4Q+ocf1FLnQ+RnHjUfepY9TAPWty58BRNza38in0kQN/LFYd/4O1a1+aFUuU/6Ztz+RxTUkxOLRbi1MHvVuO4SUYNcdIlxaTGO4jkikHVXBBq3bX5QjNUSbGo6ZDcgnGG9RXPT295Yn5cvGPTrW7FqKsBk0r3EbjBwaAMOLUZ5FwquTViEeV++uHG7svpTrq3gbLKMN6jisqfeDt8xiPzoA0baCTVtSit484ZvmPovc16WEWKJI0GEUBQPQCs3wvpKadpsbyJ/pUq5kJ6j0Fakprkqy5mddKHKipOapP1q3OetU3NccjrgdV4RTbYSv/ek/kBW5WZ4cXbo8Hqdx/U1p16dFWgjzarvNhRRRWhmFFFFABRRRQAUUUUAcL8QdNct9oi48zGCOzj/61YmlXv2uEFvlmTh1969K1WzW+sZYGxkjKk9m7GvKtRtpra4NzbDbNHw6f3sdq83Ew5J36M9PDT54W6o6mzbOKvhNwrm9G1OK7j3RnDDhkPUGuigmDAYNFNpoVRNMDHjtTXjDAhgCD2NWDScGq5SFI5q70QI7NDGrxnkLnay/Q1FA93YA7IppYB99JB8wHsehrp2WoytZOkk7rQ0U+5y9z4Y03VYxc6e5tmYZ+QZXPuvb8KyZfB+swn9zJBMvbD4P6129rbfZ7p2iwIpBll9G9a0o66adWVtTnnTi3oeX3ng3XLi1fIiB7p5g3MPQdv1qtazHT5DBcRtE6cFWGCK9eqlqek2WqxbL2BXwMBujL9DWyqdzJ010OFgv425DCra3ietOvfALq5bTb/C9knHT8R/hWbJ4R1+M4QQSD1WX/HFaKSZm4tF6W8jx1FU5b6IE9KYng7X3PzmBB7yf4VetfAd6zA3d7Ci99gLH9cU+ZC5WcndTq2sRSKOMEVrvqAFd5pfhbTLAZMAuJD1eYBvyHQVof2Tp3/Pja/8Afpf8KnnRXIzy9tUx0zSwHUNSbZZ28snuo4H1Nepx2FnGcx2lup/2YwKsgAcDpS9oP2Zwek+C55WEuqy7B18tDk/ieldtZ2sNnAsNtGsca9AKnoqG2y0khK5XxbbPd2OqxQIZJGWPao6lgQf8K259Q/fNDbR+Y68MxOFB/rVO4drW0mlJ3ytlifU/4dquCe5E2tjA8PaOukhJblftGqOOEXnyx6D+prp7TT3eZbi9IZxykY6KfU+pq1p9oLWEbiGmbmR/U/4elWqUp32HGFtxrqrqVYBlIwQRwa5W9tTpt+ET/j3k+aP29VrrKztctWutOcRgmaP94gHcjt+IyPxpRdmOSuiGylyBV/fnpWDps4dFIPBGa14zmtjExfET6+vivwwdJBbRme4XVFCp02DyySfmGGz93r34roxwOtcx4s07WL3UvDs+jXjQQ2l8JL2PzmRZocEFSB97tgHiunHSuqu4ulSta9ne2/xN+93eunlZdCVuzjfi7JfW/ge5u9JTff28scsK7d2WB9O/WtCymme/0W4eJoZ7iH9/GwwVym4qR6ggU34ipI/grUkgJWYKpjYHBU7hzVPwBHqrWOlr4hJbVLe0P2hi4fLlsAkjjlQa5U48k1pdNP8AvO6a+5cvyb8zskm6VN+cl5aWf6nbUjEKCWIAHUmlri/ENz9vv3ibJtrdtqr2Zh1J/lWCVyG7HUPqdggJa9tgBycyrx+tchqt/LqsznzXWxziONSVDj+83c59KqtFG6FGRSpGCCOorI0i4ltryXTJkYxxkmCUnqnHBz1Izj8q1UEjJzbNeK1iRD5cSjHoKzNfkltLeOa1DjMqLLsbaGQtgg+vWt60GXKnuDWH4o3jSJkiXc7Mij/voVRJdW0tyg/cIPbaMio0aW4uLiG8mluEjKmNZHJCqR0x9c1et/nIBBG4dD1FM8sIxbHzNyaAIZLqbSbSa4sZGiMSl9g5RsDoVrSi13VZYo3aWBCyglVi4H5mud8RTsLZLVY3JuZFi3cYAJ5/TNbEK5YKOgFKyY02jSTVIL7Fvr1rA8ROFmUcKfcdR9QfyqHVPA9vJufTp2ibqI5DuX8D1H61g679pOnSxWYTzZR5YLHpn0/DJqeytY7eKFrdTDIqjDJ8rDily9h83cyNS0q90pwt1EyqejjlT+NVfNbHWvSdI1b7SRaagFMrcK2OJPYj1/nU0/h3Spm3PZRg/wCySv8AI1PPbRlcl9jyuWd8da6PwdoD3U6X96hFvGQ0an+M+v0FddBoGl27ho7OPcOhbLfzrRbgYFRKrdWRcaWt2Nc1WmNTNVaY1zSZ0xRUmPNVm61NKeaZbR+fdRRD+Nwv5mud6uxutEd3pkflafboeoQZ/KrNA4GBRXrpWVjyW7u4UUUUxBRRRQAUUUUAFFFFABXCeKYVj1eTbj94oYj3rstQvEsrcyycnoq/3jXnPiHUmg3XlzDPMGPzGFN5X6gc4rixk1y8p2YSL5ubocvrRexuEubQlJc4OO9btprM1vsW/iMTED5h92uJ1LxfZNfQMtpdyIkgY5TGcfmf0pl38WNBS5S11SHyJJOis4yB6kEVwQlzfCd8mluesW+pq6ghgR6irS3St0NedWV9YXOH0i/WMnkRyHitNNTubUgXkJ2/89E5U1rzyjozP2cXsdqs4NOEgY9a5+zv0nUGNwwNXo58cnpVKpcl07GqDUqNzWPb6pHJqzaftcTCAThjjaylivHuCP1FaqVtZxtczlG25aU5paYlPrRGTHrThTFp4qkQxaKKKYgooooAKKKKACiiigDmzI2nXUkdyu1Hcsj44YE56+vNN1W6jktGRCSWGOOtdI6LIjJIoZWGCCMgiqkGmWcMqyRQKGX7vJIH0HQVopmbgWodwiQSff2jd9afRRWZoFFFYOrawwka3sSNw4eXrtPoPf3ppXE3YoiMWuo3EC8KkmVHoD8wH61t2pyorBt0YuXZmZmOSzHJNbtl0FbowZz3xG0e31Sy0WS61O20wWGq296k1wQFZ0JwgyQMndgfyrrsYrlfila6NceCrl/El7NYabbywzPcwoWdGEi7cAAnliBwO9dZIMYrsqtvDU7t2TkttPsvR9d9V007krdmH4yTf4Z1AYz+6z+Rz/Sua+C2nS6XoN7bXF/FfyJct+8jcttB+YIxPO4buQa67xEnmaBqS4yTbyYHvtOK4T4SLp+mavrVjaX/ANoubsxXtxCU2+RI8edue+4DP4VxUm71oX+zF7X2k1v0tzfO9juX+7RfaT/FL/I9QJwCa86tCWgjZzlmG5j7nk16LXn7wG0nltW6wsVH07H8sVFM56hJNHswR908g1m6xA7W6zRHbPAfNQ/hyPxGRWvbyqU8qX7p6H0pb20ZYlYcoRtJFaGYmlOs3l85DLlSO+RVDxJHsthGqlm8yNjj/fBpNAVrZIonOfKIX6e3+e1aGrxhrlwwyrAUAQwH99GfcVJfACcgdBxTIBmVcetSago89hjOR+dAGXGqXN68pKskP7tR6N1Y/wAh+dacaFS59BgfjVOythCgjQZJOT9T1rUldLeIKBmSgCo1vja0mBjoT/So2xn5c496hvLza2CrzTEcRoMn/AfjWaF1aeco0kVtARnIXfIPbPTP4GgDSd423J5ihl54blT2PtXXeH746hpcczMGkUmNyD1IOM/j1rz5vD9pLcRTXW+5ZMkmY7iT29se2K1oYxbsHtSYHUYBj+X8Pce1TOPMioS5Wdy3FRMao6NqX26N45gBcxY3Y6MD0YVdauWStozqi09SNqqznirL9Kp3BrGRrFFOQ1oeGYfN1VCRxGpf+n9azXPNdN4Rg2280xH3yFB9h/8ArqaMeaoiq0uWmzoKKKK9Q8wKKKKACiiigAooooAKZNIkMTSSHCKMk0+uZ16++0zfZ4T+6Q8kfxGs6lRQjc0pw53YpX109/dF24QcKvoKyNblktrN3gjDuOgOf6Ak/gK2Y4wiZNZd+4LEdq82d3q9z0YdkebX9z4je5U/Yo5IiSu10CAgjqPnJB+tcxrXwdHiTVo9WuLyS0lBG+2mjzkA8DcuQfrx9BXrFzH5h296uw2spQAOwH1p4bE1MPeMXdPo9Sq1GNSzkcf4Y8CRWOtRXerzW11aIrAwIGBYkYGSQOldfDo9iZpnsXuIYIo2byBJuBPbrUo03ccszH8a1dOtYreyvT90mP8AxrqniquKqJ1Lfcc8qMKUG4s5qLTopG3RF45P7yDGa1oLMtbtDcHzo3UqwYdQeCDV+KEYBxirSRgdq5IxaZu59jgL6wk8I6xY6tHJPNoyBreaNsubZGxyD1K5AOO3416JaSR3EMc0DrJFIAyupyGB7ihrdJo2jlRXjcFWVhkMD1BFcc9tf+BpZJrGOS+8OMxeS2XmW0z1K+q+3/1yfWT+uRSk/fX/AJN/wfz9d5cvaadfzO6UVieKLy4gk0u0t7prMX1yYWuEVC64jdwqbwVDMVA+YEde5BGnpeoWmqWUd3p86T27jhlP6H0Psamu7W3vbaS3vIIri3kGHilQOrD0IPBrlcXF2ktTmknscKvi68tbCQRLJPJZrJJctqZjSU7ZfL2DyfkJznkcfdGMtkaN1q9/H4I1G9jnl+1x39xAjxorOFF68ahQw2khAAMjtzWjq3hTRr6KwS4to4rTTyXihiRUjHQnjHA47Y7g8GmXniDSbc/ZfKhZXcuI22qHYtuLAHqS3OcdeauMXLZEHMf2l4tOqvZxNqBlWIS2iSRWw8wF9oN0RwoyG/1ZB24ON3y103hhNQOr60t5rN9ew2VyLaOOaOBQQYIZNxKRqc5kYdcYxx3p+k+J9L1J/tEOwMw2GUYOAD90nqPoa6COONGd40RTKd7soA3nAGT6nAA+gFOUXF2krMOtiSiiipA4HxxfraX9+dSuJooorSOSwhGoy2CXD7n81RJHy0mAmE57YAyTVQ+KL6TVraza7W3adzB/Z0kf78RfYXmEpbqTvXbkDHBH3ga9Jqh/ZNidVGpGANegYEjMTt425AJwDjjIGcU7iOdvNVuLDwn4cdrxbJbkQxXN9Mu7yF8lm3HdwCWVVy3GX9cVhWXi7XLq/wBAUzafFBdQ2rsZj5f2oySMsnlg5JIUAhQcgkFuCK9D1KwttStjb3iM8RIOFdkOfqpBrMudVttMjSysIE8uBRGqL8qRgDAUD2xihag9DmLTXNcNlpE17NHOdRhsbopHC0XkF7mFGUENkjbIc5PUHsdtTaf4rljGn3Oo6raBZbjZqNs0YT+zQY5SEds5B8xUTLdeo4IrYTxHMGG+CMr6AkGt3T72K+h8yLII4ZT1BptNbiTTOE8P65fah4gtJpCxhurpYyBvVQghvCCBnv5aZzke2cEei0UVJRleIL02tqI4mxNNlVOeVHcj/Peucto+gHSrGuTmfWp1P3YAsa/iAx/mPypbVelbQVkYzd2XbeMBa0bbiqcfSrdv1qiTL+In9lHwNq58Q21xdaUkO+4htziRlVgeOR3APUVs6dPDd6XZXNsMQSwo8YJzhSoI5+lUPFk0Nv4V1ie5s0v4IrOWV7VyAs4VCdhJBwDjHQ0vhDUYtW8JaNf29ultFcWkUqwR/diBQfIOBwOnTtXY03hE7Oyk+umqXTvpv/kT9ou6inm6fdR4zuiZceuQa8r8MJpUfiGRLEXKeIrnTob2R2H7oxxMYlx75GDXrbKGUq3IIwa8x8N6jp9nr3hWzuNMV9T1G1u7aO/3YZEicyGPGORyD1rkwqcsU4K75qc9n/K4y17pWvbyOxf7pLylH8VI9L068S+s0nQYJ4Ze6sOoNcp41R5tVgjt5Ps8qw72kChtwJIAIPYYP51pyRXGm3TXFmodH/1kROA/uPQ+9Znii8tLiGC/jkEc1v8ALLFL8rFD1x64ODxnvWSjZmLldGFYpqKSv9smilUHA2Js49e/NbVtdtF8rfNGeoNUobiF1DpJG6HuGBFWg0H8Ubfg1aGZba2hnPm2xAbuKdqELNAkhB3KMGq8U0MbZSNs/Wta1mjuYiCDnHINAGDAcTJ9asampFwD6ip2sWF4uwEoTn6Vcu7Ez7T0xQBR0yIYaVhwBxVKdy8rMfWuigtdkBjXpiqn9nRBiZG4oAx40JywHA/nUkdrI/OMD1NaW+3Egji28fqaoXV1ICwY7FXrQAjW4H8YAFQuoU8MDVSTU1yQkc07eiRkj8zx+tUL2bVJ4HNpa/ZmXlTJIGY+20ZB/OgDe0hiuv22043RSBvccf1xXUsa4XRYJ7TVrC4ubl55mYxPkAKAyn7oHTkCu5Y1y1tzpo7EUhwKoTtVqduKoTGuWbOuCIWrvtLg+zafBF0KqM/U8muM0mD7TqUEeMruy30HJrva3wkd5HPi5bRCiiiu04wooooAKKKKACiioLy5S1t2lk6DoPU+lJu2rBK+iKWuX32aHyoj++kH/fI9awbaLuaGL3Vw0spyzHP0q4qhErgnJ1JX6HdGKhGxUvH2rgViT/MSTWreNkn0rJPzyYrCpudNNaDbWAySbj0rXRAqio4ECKMVMKUVYJO5NbQmeVUXjPU+lF3Gn2sxKcrEBkepPrTradrdmZF3kjGM4plvG7PJJLjzJG3HHb2rphZR03Oed3LXYkjTJq0iYrP1jV9P0O0+0ancJCh+6p5Zz6KOprnt3iDxWP3fmaDozfxH/j6mX2/uA/n9RXTRwspx55Plj3f6d/kVyuWuyNbWvFWm6TP9l3SXmoNwtpar5khPuB0/Gs8SeMdYGY0s9Btj0Mg8+fH0+7+BrX0vSdH8L2MjwRxW0YGZZ5Dlm92Y8n6VS1TxjaWdxZeTGtzZ3AVmuEkGERn2bsAHgMQDnHXjODXXSS2w8OZ93+i2+TuxrtBX9TN074dpaNNIuvavFLMd0hs5Ft1Y+u0A1fHgn/qZvE//AIH/AP2NZMJ8RTSW0X2m8+22013FJL9lIQjaxjbn5WB2jHXG4D62n/4Se+vo47jz7e1ntowyxxoVG6LEgYk5Vg5Pc9BgHmumbrt3lVX9advuLk531kie78Ds9vIkXiXxG8mMhJL/ACD9RtrzzWvA962qIwvZWTgM10xaVcehxz+ldhDoPiD+z40ijlhkSwt4JBJOgklZJCZEEikkKVPHPT05rt9Et/K0uKGSza2CltsMk3nFRuJ5Y5/LJx0qvrdXC+9CopdOhEqk6fvRlf7jyyHw/e6zqjXGyTTzyuLR8SyD1dhwPy/Guzg8CR+TGLjXfEEjBQMG+OF9hx0rsFUKMKAB6AYp1ccsdVdlF2SMVVmupyH/AAglp/0GNe/8Dj/hR/wgGld7rVSe5N4/NdfRUfXK/wDOx+2n3OQ/4V/pB4ebUnXurXj4NH/CvPD/APzxuv8AwKk/xrr6q/b7Xz/J89PNzjGe/pT+uYjpN/eL20/5jmv+Fd+HG4ktriRe6tdSYP8A49WDqfw60u3mdoNOaSAnK7ZZCQPQjdXptFCx2IX/AC8f3sHVqP7T+88kTwPpkjbU0uUn2eT/ABre0/4cabFbl0N1YXZ5WS1uGDJ+ZIrvaKbx+If2397EqtRfaf3nH+H9U1HTNcHh7xDMLiSRDJY3u3b56jqrD+8B/noT2Fcd8TIzBpNnrEQPnaVdx3HHUoWCsv0OR+VdfG6yIroQVYAgjuKVdKcY1krXun6r/NNFVLNKa6nE3B36hdsepmcfkcf0q9bJwDWfJxfXQ/6byf8AoZqe51Sz02KNr2cR78hFALM2OuFAJOO/HFQtjje5rRdqtw8GudHiXRxJAov4W87aVK5ZRu+7uIGFzkYzitSz1awuW2295BIftD2uFcH98gJaP/eAViR7UxGjftImn3LQIjzCJiiuMqzYOAR6VleBNSv9W8IaZfaxatZ6hNFumgMRi2HJH3TyBwMZ7GovHekv4g8GavpcLMs9xbsIirFSJB8ycjtuArzf9lyxki8JapqNwXM13eeXlySSsajHX3Zq9ejhKdTLauIclzRlHS2ut+t+ur2+yZuTU0j2uvNYtUu9JXw/HZ6fFdJNrEljNI0Rd7ZWycqR06ck16UOlec382vW2ian/wAIurPfRa580aorFoCy7h83HTJzwfevHw6Tx9FO2vMtXZarqzup64WqvOL/AD/zPQm5GGGRVO4sIZc7lB/Cr5AJpCopnKc1L4X06STebWHfn72wA1NHokEA+QAVtketV5mVQSaAKSWUKEbgMVYT7PGflHNZd5eYbCmqouWJFAHRiRACwqu14jyeXGeagDEWrFj0FZNrIRcbs96ANC71B4X2pThP9otHI+/jpWZenM7GnWExjmAP3TxQBWOQ3oRUhkWXlj83Qkd6sahb7WMico3p2rBvobxcy2nlySLyoJ2E+xPQj8BQBq+USMqQR9aYVI6gisiXWlt4s31tcW0nQbkLqT/vLkVLaa3p11GGju4gccozYYe2DQBq2i+ZqNmv/TTd+QJrqHPFYmhWjvN9slUom3bErDBOerEfy/GtiVsCuStJOWh10YtIrTtzVKU81PM2TVZzlq45M64o6Dwhb5lmuD/CNi/j1/pXT1n6DbfZtNiUjDP85/GtCvSox5YJHnVpc02wooorUyCiiigAoopGYIpZiAoGST2oASR1jRnchVAySa5i/um1C54yIl4Uf1pNS1F9Qm8qDItwf++vepLaHYorkqVOf3VsdUKfIrvcIogopZjxU+3ioJQcGotZFp3Zk3xwpqnbplwat6lv8qQxIHkCkqpOAT2Ge1YNj4l09VKajINOu0/1kFydpB9j0Ye4qFQqVbuCvbt/kdUE2tDoVFSoK5mbxroUZ2R3TXEvaOCJnJ+nGP1pqa3rmpOE0XQpIlP/AC31BvKVR67ByRW8cBX3lHlXnp+Y3CW70OplligiaWeRIokGWdyAFHqTXON4kvdYle18IWomAO19QnBWCP8A3e7H/OCKZa+E5NSmjufE9++osDuS2QFIE/4D3+px71015qFjodgNyhUTaiQQJzljhVAHAyeATge9dFOFKk7RXtJf+S/5v8F6mbcVtq/wM/QvCVtZ3Q1DU5pNT1Y8m5uOQh/2F6KKm1zxElpBOumql7dxxSSbFYFR5bKHBx/Eu8Hb1OO1YWqXmr63qt7oqxLHCh6xAgqRhlEjMCCjA4+7145AJrc0bwwLS70/ULmZW1KCN45pI0CiYN90HAA+UYGcDOPwrpnFJqpiZXfRfLTbZdNCZae9UfyMaPSNa1mKaS4vByfMhkPEYkXDwTQjkqCDhlJ9a6fRNCtrG1tmmghlvk3SNOyqzK7ks+1sDAyT0A47VsUtYVMTOouVaLyMpVW1YMUYpaK5zI4/xD4ivLQ6vPDdWdjp+klVuJbiymuixMayFsRsCiBWGWIP8XTHMeveMprSx1OW0sWCRRXi21y7qVea3RywKZzt3Iwz3wegwTuax4b0rWJJH1C2aQyx+TMFleNZo+fkkCkB15PDZHJ9azJPBVlca9d6hdyPLb3CSp9kBZY8yIEckbsZIzyAuc85IBD0Fqa2tapJYy2lvaWjXl5cltkQcIAqjLMWPTGQO/JHbJHPw+P7Wa702OGwupob2GOQNCDI0TvD5yo4A2qSuMAtkkjAxzW14q0Ia9aQRLcNaywy+YkyA7lyrKQCGBGQ3POD0IIqC08G6Ja/ZTHbSFreNEQmd8EpGIlcqDtL7AF3YzgAUaBqYo+IkH2eKV7NIwzsJGkukVIAAp2ysf8AVyEPwjYztbnAqeLx9byXF+sem3zw228JIq4EpWZYSMnCglmBXnkAk4xitVvCOjNHseG5kBzv33kzGVSACkhL5dMADY2V9uTVgeHNLE88v2d/37Fnj86Ty9xcOWCbtqksAxIAJPXNGgaleLWZrmx1gvC1vNZzrbmM4yhaKJ+oJB/1nUY9McZPIHUrUXn2cy/vs4xg9fTNd5f6dH9j1D7NHtlumE0mM/O4VVB/75RR+FeYyafF/wAJEhy3zL52P9oGubE1a1JR9ik7ySd+zOrCUaNVzVZtWi2rd0eq6RO1xpsEj8sVwT64OP6VcqnpELW+mwRuMMBkj0JOf61crpe5yrYKKKKQynq9imp6Xd2Mv3LiJoifTIxmsD4dak1zoS6fdnbqWmH7LcRnqNvCt9CAOfY11dc7rnhOw1W+F8s13YX4Xabmyl8p2HoT3rppTg4OlU0T1T7P/g/5GkJKzjIyr5fL1W9T/pqW/MBv61ma9YT3ptHtLYyTRbwJY757WSMHHAKqQwOBkHjgHBPSHWvDF1Z6jhdf1RzIgcPI4Ykjg549MVFBoN+2AfEOoAd9oUH862VKk1/EX3P/ACMnThf4vwYkWha+k8EiSiO+PlGe+jv22ykBQxkg8vYzbRtBABYAcrxifTPC19Z+IrC+ikgW2+33d5eR7jlmYziJ14+9tmCt/ur/AHasx+GLlv8AmY9Z/wC/w/wqZfCDtzJ4i8QFv9i72j8sU/ZUv+fn4MXJD+b8Gbmua3b6NbGW4I6ZOTgAeprC8Da1o8cQ07TgqRzTzTIwPBd5Gdl6DHLcD0xWR4k8D+ZASNR1W6yuC1xN5pUjpkYGRVXwt4QnjYWqu/kM4lludu0jHQL6H396nEyhSw0vYzcp3WltH/lu9enY3oUcNL45/wBfr6dfxPW1+6K4HVrDU9R0nxlpug3UlpqckytBKkpjKMcHO4cjIB6V0M1xP4e0yJrh7jUYvNxJK2N0SHvx97B/nWVc2SaneeMtOMixx39kib2yAgaJlJP55rz6WIUcXh5PRxkrpq9tG/mtDSFFxoVraxa0fe0o/dv1OssVmSyt1uSDOsaiQg5G7HPP1qcnAzWH4Ft4bTwdo1pbahb6jDbWqQJd27AxyhBtyCCR2x17VszOEQmu+vFQqSinezfl+HQ81bEM8gVSSa57UL5mk8uMF3PIUenqT0A9zVi/uJZ50trYbppDhR2A7k+wrN1mGO3uF02IllCCW5kPWViflU+wxnHuKxb6FJdTPguXnlOFDRgffXOM+gJ6/Xp9a0bOLc29uEXk+9QxA5CqoJ+lWbiTagjBzjrTEXd+/TJZD1LYrJiOJFPvWgzgaSFHdqxoJxLK4XooB+nUfzBoAv3qneD61XGQw9a0LhBJbowODiseVntZd7EmE9c/wH1+n8qANqCYMsiOMgVE0ETZZGyf7tV7ORTL94EEkHHrTLhvILliQF5zQA2WL94GdBuXODjpVTUIIpLaUtGpcKdrY5B7YNXkuS6Aq4dCMg5yDTrGD7Xeqh+4hDyf0H4n+tKTsrscVd2R0kJf7PH5v+s2jd9cc1BO3BqeRsCqM79a82TPRiiB25JqfSbU3l/HHj5Adz/QdaqtXV+FrTybMzuPnmPH+6KVKHtJ2HVnyQbNsDAwOlFFFeoeYFFFFABRRRQAVzPiC/ae5+xQkiNT+8I/iPpXTVw8OXv5mbqXJP51hXk0ku50YeKbbfQv2cARRgVeC1HCBirAArKKLkxoFRTJkcVPimyDI4qmhJmDqdu0sMsccrQu6kCRMZU+ozWLa+GtLt2MktuLy4b7093++c/i3T8MV1FzC7E4FZ1wjxjJFZe1qU01B2TOqnJ2smRwQxW42wRRxr6IoH8q0rdQmm3cx6lSg/Ln+lZSSZNWkd2iMe8hCckDvWVOfvc0gqxbjZHO+LYdVlu9PTT7meK3n/cZiZk8mTqsjbRllwCMHjpnFW4/B0U2u3d5dvG1tMGDRqCGlVgNyuc9mG4Ec5xyAAK6CLtVuI1308bUjBQhpZNfeJ1GlZE8YCqAOg4GakFVL7abKbfcm1XaczAgFPfJ4rmrHW9YMxjsbYa1bAcXAX7Nk/U/Kfwriq4mNKSjJPXtr+C1/AKWFlWi5Ra076fi9PvZ2NLXOf2p4hbhfDqIfVr1CP0FL/aHiP8A6AcH/gWv+FH1uHaX/gMv8g+pVP5o/wDgUf8AM6KsTxNr0WiW6nZ51zJ9yMHH4k+lVmv/ABIFZzpVnGqjJ33Ofx4ri9Sm1PVbtrme3hJPCjzOFHoK3w9enOV5RlZf3Zf5GNfDTjG0Zxv/AIo/5i3HjXXXYlGt4x6LFn+eaZH4415CCzW0mOzRdfyIqo2n3zf8srf/AL6NN/sm/b/lnbj3ya9VYvD2t7GX/gJ5/wBUr/8AP6P/AIEjai+ImoKP32nW7n/Ycr/jUyfEecff0lT9J8f+y1z39j3+fu235tUiaFft2tx+dQ6+Hf8Ay4l93/BKWHrL/l9H7/8AgG5J8Rbon91pkaj/AGpSf6Crem+ObiUGa+trK2tAwTzZbnygWPRQW6n+XfFc2NA1AsAPs5J4HBri/Ft1HLqTabd7p0053hXyjtj3Z+c47nPGfRRTVSlP3YUJfh+si4Yepe8q8bfP/wCRPo+1nS5hWSPODwQeoI6g+9c7NbQjx9b4iTmyZzx/Fv6/Wuc+H8+taloUJsL+CCBP3IEsW9xsCj8flK1vtoOuNqKXx1mD7SsZiDfZRjaTnGM14WLlU5lFU5aNPp0+Z62Fp04puVWOqa+11/7dOsrB8SJqLXVi2lvKGjEkjKM7JCAMI/bnkDPeov7M8RMfm8QRoP8AYskOfzNL/ZOv/wDQy/8AkhH/AI0qtSdWPL7OS+cf/kgo06dKan7WL9VL/wCRMpE1pobCMG+Av4kSZmZ91syvksf7uVJHbpXbVzv9ja0eX8Rylv8AZtUUflR/Ymr/APQxz/8AgOlZ0PaUb+5J7buP/wAl3uzTEeyr2/eRW+yl/wDI9rI6Oiuc/sDUP+hhvv8AvlaP+Efvm4fxBqBXvt2qfzro9vV/59P71/mc3sKP/P1fdL/Is+KLbzLNblR81uck/wCwev8AQ/hWBA+MVqt4amZSra7qpUjBBkGCPyrmtT8PTadc7JL++Nuf9VIsmB9Dx1/nWkK9bb2f4oieHob+1/BnQ28vTmr6OCK4pdNYcrqWog/9ds/0qzCNYtMNbXaXqDrFMu1j9GH9ap4irHWdN28mn+G/3XIWGpT0hVV/NNfjt99jsk6VKnWsfQ9Vj1JHXY8NzEcSwP8AeQ/1HvWxHXTTqRqxU4O6ZzVaU6UnCas0Tr0rldLhnt/HepR3UvnLPbCaMkdE3ABfw5FdUvSufuv3fjqxf/nrZvH+Tbq5cZHWnPtJfjp+p1YKTtUh3i/w1/Qp/C630ew8IQ6d4dvpr6xsZ5oPMmQq4fzCzKQVHQse1bOq3QijYk4AGc1ieBLjRUm8S2Oh21zbG11OQ3aztnfM4BZ05PynjHT6VdkT7fqkNuw3REl5B/sj/E4FezmF/rE5O+rvra+ut3bTW558FdJGh4esmhha7uFxcz84PVE7L/U//WrF8RQGHW5JCPlnjVgfUjgj+X512VUNX05NStvLZjHIh3RyAZ2n+o9q81S1uzocdLI48SBBnO0dzTQwkYhDuwcZHrVPxHZ6lAkdk0XlNcNsFwjBlCjkkDrnHY+tT2sK20CRIzFVGASea2vcx2NPG+zYL2PHvXMGRbLXQgVgLwAAHoGXJJH1B6V0cL4tHwcEEGsnW7cXdm3lhkmQiSNlGSrjoR/X2zQBsxSAgRN0K/rVG5iDq8b7sHg4JH8qzfDuoyajYmaUBJUkMbqP4WGM1rStvwe/egDG0xG068eyeQtFJmS3LHn/AGl/Dg/Q+1bUrCRQT16GszU7Wa7msUswpu1nDx5OOADuGfTGa00sdRZtpsijf3mkXb+hz+lJyS3Got7FHRtNne+vILaWOO1TbJhlJKls5Cj04z+NdZZ2sVlB5cWTk5Zm6sfU03TbIWMDAtvlc7nfGMn0+gqV2rjq1OZ26HZSp8qu9yOVqpyNk1NM1VmNcsmdKRNY27Xd5FAufmOCR2Hc13saLHGqIMKoAA9BWD4VsdkRu5B8z/Kg9B3NdBXdhqfLG76nDiZ80rLoFFFFdJzhRRRQAUUUUAFcZqsZsNWkJB8uQ71P1rs6p6np8WoQ7Jcqy8qw6g1lWg5x03NaNRQlrsYEF2uAc1Mt9F3YVQvdGvrXJjTzox/FH1/LrXGaxpV3LdvJFcyxOeqElSK4ZTnDRo7o04z1TPSUuY36OKlDA9DXksd3rGmt88nnoOzdfzrqvD3iBr2FmaN0CEKxPQE9OaqNe+5MqFtUde4yKz75NyEYqWO6DKDUdxIGBq5NNERTTOcYmK52noelaUByKydabbJGVPO7FadmSUXPpXHH4rHZP4Uy/HVqKq0Yq1GOK6oHLIkkhjniaKeNJI26o4BB+oNTqABgDAHQCo0qUVsktzFt7C0UUVRJjeK7n7PpDoDh5iIxz26n9BXl2tfbJrpEsLxoFiAyFbG49ef5V2vxIujCLCMfxF2P4Y/xrwzxFrF9Y65c5VvLY7kI7g1vW5qeGjJdWd2SUoV8bKMrXUdLq/Y7uG58Q26jJhuAP76c/piraeI9RhX/AEjSlY+qSEfzBrznSfF9+b62jtyGnaVVRJMbWYkYBzxjPrxXsOpazGut+IbbTv7Ma+iELWEZaLa8Jz5hXPylgfXnFc0MTPpJ/mexistowklOnF37Nx6pdPX8GZC+LiPv6XMD/vg/0qVPGkY66Xc/gQa1tE1TTJLXydUudGhvb+WWOMBgwTaCqlCoKgb/AHAwOM1wB8aCO4eN4rcMjFSMDqKc8XONrz/Azw+UYes5KNDb+8/w+47PS/FyXdxKBYTwtDDLPubBHyIW/pivM9N0W4ay+3XcsCM4Mghkk/fyIHCGQL/d3sBnPU12Gl+LIXt9Sl8qDMVnI5wPoD/OsC+lOoeM7y+C/wCjxeHrNI8fdBkaKTA/FnP4GujCY6qqsYqV02unmc+OyihChUkqfK115m7WV/x0PQvhK2yKeFRhA7HH1C//ABIr0ivPPhTCfs80xHBd1B9wE/xr0Otsw/js+cwn8JXCiiiuI6QooooAKKKKACmSIkiFJFV0PBVhkGn0UAZX9gab5m8W5HfaJG2/lnFZOoRQW+syR2yqi+WpZFGAG5/piurriI5TcXtxO3V5n/IHaP0Aq4XbM52SGajiz1vSr9PlEr/ZZj/eDD5c/QiuqaRYomkc4VQST7Vy/iiNn0Cd0/1kJWVT6FSP6ZrX1CUXGhSSx/dkjDj6HBrCj7lepDvaX36P8vxOmt7+Hpz6q8fu1X5/gMsfEEc96sLxGNHOFYtnntkUzXP3finw9L2JmjPvlBiuWBIII4I710XiK4DSeG7jPzPdx/kw5p47Sjfs4v7pIMAr1uXupL74tFLR9WtG8Z+LtIttMhs5bT7NPJcIfmu2ljJLMMDG3AXqa2/DSiW5vbg/wsIV/LJ/mPyrIuNU1Q+OtQ0ySyA0dbCO4julhYbpS20oX6E4GccHFdD4ZUDTC46ySux/76I/pXqZgrSi7WvGPW/2Vr897dNtjjpbmtRRRXnG5h+KrGS6tIZ4FLyWzl9g6spGCB79/wAK5hGV1DKQQe9eh1lXuh2d1MZcPDK33miON3uR0z71cZW0ZEo31RyithWHrTa3JfDcwJMN2jDsrx4/UH+lRR+HLt2xLcwxL/sKXJ/PGP1q+dEcjOP01li1/VoQQEfy5QM/xFcH+QragWS5fZaxtM/T5eg+p6CusttF062hWMWsMhHJeRAzMfUk1bCrGgWNVVR0CjAFQ6tti1SvuZGk6ULJjPcMJLphjI6IPQf496vuae5qFzXLOTbuzpjFJWQxzVeRqkc1WlbismzZIgmbmpNOtGvryOFeAeWPoO9V2yzV1/hyy+zWnmuMSS8/QdqVKHtJ26Cqz9nG5qxIscaogwqgAD0FOoor1TzAooooAKKKKACiiigAooooAKjmgimGJokkA7MoNSUUWuF7HP6x4ZtLyNmtlEM3YD7p9sdvwrmdE00Wc2o2jqUaUDch7Ef/AFjXo1YPiGEQ3VpfIAPn8qT3B6f5965K9CPxxOqlWk/ckcnaTSW8SRu7OUG0sepqWa/Cxkk4FWtU0wfandGZN3JA6fWqiaUpYF2LfWuC0lod8ZQkrmcN19cKdp2Ke9b9uu0AUi2yxJhFAp8XWqjG24pz5loW4+1WU6Cq0dWUroic0iVTzSG7t1u47Vp4hdOpdYS43so6kDrjmlWuO8fadca1Pb2Nn4fS7uFXzI9SmuPIS1Of4XT94W4zgD0rRyaV0c1WThG6VzuKK8507wl43itEim8esgHBUaekxx/10c7ifc1ZPhDxQRg+Pb7B44sYhRzy/lf4f5mKrTf/AC7f4f5k3xRtmews7pVJWF2ViOwbHX8RXmssUU64mjjkA6b1Br0C68A6td27wXPjXWJIXGGRo0wa888RfD/WNFncjUtUuLTqs8bZGP8AaGODXq4LEtw9k4X+aODEqqp+1jFr5/5FWTQ9MlJL2ijP90kVAPC2kc4WdCf7rj/CqI0j+9q2r59rn/61PGh25+9qGpk9ybg8/pXTPC8+9BfeiqWcY+l8FSX3lz/hFNN7TXAHuQf6U1vCenj7s8w+oBqt/YFieWuL5j6mc5NH/CO6YeXFw59WnbP86x+of9OV/wCBP/I6P9Ycz/5+fl/kbmg+F7Qf2lFFPI7z6fcxqrL1Plkjv6gVQsLyddGtLG4njaKBQqHy1VioztDMBltuSBknGaqReHtEWVHnszOoYEq8zjcPTINdHo3w88P3+qhrFEuLRzvW3LSeYoz9x+wA7tnkDjkgVUMM8PL2ns4q395//IkVs2x+LpujOV035f5HongJ7XTdGjN1e2sfmDcFaVRy3zHv/d2D8K6OXXtIiAMuq2CA8Za4Qf1rlh8PvAuneRFdabYLNIAq+fKQZD7At1+laMXw98JRsSugWBOMfNHu/nXk1qlSrNzaWv8AXY2pxrQiopL73/kXb3xd4ftLZpn1nTSB0Auo8k/nXBR/Fu31LV5dO0pWa5G8QkqBHMwGQA+T1x1xXY3PgDwvJCyxaFpscn8LC3U4P5Vxa/Cy20/VZr+whniuGDCJonBSFmBG5FI9zweKz/eaWsRV+s3XLa3U0tN+KNlDL5HiDOnXK48yG4Xaw91I+Vh7itf/AIWj4M/6DsP/AH6k/wDiaz9B8AW1qD5tsrM53S3FyRLNKfUk5/oK7tLC0RFRbaEKowPkFNqfdF01iLatfd/wUcfJ8WPBMbbW1tSf9m2mYfmEpv8AwtvwR/0G/wDyUn/+IruYoo4lKxIqKTnCjFJFLHKpaJ1dQxUlTkZBII+oIIPuKVqndfd/wS+Wv/Mvuf8A8kc3pfj/AMK6pKsdnrlmZG4VZGMRJ9AHAzXTjkcVkax4Z0TWYGi1PSrO4UjGWiAYfRhyD9DXJ+EEufCnjSXwm9zLc6RcWpvNOMx3PDhsNFnuO49PxNHNKL94XPUg0qlrPqv8v+CdLc6rqsXie10yPTrF7eeN51nN66uI42jVyU8ojd+9GBuwcHJFecaR43t7m2W4azlSR45rkwBwzL88exB0B3idCDwB3749bksYpNUt79t/nwQyQJg8bZGjZs++Y1/WvOLrwTpVprTqY5iqaeunqDIRugwmCcY+YNGSGGMZPtjeBrPY3rIajfWV3Bqlna2wePYhguTMGyCDnKJgjj161maJ4k0+Pw0tnfzmK5SNogpjY5HIHQfQfhWzoNhJZiQy6heXrPgA3BT5AM8AKqjvyTknjJo8H4jGq2ZHEN2+0f7Lcj+tcmJjUWIpyptJtNaq/Z912fU7cLKm8NUjVi2k4vR27rs+66HCz6s8cQlVFZZHITtgDHWtK4lvtR0zT9TljWGxsZEEY3ZMjFxk/QYAomsIVmmV4w2W+ZT0yOM49a1Z1EngXVIFAAjKsAOMAFT/AENcOIwmJlSqSrVLxSuku61+6+tvl0O/DYzCxq040KdpN2bfZ6ffbS/z66WtcGvDxzA0e7/hG/7PYSDKYFxv4P8AfztH0rpfDoxo9v77j/48a5PxJY6jd+KfD2qW96sWnRW0y3Fs0zKZmdRtITocdyeldZ4d50a1/wB0/wAzX0mLlGUKTjb4eit1e/d9b9rHg001JpmlRXkN3BPosOt32l2X7+CyvZWvp9JMF3bny2ZW+0H5J8sAMBT6k8YOpcNr7W+py6Z/ackS294bCW6t8XCv5Ee3AZdwHm79oYc4PBXbXFY0uelU0MCSAQSDg+1eea5HrlobiwtrjVXtmu1MV9sed4x5IONse0spfPUhVPUgYFbXw9TUfsN/cazDLFe3MtvNJ5ibCzfYrZXOP99XH1BHaiwXOrpppTTGNSykIxqFzT2NQsazbLSI3NQSNUrnrVWQ1jJm0UMkaq0hz0p7mkjjLsAASScAVDLLei2P2u7G4fu0+Zv8K7MDAwOBVPS7QWdqqfxnlz71cr0KFPkjruefWqc8vIKKKK2MgooooAKKKKACiiigAooooAKKKKACqGuxiXSLoEZ2oXH1HP8ASr9VdUYJpt2zdBE38jUzV4sqGkkYl8u6NGI5K1Vj6VblIl0pXB/gBH5VUXljjvXny3OyD3Q5+Vqugw1WGHFR45qWaomj7VZSq0dWU6VrEzkSCpFqMU9a0RmyQUtIKWrICsefX7aPUnsore9uWidY55LeAukLMAQGI74Kk4zgEE4BrYrATStTs9Uu5dMvbRLO8nFxLHPbtI6NtVWCMHAwwUHkcEk8jCgAhlg8K+IJZEEml3c6P5bmCZS6uckKSpzn5W4Poaw77wn4UN1DbLqaWt1OzLDD9qQtIykhgqnkkEEHHQg0WXgS/iivJLjV0n1B4YVhu2SR2E0MhkSV98jZy2Mou0Yyo4qyvgQQalp89veb4YI7VJY5mm/eNBIZBJhJFVmLMT86sA3PPIO8MRUhpGTMpUYT3ic9c+GfDEMZll8WWMUWcbpJogM4Bxnd6Mp+hHrV1PBvh2O8ktZ9fQ3MMfnSwiaNXRMZ3kHJC4IOTxXSaf4W+yWmjQefG39n6VLpxIjxvZxDl+vH+qPH+1WV/wAIFO+mf2ZNqMX2ALKylbc+b5kls0DZYtgqA7MBjP3RnjnX69X/AJiPqtL+Umm8N+EdFQy6pc28aoQGe8uggBIOAeQOcH8jXW6fbWdtbINPihjgYBl8oABh2OR1+tclfeFNVv5p7u6v7EXsjRlJIIp4fK2K65VkmDZO85ycEcEd66+xhkt7K3gmma4ljjVHmYAGQgYLEDgE9eKwqVp1Pik2awpxh8KscV400u9m1ie40rT7m4u5rZIgJoLaezlKsxVX3sJExuOcYGDkBjxVPxPdeIbXQ9VUQ6lEbSPVJ2vFlQIyFJmgCkPuyAUAyBgr9K9JorO5VjmPDtvqUdhrHlre2wlkJsY9Rn8+SP8AdqMklmO3fuIBJ/AYFcrqGna9Lplmmnw6/aqAwvfPu3nlaXaArIVukIUHfwG25ZTtIGV6zWL/AFRtX1G10jyzNZactzHC4GLiWVpFjBJIwB5LcZGSw5ABrFtte1M3UWlvdzxX9zcxRH7dZKj2yNFM+4bGKSbvIZRg8Hru4BAJTZa9a2V5qcZ1C71S3ukeK1e5CrcQBUDps3eWCcyEHs2OcVc8Qi80vwLEb69d5oTA1/OlwIGdTIvm7HLLszlgPmBxwCDim3V1rEV9Nph1P5rW2F008NkHmmDOyqipkqdu35iBzvTGOc2NB1qS9vtIZbtbyy1bShfwuIfKwU8rLBTkgOJ1O0kldp5OeADz3UNZnTwxbzNdamBdRagNKVNUCzGYXDiEsfNBmGwx7cGQexLLn1LwtazWemTx3MZjka+vJQCQfle5ldT+KsD+NbFFFwSK11MVkigjdUkkyQW9BjOPfkVw3ie2e3+Kvgt3ncG5hvYi+cYCxhvpiup8SQMYYbpOTA3zf7rYB/UCuA8cT48T+DJifuXcseD/ALUeKU0uS/mvzRy4pvl+a/NHpdhciaa4h8wS+SR84HXOf8KyvFMXlz2l0OhJgb8eVP6EfjVnw1CVtpbgn/XOcD0C5H881D4quJZFh0mytkuL69SSRBLKYkjWPblywVjwzIAApyT2GTVXtLQ6bXjqMsGytUtLb7P4w1OLoLiCOcD/AHflrH0zWbqLVbLTr+waG5lSUyukqvHGyEAqDwxyCCDtAxVrWLuLS/EunX9wSsEkLwuwGcY5HT3NYY2SpqFV7Rkvx0/U6MDF1JTpR3lF/h736FfVk8vUrlf9sn8+f60+1df7D1uJjgG1ZvxAP+IrP1vWLa91WSbT5BLAsXmOSpUkgYwM49Kz9KnutcnbT4AkAmXEj5/gBBI+vFc+IzGhKDpQfNKV0ra307nThssrxmqtRcsY2bvpZX7b3/4Bp6zY2d7feAtVuNUitbqzhmSG2dQTdGSFVYKcjBGM9DXdeGWzo0I/us6/k7CvN74aRNpPgu41a4uIriG8MdmsQyskx3KFfg8YHtXoXhV82M8f/PO4cfnhv616zm6uBw0238HVabt6Prvf1djhrw9niqse0n+ZkaL4l1DUks7W90eFprz7ScJODH5UUqRsWBGf+Wg45zjsDwmleMpb6DT5o7FXtpfssVxN5uxkmnjSQBY8HKgSJklh1wM4NXrWfwppl5ezQXul29xatJ9pP2pR5BkdS4YFvk3Mq8cc+5rIvNL8Kxa5o99JrFjaRwwwta2omhRZVQMI2BPzMAM4IP8ADjOMg85I7SfHkuqQxSW2iXaC6eIWbzrJDHKsgcqWZ4xggJkhN4wwwT0qWLxncOLPz9OW2+1uixHzvNPF1FbyhhhcYaYbTk5HJAPy1atf+EOs/s11b3ekxJcSbrZxdLsdgSv7v5scFiML3PrTxP4ZaKze5Nna7bqa2tluZFjLSpcjcEBPOZYlYY9F+lAFQeM5AJHuNPjggeGeW1drgsZDFKkRVlVCVLNIu3bvJ9M4BNA8UT6zq9pAbZrVTDd+fE6uCJIntwpG9VbGJT1UHnpWq+naFexR2/l2cymOZI0DgkqZFMmMHtIqEkdGA6GpbDRdN011extI4XUOAy5z85Uvz3JKISe+KltFJMuuahY09zzULGsWzZIZI3FVZDU0hqu9Ys1Qzqa3fDtmGY3Mg4XhPr61kWkDXFwkSdWPX0rtIY1hiSNBhVGBW+Hp8z5n0MMRPlXKh9FFFdxxBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWX4mk8vRp+cbsL+ZFalZXieye/0K6ghBM23cgHcjnH49PxqJq8WkXStzq/c5a1uXEYi3Ap2Ga0IRnk968+huZF6scjjrWzpWum3YJMd6e/UV5sdNz150GtYnXsvFQEc1Ja3cF3EGhcMD2p7pzWrRyrR2ZGvWrCGoNpqVDihCZOKctMU08VojNkgp1MWnCrRLFooopiMzxK9zHoN69jM8F0Iz5ciQNMyn2RQxP4A/Q9K4eyufEdzasVXVLV3NtEs7Qh5AjXgWRgXhQ4ERP30BA59GPpdFAHnNzq3iDS7PWIHGq3MotrpNOlFgZmaZXfyyxSPHQx4LAAgdzmtbw3d6rJ4t1OC8a9nsh5pSV4WiiTEgCIFeFcnaSAySOGCknGVrsKKdxBRRRSGFFFFAGZfaLaXt8bm4XeslubaeBlVoriMnIWRSDnBLY6febrmo4fDeiw2E1lFpVmLWYhpI/KBDkfdJ9SMDB7Y4rXooAxm8MaG1rFbNpFiYImZ0TyV+Ut94/U4GfXvU9no9raX4uYAVEdutrBAoVYreMdVjUAYBwuev3VxgCtKigAooooAy/Ec3laW6AZMzCIe2ev6Zrzr4iQ+X/widxn/AJjVvHg+jBuf0r0PxLC0mm70yTC6ykeoHB/Qk1578T5x/wAI1p0gI/calbS+3DY5/Oif8NnJi/gZ2/h65aK6ksXyUYGSM+hzyP1z+dX9Y0mPUWt5RcXFpd25Yw3NuQHTcMMMMCrA8ZDAjIB6gEZejo0mtbwDsiQlj7ngD+f5V0hNVPRnTDVHB694d+x6zpWqLqF8/lBoJN5RvMZudzkrnnGOMYwoGKfr77F0u6H/ACxvE3f7p4Nddf26XlrLbyZ2yLjI7Hsfz5rida3y+G7tHGJohk+zIwz/ACNc+Kblhp23Sv8Adr+h04O0cTC+zdvv0/Ut+MLVJprSZshlyAwPP0+nNZuiJFa6jA0SKmXAOBjrx/WtzW2Fzo9vcL32v+BH/wCqufjbZIrjqpBrpjTpt+0SV31OWVSoo+zbdl0/rzMvWbjSbTQNN/tqzkuxb66kdsI3KmKfcdjnBGQMng5+leh+GMLNfp6skn5jH/stee+K9Tt9E0bWbq60621GKHVY5BFOAQpkYAOuQfmGciu80JimtOuflkgPHurD/wCKNaUIv+zaLs7JyW+mjWy6efc3xn+9zfez+9XKsfhrU4be1ghv7Ex6fcG4s99qxJJ3giX5/m4kbkY+YBu2KZb+DXiWXfeRu0r2cjkRYXdDeSXLYGThSZCqjJ2gDrXZUhrC5nY4DU/CGo3Oo3kFvPbJYX9vdxXEskW5lWeRWKoAw+bGeSCM8+xfqPgWS5kV0vVIZroSxyGZY3jmuGmwRHKmcbypDZDe1d2aaaV2FjmdC8NyaX4i1PVTcRSNqOTNEsW0RkN8nlnsCp+fP3m+bjJFdA9SGo3qJMuJA9QtUz1A9ZSNURP1qBzUjmoGPNZGp0fhu2CwtcMPmY7V9h3/AM+1bVVtMQR6fbgf3Afz5qzXp048sUjzakuaTYUUUVZAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUhIUEk4A6k0tU9YhkuNKvIYf9Y8TKo9SRSY0rux5J4mh+2a1dXOjptt3boehbuR6Ann/ADisc2uoDloh+BrorW7WBfLZdpXgginy3Cy8Itea7N3PoYycUo2MC01C8snB8uVcegzXX6R4piuCkVwjiQ8ZCmqMGnT3LZxsX1NdHpOl29oAwUNL/eNOF76GNedNrVamgMMNy9DSYwan28UhWtLHBcRakFMUVKoqkJjlpwpBS1aIFooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigBkrKkbs/3FBJ+leQfE5WPw6vplXHlPFIF/wC2q8frXr00Ylhkjbo6lT+NeW+PFLfDrXLeXIkjiw3HdWB/pRLWnL0ObFq9KXozrtNuDbapEN37q4Gw+meSp/p+NdC7VxljN9oh0eUAEv5LcfQE11jNk0VX1Oij7yuY9n4glvpC9npF9PYneI7pXiCyFc8hWcNgkbQSOSQeF+aueF62o3uuWktpNaXAAV4ZGRsM0YPBUkHgqex5+hO1baBfWkUlvp+tT21ntl8iPyI3MRcNj5iOVUtkDrwASRkGmmiS6Hp1t5lyt0VmIaURbGbfyzOdxLMWCkk1MUpXi+pcm42kt1qVbDVLSTwyLaa4jjuIIgrRudrAr7Hr07Vz76vFF5YljdWcbiBzgHp+lds2n2V6M3VrDKxGNzIM/n1rjpNHjWYpckyNExUHocDsfWuOpTx0IxhRa00v/n/wPPyO+nUy+pOVSspau9v8tvx8vMdrGo6xaeF/EOt+HbGS5u3NsLWHyWkMhBVJCEHJGCTx6e1djbEx6zZHsXZT+Kn+uKy/EiaxJ8PbhPDGRrHlgW20ovO8Z+98v3c9atXTvawW9xNnzIDHI/4Ebv617NOiqWChG6cuad++vK9V0je/L8zzK9b21ZzSsrJL0SsvnZana0hpaQ1xlDTSGnGkNJjGGo3qQmoJDUstELmoJDUzmq8lYyZrFEEhqAnmpZDUPesjY7y14tYf9wfyqWobE7rK3PrGp/Spq9ZbHkvcKKKKYgooooAKKKKACiiigAooooAKKKKACiiigAooooA5LxdpMKst6kS/OcSY9exrEtoYkIwgr0G/txd2c0DY+dSBnsex/OuGt0O0ZGCODXn4inyzuup6OHquUOV9C7CM4q9CMVXto8gVfjTFEIinIeo4oK08CitrGNxmKcBS4oosFxRS0lLVEhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFec+Pgt1onikpnb9llHHcrHz+or0QmuD1uEi0161OdzxzYwM8OpI+vWmtU0ZV1eDRB4RuNvh7w7cttINrBux23RgH8s12g5NedeDJftPgDRAmNxt0iGPUHb/AEr0iMVnLWMX5FYSV6a+RJGKh1i3NzpVzEv3yhZP94cj9QKtIKkFOOhrLU5XT5Q6KwPBGRVbU9LmmuTLbKGD8kZAwfxpbJDbTS2xOTBIyfhnj9CK24DwK6jlOf8AGej3174FvdM0q8js7541WO4eVo1Q7gSdygkd/wA6t3UBNksUpDExhGOc54wa84/agW7XwVYzW1zPHb/axDcRJIVWRWUsNwHDAFB16E12XhCyvrLwZpMOr3E1xqHkB53mbcwZvmKk/wCznb+FevWwvJllKvzr3pS0trsru/yWnS/mZqXvtHa6JObnSLOV/vtEN3+8Bg/qKuGsXwo5NjPCf+WU7AfQ4b/2Y1sk14EtGdkdUITTSaQmmk1DZaQMaienmmOKhlIgaq8lWXFQSCspGsSpJUQ+9U8gqED5qzsadDttLbdp1ufRAPy4q1WfoLZ02MehI/WtCvVg7xR5c1aTCiiiqJCiiigAooooAKKKKACiiigAooooAKKKKACiiigArjZUH2u4Cfd818f99Gup1G5FratJ/F0Ueprl7cc81zV2nZHVh00my9aphRVtRxUEI4FWBUxQ5MWiiirICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKTNITQAuaQmmM2KhkkqXIpK493rPu4ILhsyxhjjbn29Kld80zqazc30NFBdThfg9FGPC/wBhmXdc6XeT2r7jkhg5P8mr0WMVwOoeH9d0jxHdaz4Ra0mS/wAG8sLpiqs44Dow6H1/r2sLqPxAHTQNG/8AA0/4VnCTirO+hxU5+xgqcovTTRX9DvVFPFcENT+IP/Qv6N/4Gn/CnDU/iF/0L+jf+Bp/wrVVF2f3D+sLs/uZp6xEINccgY8+NZPqR8p/QLVy1bIFcVr1746Jtp7jQtJTYxjBW7J+968f7IqO3vPHsikxadoUY6ASTyE/Xjit41VbZ/cYyrK+z+5m94ytdK13T103UX3ItxDMwC7h8kisVP1AKn61qzsk8IeJgyHoRXgetah42i8TQxNCyHcoEduhaFvXJI+uc9K9s0FH+yTE52Fvl+uOf6VpDEyqx9nraLe/na/5IilWVVysmrdy74ckKandQn7rxK4+oJB/mK1NedI9F1B5ZTDGtvIWkEhjKDactuBBXHXIIxWLZSfZ9atj2k3RH8Ru/morV8S6mdF8P6lqYga5+x28k/kqcF9qk4z26dayqfEd0Nji9N1jVfsenyWt4slnDHpikOhlafz5FSRmkLEnAORjuOcjisf/AISfXrLQtNWPU7CWfbP59xeYiCzoUAt3JzhvmYkcMe3Q57uXxTbRJdmSzvUNpGJJxIqRrHkAhS7MEBIPrgdyKr6X4ysdWjhbSrW8vWYEyrB5beQA7Jlm37SCytjYWztJHAqPkX8ymuo63ctabbqCFLzVLmxXba5aGOL7ThslsFj5Sc4A56GsafxH4ittHiuHkt5pbm1jmZvI8tbb98kbt1PG1i3OQpGT8uRXXaN4kivvCMWv3lrPYwNbC5eOQbmClA3y4+91wOAT6VQm8VTS6vp2nWmm3EdzLOyXSXCqTboqoxJ2sQcrIpBBIHOeQRSH8zk77xDqd3YWsVzqlpC7CGSNrT5xek3bowV++1EQtt7uT93FWZPEOpRmFRLHC+A0Fu8Zdr5zcSI0aknPyoqHjpvyflGK6DXfFUmn399applxL9le0Hmrgq4mlVCAOu4AnA7kdqp6t4/0fS4EbUvOtJt0gkgmaNXiEe3eT8+GxvUgIWJzwDg4h+hUXbqcvceI9SsP7Ot7eZBJ5m+RLpv9ej3ToQnBZmVRnjaFBUknOKrTeINastOt0j1KyeXzrpZp7rEawyI4EcLkk8sGJxwxA49a9XcVGw5rNSXY15X3MO38R6tbeHJrl7y2thLqLWUDFBHHAAGbfLK+4BTt252dWUAZNdD8PNTv9Xae71LAmlsbORkTcIw5D7ioPQEj69K2vDR/dzL7g/zrarvpu8UcFRWkwoooqyAooooAKKKKACiiigAooooAKKKKACiiigAooooA5vXpjJebAfljGB9e9VLfrUd5IWu5SepY/wA6dC1efKV5XPQjG0UjTh6VOKqQtxVgNWsWZSQ/NLTM0uaq5Nh1FNpc0xC0UmaWgAoopM0ALRSZozQAtFJmjNK4C0maTNGaLjFzRmmk0hai4WHZoJqMtTGelcdiUtUbPUTSVGz5qHIpRHSSVAzZpTzSquahu5olYaATXCeKF1hPF1u9l/aFzb5hUW8QuIkT5vmcSJ+6PB5EnYcda9DRKlVaThcxrQ9pG17Hmlnrniy8WWGBEE1nfxabPKtt5iuxlO+XaDwixmM9R949MVWu/E/jHT9Ke6v41jUwDDnT3Xy5BepCM5JyXjZnA47Yr1WKJIwwjRUDEsdoxknqfrT5Io5oykqK6HB2sMjg5H60/Zu25yvDza+N3PMbnxL4wih0/wAnTLqRmnfdI1hIBNEJwilkAJjYoSxDFePXpVa4bxWZWWGbUzcwazdMjSWcjRiDy5TGewdD8uBnAOPpXrVOqvZN7sl4ZvebPJtW1fxlfrBBJYLaxS2lvKQbSY7nMQaT5gpEbLJxh2X7vOc1h6JqXiSG2s5EgvZ5fsMazzTWshaNjMA5CceYwXJGOT7ivdDzwelcbpqG23W7EloWMeT7HAP5YNaQpN/aInh5Xu5MtaTaw32nwz3atNM2cySW7W7MMnBKHkcY6/p0rTeNUjCooVRwABgCkhbipW5WulaI0SsrHP6mxt9s6jmF1k/AEE/pmui1Kzg1PTrqxu1LW11E8MgVipKsCDgjkcHqKyNRjDKykcEYNOkhk1XwfLalfMlmtmgYeb5e44Kn5sHHQ9j9DWdVbM2pPdDpfDVnNZXVvPLdSNcPFK8zSfvPMiKlHBAxkFFPTHHTHFV9P8MafBItxZXd+sokfzZVuCWnPmFir56gMW+mSBgHFcTD4O1T7TLYvpWnbWtgLe6CrH9iYyEiRTHEqNKPvfKE/hHq1bWqeCrjUbO+W6itJ5jb6iLRpTu8qaa4aSJwSPlIBHzDkdqyt5ml/I6NtK0zSvDFzp93JKdIWIxsJZC3lxY2hFI5AA4HcetSaf4es7K7W7D3E12Gdmmmk3M5ZVU57cBFAAx09STXG6t4L1i+1+/vglkrT+cnnI6oZI2GI1ZViDEjC5LO3IyOMAdV4s0aXUrmwlFhZapbwCQPZXrbYyzbdsnKsCy4Ycjo7HtglguTX/h60vNQa8kecO5hLosmEZoZBJGxHqCPxHXtWbq2habHP9qe5urO4nmKedBKVZml2Apx2JRfpjgjmsd/BmoM84FvYwFjJ5txFM2+7D3CSKH+UH5EUqOTjouBmp77wjIPEMc9ppumG2jureaC4J2SWsSABoY1CcAkM3BGfMbPTlNeZSfkdW61EVNXWSm+XntWPKbcxa0F9t1t/vKR/WugrnLMGKdH9DXR12Ufhsclb4rhRRRWpiFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHD3eVvJlPUOR+tIj4NW/EduYNRMgHySjcPr3/AM+9ZgavLqe7Jo9SFpRTNSGWrKy1kRy4qws1OMyZQNISU8PWes3vUiy1opkOBeDU4NVMSU8SVSkQ4loNS5quHpd9VzC5SfNJmod9BejmDlJt1JuqDeKQyCjmDlLG6k3VX8ykMtLmHyljdTS1VzLTWlpOQ1EsF6Y0lVmkphkqHMpQLLS1Gz1Duz3oFTzFKJJuzS01VNSqlNA9BFXNSolKi1Mq1aiQ5CKtPC04ClrRIzbAClxRS07CCiiimIK5fU0WDW5gOPNRZfx+6f8A0EfnXUVg+J49sllcAdHMRPswz/NR+dVF6kzWgtu3Aq0DkVQtmyKuoa2MSreLlTS+GzhLqEnJSTeo9FYf4hqmuBkGqelMIdYwek0ZX8RyP0LVE1dFQdmb+2nAUuKXFYWNxMUYpaWnYLjCKjZanxRszSaBMq7MmnLHVkR1IsVCgNzIUirUhOYl+mKrrHViIYBFbQVjGbuPooorQzCiiigAooooAKKKKACiiigAooooAKKKKACiiigCtf2kd7bmKXjurDqDXG6hYT2UmJVyp6OOhru6bIiyIUkUMp6gjINYVaCqeptSrOn6HngbFPEldNe+HoJSWtnMTH+E8rWNcaHfQ52xiRR3Q5/TrXFKhOHQ7o1qc+pWEtSLNVN0kibbIjIfRhigE1ldo05UzRWf3qRZ/esveacJSKpTsS4GsJh608Sj1rJE1PWaq9oT7M1PNpPM96oLL708Pmq5xcha8z3ppkqDdSE0uYOVExlpPMNQ0ClzDsiXfRuzTBTwKLgIc0AE06nAUwuIq1KqUqCpVFWkZtiKmKlVaAKeBWiRDYqipBTRTqtEMWikpRTELmlptKKAFooopiCqWsQG406dFGXA3qPccj+VXaSgDmbQ5Ax0q/Gapi3+zztEv3VJA+nar0Smt7mFgkGVrPYGO6ilx/q3B/Dv+ma19mRUMluGByOtJsaRq0YpYgSinuRUoSsrGtyMLTglTBKeEqlETkQhKcI6sCM08IBVKJDkV1jqVY6lAx0oqlEnmECgUtFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUANdFkXbIqsvoRkVRn0axm/5YhD6px/9atCipcVLdFKTjsznbjw0p5t5yPZxn9RWZcaHfRZxEJAO6HP6da7WisZYWnLyNo4mcfM87khkiOJEZD6MMUwZFeiuiyLtdVZfQjIqhcaNZTf8sth9UOP/rVhLBv7LNo4tfaRxqsalVq27jw4QSbeYH0DjH61l3NjcWv+ujZR69R+dYSpThujaNWE9mMDU7NRp1qdVzSWpTGU4CpBHTwtUoktjFWnhacBSgVVibjQtOC04LTwtUkJsFFSKOKRVqQCrSIbFUU+kApwFWkQ2Ap1GKXFMkSlFLilxTsA2lFO20u2nYVxtFPC04LmnYVyLFLipQlPEdOwXMi/g/erIB1pY0B7VrSQCRQCOlEdoq9qtIzbKKREjgVIttk8itJYQKeEUdqdhXKsMZ24x0qZYj9Kmop8ouYYIwPengAdKKKYgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKRgGUhgCD1BpaKAMHV9JVFM9quAOWQfzFZUXBrs65/UbIQXGUH7tuR7e1cdajZ80Tro1b+7IqAZpwWpo46kEdQoluRWCU4R1ZEdOEftVcouYrhKeEqYJThHVKJPMQhaeFqYJTglUokuREFpwWpQlOCVXKTzEIWnBamCU4JT5RcxAFpwSpwlKFp8ouYgCU4JU4T2p4jquUnmK4SnBKnCAU6nyi5iERmnhBT6KdhXAADtRRRTEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVFcRCaIqevUexqWik1fQE7GSIsHBHNO2Vdmj+bcO9MCVlyWNua5XCUojqyEpQlPlFzFcR04R1YCe1O2VXKLmK4jp2ypwlLtFPlJ5iEJShKmwKKdhXIwntTtlOoosFxoQU4ACiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic model showing most of the putative actors in CH pathogenesis. Pain afferents from the trigeminovascular system synapse on the trigeminocervical complex (TNC), and then project to the thalamus and lead to activation in cortical areas known to be involved in pain transmission. Either a direct influence of the hypothalamus or a reflex activation of the parasympathetic outflow from the superior salivatory nucleus (SSN) predominately through the pterygopalatine (sphenopalatine) ganglion, leads to the parasympathetic symptoms ipsilateral to the pain. A third-order sympathetic nerve lesion, thought to be caused by vascular changes in the cavernous sinus loggia with subsequent irritation of the local plexus of nerve fibers, results in a partial Horner's syndrome. The key site in the CNS for triggering the pain and controlling the cycling aspects is in the posterior hypothalamic grey matter region, modulated by phase-shifting in the suprachiasmatic nuclei.",
"    <div class=\"footnotes\">",
"     Abbreviations: Ggl = ganglion, HT = hypothalamus, ICA = internal carotid artery, NV = trigeminal nerve, PPT = pterygopalatine, SCG = superior cervical ganglion, SN = suprachiasmatic nucleus, SSN = superior salivatory nucleus, TNC = trigeminal nucleus caudalis",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005; 366:847.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35733=[""].join("\n");
var outline_f34_57_35733=null;
var title_f34_57_35734="Colesevelam: Drug information";
var content_f34_57_35734=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Colesevelam: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/39/23156?source=see_link\">",
"    see \"Colesevelam: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/47/35573?source=see_link\">",
"    see \"Colesevelam: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F154425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Welchol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F154426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lodalis&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F154442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antilipemic Agent, Bile Acid Sequestrant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F154429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      <i>",
"       U.S. labeling:",
"      </i>",
"     </b>",
"     <b>",
"      Dyslipidemia, type 2 diabetes (combination therapy with insulin or oral antidiabetic agents):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Once-daily dosing: 3.75 g (oral suspension or 6 tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Twice-daily dosing: 1.875 g (3 tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Canadian labeling:",
"      </i>",
"     </b>",
"     <b>",
"      Dyslipidemia:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Combination therapy: 2.5-3.75 g (4-6 tablets) daily; maximum dose: 3.75 g (6 tablets) given once daily or 1.875 g (3 tablets) given twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Monotherapy: Initial: 1.875 g (3 tablets) twice daily or 3.75 g (6 tablets) once daily; maximum dose: 4.375 g (7 tablets) daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9837607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/47/35573?source=see_link\">",
"      see \"Colesevelam: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Dyslipidemia (heterozygous familial hypercholesterolemia):",
"     </b>",
"     Children 10-17 years (males and postmenarchal females ): Oral:",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     Once-daily dosing: 3.75 g (oral suspension or 6 tablets)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     Twice-daily dosing: 1.875 g (3 tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Due to large tablet size, oral suspension is recommended in pediatric patients.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F154430\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13389335\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary; not absorbed from the gastrointestinal tract.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13389334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary; not absorbed from the gastrointestinal tract.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F154406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules for suspension, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Welchol&reg;: 3.75 g/packet (30s) [contains phenylalanine 48 mg/packet; citrus flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Welchol&reg;: 625 mg",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F15837498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lodalis&trade;: 625 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F154391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F154409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Educate the patient on dietary guidelines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Granules for oral suspension: Administer with meal(s). Powder is not to be taken in dry form (to avoid GI distress).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablets: Administer with meal(s) and a liquid. Due to tablet size, it is recommended that any patient who has trouble swallowing tablets should use the oral suspension form.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F154407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of elevated LDL in primary hypercholesterolemia (Fredrickson type IIa) when used alone or in combination with an HMG-CoA reductase inhibitor; management of heterozygous familial hypercholesterolemia (heFH) in adolescent patients (males and postmenarcheal females 10-17 years of age) when used alone or in combination with an HMG-CoA reductase inhibitor, in patients who after an adequate trial of dietary therapy  have LDL-C &ge;190 mg/dL or LDL-C &ge;160 mg/dL with positive family history of premature cardiovascular disease (CVD) or with two or more CVD risk factors; improve glycemic control in type 2 diabetes mellitus (noninsulin dependent, NIDDM) in conjunction with diet, exercise, and insulin or oral antidiabetic agents",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling (Lodalis&trade;): Adjunct to diet and lifestyle modifications in the management of primary hypercholesterolemia (Fredrickson type IIa) as monotherapy or in combination with an HMG-CoA reductase inhibitor",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F154440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Actual frequency may be dependent upon indication. Unless otherwise noted, frequency of adverse effects is reported for adult patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Gastrointestinal: Constipation (9% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (children 4% to 8%), fatigue (children 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypertriglyceridemia (4% to 5%), hypoglycemia (3%), CPK increased (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Dyspepsia (4% to 8%), nausea (3%), vomiting (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (4%), myalgia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Nasopharyngitis (children 5% to 6%), upper respiratory tract infection (children 5%), pharyngitis (3%), rhinitis (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (children 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal distension, bowel obstruction, diarrhea, dysphagia, esophageal obstruction, fecal impaction, flatulence, hemorrhoid exacerbation, infection, pancreatitis, transaminases increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F154412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     History of bowel obstruction; serum triglyceride concentration &gt;500 mg/dL; history of hypertriglyceridemia-induced pancreatitis",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Hypersensitivity to colesevelam or any component of the formulation; bowel or biliary obstruction",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F154395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disease: Use in patients with gastroparesis, other severe GI motility disorders, or a history of major GI tract surgery is not recommended due to constipating effects of colesevelam. Patients with dysphagia or swallowing disorders should use the oral suspension form of colesevelam due to large tablet size and risk for esophageal obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertriglyceridemia: Use with caution in patients with serum triglyceride concentrations &gt;300 mg/dL and in patients using insulin or sulfonylureas (may cause increased concentrations). Discontinue if triglyceride concentrations exceed 500 mg/dL or hypertriglyceridemia-induced pancreatitis occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Patients susceptible to fat-soluble vitamin deficiencies:  Use with caution in patients susceptible to fat-soluble vitamin deficiencies. Absorption of fat soluble vitamins A, D, E, and K may be decreased; patients should take vitamins &ge;4 hours before colesevelam.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Decreased absorption (orally administered drugs): May decrease the absorption of many drugs; refer to Drug Interactions for further detail.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenylalanine: Some products may contain phenylalanine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use in diabetes mellitus: Colesevelam is not indicated for the management of type 1 diabetes mellitus (insulin dependent, IDDM), particularly in the acute management (eg, DKA). It is also not indicated in type 2 diabetes mellitus as monotherapy and must be used as an adjunct to diet, exercise, and glycemic control with insulin or oral antidiabetic agents. Combination with dipeptidyl peptidase 4 inhibitors or thiazolidinediones has not been studied extensively.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use in hyperlipidemia: Secondary causes of hyperlipidemia should be ruled out prior to therapy. Minimal effects are seen on HDL-C and triglyceride concentrations. Colesevelam has not been studied in Fredrickson Type I, III, IV, or V dyslipidemias.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F154400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: Bile Acid Sequestrants may decrease the bioavailability of Amiodarone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents (Thiazolidinedione): Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtorvaSTATin: Bile Acid Sequestrants may decrease the serum concentration of AtorvaSTATin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chenodiol: Bile Acid Sequestrants may decrease the serum concentration of Chenodiol.  Management: Administration of chenodiol 5 hours or more after bile acid sequestrants may reduce chenodiol adsorption in the gastrointestinal tract.  Monitor for decreased therapeutic effects of chenodiol in patients receiving bile acid sequestrants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Estrogens).  Management: Administer estrogen-based oral contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Progestins).  Management: Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Oral): Bile Acid Sequestrants may decrease the absorption of Corticosteroids (Oral).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Colesevelam may decrease the serum concentration of CycloSPORINE (Systemic).  Management: Administer cyclosporine at least 4 hours prior to colesevelam.  Monitor for decreased cyclosporine concentrations during concomitant colesevelam therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Bile Acid Sequestrants may decrease the serum concentration of Deferasirox.  Management: Avoid combination when possible; if the combination must be used, consider a 50% increase in initial deferasirox dose, with monitoring of serum ferritin concentrations and clinical responses to guide further dosing.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethinyl Estradiol: Colesevelam may decrease the serum concentration of Ethinyl Estradiol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ezetimibe: Bile Acid Sequestrants may decrease the absorption of Ezetimibe.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glimepiride: Colesevelam may decrease the serum concentration of Glimepiride.  Management: Administer glimepiride at least 4 hours prior to colesevelam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     GlipiZIDE: Colesevelam may decrease the serum concentration of GlipiZIDE.  Management: Administer glipizide at least 4 hours prior to colesevelam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     GlyBURIDE: Colesevelam may decrease the serum concentration of GlyBURIDE.  Management: Administer glyburide at least 4 hours prior to colesevelam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Bile Acid Sequestrants may decrease serum concentrations of the active metabolite(s) of Leflunomide.  Management: Unless using this combination to intentionally enhance leflunomide elimination, consider an alternative to the bile acid sequestrants when possible.  Separating drug administration is not likely to be effective at avoiding this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: Bile Acid Sequestrants may decrease the absorption of Lomitapide.  Management: Administer lomitapide at least 4 hours before or after administration of a bile acid sequestrant.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Bile Acid Sequestrants may decrease the absorption of Loop Diuretics.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Bile Acid Sequestrants may decrease the absorption of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Bile Acid Sequestrants may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, bile acid sequestrants may impair the absorption of fat-soluble vitamins.  Management: Avoid concomitant administration of multivitamins and bile acid sequestrants (e.g., cholestyramine). Separate administration of these agents by several hours to minimize the risk of an interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Niacin: Bile Acid Sequestrants may decrease the absorption of Niacin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: Bile Acid Sequestrants may decrease the absorption of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Norethindrone: Colesevelam may decrease the serum concentration of Norethindrone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Olmesartan: Colesevelam may decrease the serum concentration of Olmesartan.  Management: Administer olmesartan at least 4 hours prior to colesevelam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Colesevelam may decrease the serum concentration of Phenytoin.  Management: Administer phenytoin at least 4 hours prior to colesevelam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pravastatin: Bile Acid Sequestrants may decrease the serum concentration of Pravastatin.  Management: Administer pravastatin at least 1 hour before or 4 hours after administration of bile-acid resins (eg, cholestyramine, colestipol, colesevelam) to minimize the risk for any significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propranolol: Bile Acid Sequestrants may decrease the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Raloxifene: Bile Acid Sequestrants may decrease the absorption of Raloxifene.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teriflunomide: Bile Acid Sequestrants may decrease the serum concentration of Teriflunomide.  Management: Unless using this combination to intentionally enhance teriflunomide elimination, consider an alternative to the bile acid sequestrants when possible.  Separating drug administration is unlikely to be effective at avoiding the interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Bile Acid Sequestrants may decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Bile Acid Sequestrants may decrease the absorption of Thiazide Diuretics. The diuretic response is likewise decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Bile Acid Sequestrants may decrease the serum concentration of Thyroid Products.  Management: Administer oral thyroid products at least 4 h prior to colesevelam, and at least 1 h before or 4-6 h after cholestyramine.  Specific recommendations for colestipol are not available. Monitor for decreased concentrations/effects of the thyroid product.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ursodiol: Bile Acid Sequestrants may decrease the serum concentration of Ursodiol.  Management: Administer ursodiol 5 hours or more after bile acid sequestrants to minimize ursodiol adsorption in the gastrointestinal tract. Monitor for decreased therapeutic effects of ursodiol in patients receiving bile acid sequestrants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vancomycin: Bile Acid Sequestrants may diminish the therapeutic effect of Vancomycin.  Management: Avoid concurrent administration of oral vancomycin and bile acid sequestrants when possible.  If use of both agents is necessary, consider separating doses by at least 2 hours to minimize the significance of the interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Bile Acid Sequestrants may decrease the serum concentration of Vitamin D Analogs. More specifically, bile acid sequestrants may impair absorption of Vitamin D Analogs.  Management: Avoid concomitant administration of vitamin D analogs and bile acid sequestrants (e.g., cholestyramine). Separate administration of these agents by several hours to minimize the potential risk of interaction. Monitor plasma calcium concentrations.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Calcipotriene.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Bile Acid Sequestrants may decrease the absorption of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F154402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F154415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects have not been observed in animal reproduction studies. Colesevelam is not absorbed systemically, but may interfere with vitamin absorption; therefore, regular supplementation may not be adequate.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F154434\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Does not enter breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13389262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to lack of systemic absorption, colesevelam is not expected to be excreted in breast milk; however, the tendency of colesevelam to interfere with the vitamin absorption may have an effect on the nursing infant.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F154416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken with meal(s) and a liquid. Follow dietary guidelines. Some products may contain phenylalanine.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F154414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pack",
"     </b>",
"     (Welchol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.75 g (30): $324.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Welchol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     625 mg (180): $324.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F154404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum cholesterol, LDL, and triglyceride levels should be obtained before initiating treatment and periodically thereafter (in accordance with NCEP guidelines)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F154417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Cholestagel (CZ, DK, EE, GB, NO, SE);",
"     </li>",
"     <li>",
"      Welchol (NO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F154394\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cholesterol is the major precursor of bile acid. Colesevelam binds with bile acids in the intestine to form an insoluble complex that is eliminated in feces. This increased excretion of bile acids results in an increased oxidation of cholesterol to bile acid and a lowering of the serum cholesterol.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F154411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lipid lowering: Therapeutic: ~2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Reduction of hemoglobin A",
"     <sub>",
"      1c",
"     </sub>",
"     (Type II diabetes): 4-6 weeks initial onset; 12-18 weeks maximal effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: None",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (0.05%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Davidson MH, Dillon MA, Gordon B, et al, &ldquo;Colesevelam Hydrochloride (Cholestagel): A New, Potent Bile Acid Sequestrant Associated With a Low Incidence of Gastrointestinal Side Effects,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1999, 159(16):1893-900.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/10493319/pubmed\" id=\"10493319\" target=\"_blank\">",
"        10493319",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2001, 285(19):2486-97.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/11368702/pubmed\" id=\"11368702\" target=\"_blank\">",
"        11368702",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fihn SD, Gardin JM, Abrams J, et al, &ldquo;2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(25):3097-137.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/23166211/pubmed\" id=\"23166211\" target=\"_blank\">",
"        23166211",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rodbard HW, Jellinger PS, Davidson JA, et al, &ldquo;Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control,&rdquo;",
"      <i>",
"       Endocr Pract",
"      </i>",
"      , 2009, 15(6):540-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/19858063/pubmed\" id=\"19858063\" target=\"_blank\">",
"        19858063",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith SC Jr, Benjamin EJ, Bonow RO, et al, &ldquo;AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(22):2458-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/22052934/pubmed\" id=\"22052934\" target=\"_blank\">",
"        22052934",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Staels B and Kuipers F, &ldquo;Bile Acid Sequestrants and the Treatment of Type2 Diabetes Mellitus,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 2007, 67(10):1383-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/17600387/pubmed\" id=\"17600387\" target=\"_blank\">",
"        17600387",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steinmetz KL, &ldquo;Colesevelam Hydrochloride,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2002, 59:932-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/12040732/pubmed\" id=\"12040732\" target=\"_blank\">",
"        12040732",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zieve FJ, Kalin MF, Schwartz SL, et al, &ldquo;Results of the Glucose-Lowering Effect of WelChol Study (GLOWS): A Randomized, Double-Blind, Placebo-Controlled Pilot Study Evaluating the Effect of Colesevelam Hydrochloride on Glycemic Control in Subjects With Type 2 Diabetes,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2007, 29(10):74-83,",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35734/abstract-text/17379048/pubmed\" id=\"17379048\" target=\"_blank\">",
"        17379048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8954 Version 47.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35734=[""].join("\n");
var outline_f34_57_35734=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154425\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154426\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154442\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154429\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9837607\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154430\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13389335\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13389334\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154406\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837498\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154391\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154409\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154407\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154440\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154412\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154395\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299081\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154400\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154402\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154415\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154434\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13389262\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154416\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154414\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154404\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154417\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154394\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154411\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8954\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8954|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/39/23156?source=related_link\">",
"      Colesevelam: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/47/35573?source=related_link\">",
"      Colesevelam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_57_35735="Cefotaxime: Drug information";
var content_f34_57_35735=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cefotaxime: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/61/34771?source=see_link\">",
"    see \"Cefotaxime: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/23/40310?source=see_link\">",
"    see \"Cefotaxime: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Claforan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F147494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cefotaxime Sodium For Injection;",
"     </li>",
"     <li>",
"      Claforan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F147542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Cephalosporin (Third Generation)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F147497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     I.M., I.V.: 1-2 g every 4-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Uncomplicated infections:",
"     </i>",
"     I.M., I.V.: 1 g every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Moderate-to-severe infections:",
"     </i>",
"     I.M., I.V.: 1-2 g every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Life-threatening infections:",
"     </i>",
"     I.V.: 2 g every 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute bacterial rhinosinusitis, severe infection requiring hospitalization:",
"     </b>",
"     I.V.: 2 g every 4-6 hours for 5-7 days (Chow, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Arthritis (septic):",
"     </b>",
"     I.V.: 1 g every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Brain abscess, meningitis:",
"     </b>",
"     I.V.: 2 g every 4-6 hours in combination with other antimicrobial therapy as warranted (Kowlessar, 2006; Tunkel, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Caesarean section:",
"     </b>",
"     I.M., I.V.: 1 g as soon as the umbilical cord is clamped, then 1 g at 6- and 12-hour intervals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Complicated community-acquired intra-abdominal infection of mild-to-moderate severity, including hepatic abscess (in combination with metronidazole):",
"     </b>",
"     I.V.: 1-2 g every 6 -8 hours for 4-7 days (provided source controlled).",
"     <b>",
"      Note:",
"     </b>",
"     For severe infections consider other antimicrobial agents (Bradley, 1987; Kim, 2010; Solomkin, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonorrhea (CDC, 2010) (as an alternative to ceftriaxone):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Uncomplicated gonorrhea of the cervix, urethra, or rectum (unlabeled regimen):",
"     </i>",
"     I.M.: 0.5 g as a single dose in combination with oral azithromycin (preferred) or oral doxycycline (alternative to preferred)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      Note:",
"     </b>",
"     May also administer 1 g as a single dose for rectal gonorrhea in adult males (per the manufacturer)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Disseminated:",
"     </i>",
"     I.V.: 1 g every 8 hours continue for 24-48 hrs after improvement begins then switch to oral therapy. Total duration of therapy at least 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Lyme disease (as an alternative to ceftriaxone):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Cardiac manifestations:",
"     </i>",
"     I.V.: 2 g every 8 hours for 14-21 days (Wormser, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      CNS manifestations:",
"     </i>",
"     I.V.: 2 g every 8 hours for 10-28 days (Halperin, 2007; Wormser, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Peritonitis (spontaneous):",
"     </b>",
"     I.V.: 2 g every 8 hours, unless life-threatening then 2 g every 4 hours (Gilbert, 2011; Runyon, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Sepsis:",
"     </b>",
"     I.V.: 2 g every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Skin and soft tissue:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Bite wounds (animal):",
"     </i>",
"     I.V.: 2 g every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Mixed, necrotizing:",
"     </i>",
"     I.V.: 2 g every 6 hours, with metronidazole or clindamycin (Stevens, 2005)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F147520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/23/40310?source=see_link\">",
"      see \"Cefotaxime: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Usual dosage range for susceptible infections:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants and Children 1 month to 12 years &lt;50 kg: I.M., I.V.: 50-200 mg/kg/day in divided doses every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Acute bacterial rhinosinusitis, severe infection requiring hospitalization (unlabeled use):",
"     </b>",
"     Children: I.V.: 100-200 mg/kg/day divided every 6 hours for 10-14 days (Chow, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Arthritis (septic):",
"     </b>",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Brain abscess:",
"     </b>",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Caesarean section:",
"     </b>",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Community-acquired pneumonia (CAP) (IDSA/PIDS, 2011):",
"     </b>",
"     Infants &gt;3 months and Children: I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     May consider addition of vancomycin or clindamycin to empiric therapy if community-acquired MRSA suspected. In children &ge;5 years, a macrolide antibiotic should be added if atypical pneumonia cannot be ruled out.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Empiric treatment,",
"     <i>",
"      Haemophilus influenzae",
"     </i>",
"     , group A",
"     <i>",
"      Streptococcus",
"     </i>",
"     , or",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     (MICs to penicillin &le;2.0 mcg/mL), patient fully immunized for",
"     <i>",
"      H. influenzae",
"     </i>",
"     type b and",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     , or minimal local resistance to penicillin in invasive pneumococcal strains (alternative to ampicillin or penicillin): 50 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Moderate-to-severe infection, patient not fully immunized for",
"     <i>",
"      H. influenzae",
"     </i>",
"     type b and",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     , or significant local resistance to penicillin in invasive pneumococcal strains (preferred): 50 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Moderate-to-severe infection,",
"     <i>",
"      H. influenzae",
"     </i>",
"     (beta-lactamase producing) (preferred): 50 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Complicated community-acquired intra-abdominal infection (in combination with metronidazole):",
"     </b>",
"     Infants and Children: I.,V.: 150-200 mg/kg/day divided every 6-8 hours (Solomkin, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Gonorrhea (CDC, 2010) (as an alternative to ceftriaxone):",
"     </b>",
"     Children &ge;45 kg and  Adolescents &ge;45 kg: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Lyme disease (as an alternative to ceftriaxone):",
"     </b>",
"     <i>",
"      Cardiac or CNS manifestations:",
"     </i>",
"     Infants and Children: I.V.: 150-200 mg/kg/day in divided doses every 6-8 hours for 14-28 days; maximum daily dose: 6 g/day (Halperin, 2007; Wormser, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Meningitis (in combination with vancomycin):",
"     </b>",
"     Infants and Children: I.V.: 225-300 mg/kg/day in divided doses every 6-8 hours (Tunkel, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Peritonitis (spontaneous):",
"     </b>",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Sepsis:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Infants and Children &le;12 years: I.V.: 150 mg/kg/day divided every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Skin and soft tissue:",
"     </b>",
"     Children &ge;50 kg or Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Typhoid fever:",
"     </b>",
"     Infants and Children &le;12 years: I.M., I.V.: 150-200 mg/kg/day in 3-4 divided doses (maximum: 12 g/day); fluoroquinolone resistant: 80 mg/kg/day in 3-4 divided doses (maximum: 12 g/day)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F147498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F147499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Manufacturer&rsquo;s labeling:",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     Renal function may be estimated using Cockcroft-Gault formula for dosage adjustment purposes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;20 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Dose should be decreased by 50%.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Alternate recommendations:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children:",
"     <b>",
"      Note:",
"     </b>",
"     Glomerular filtration rate (GFR) should be estimated using an acceptable pediatric method (eg, Schwartz equation, Traub-Johnson equation, or a height/weight nomogram):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     The following dosage adjustments have been used by some clinicians (Aronoff, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GFR 30-50 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 35-70 mg/kg/dose every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GFR 10-29 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 35-70 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GFR &lt;10 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 35-70 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Intermittent hemodialysis (IHD): 35-70 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Peritoneal dialysis: 35-70 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): 35-70 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: The following dosage adjustments have been used by some clinicians (Aronoff, 2007; Heintz, 2009; Trotman, 2005):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR &gt;50 mL/minute:  Administer every 6 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR 10-50 mL/minute: Administer every 6-12 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR &lt;10 mL/minute: Administer every 24 hours",
"     <b>",
"      or",
"     </b>",
"     decrease the dose by 50% (and administer at usual intervals) (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intermittent hemodialysis (IHD): Administer 1-2 g every 24 hours (on dialysis days, administer after hemodialysis).",
"     <b>",
"      Note:",
"     </b>",
"     Dosing dependent on the assumption of 3 times/week, complete IHD sessions (Heintz, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Peritoneal dialysis (PD): 1 g every 24 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT) (Heintz, 2009; Trotman, 2005): Drug clearance is highly dependent on the method of renal replacement, filter type, and flow rate. Appropriate dosing requires close monitoring of pharmacologic response, signs of adverse reactions due to drug accumulation, as well as drug concentrations in relation to target trough (if appropriate). The following are general recommendations only (based on dialysate flow/ultrafiltration rates of 1-2 L/hour and minimal residual renal function) and should not supersede clinical judgment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     CVVH: 1-2 g every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     CVVHD: 1-2 g every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     CVVHDF: 1-2 g every 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F147500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage reduction generally not necessary unless concurrent severe renal impairment. Consider dose reduction to 0.5 g every 12 hours in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;5 mL/minute (Wise, 1985).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F147472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Claforan&reg;: 1 g (50 mL); 2 g (50 mL) [contains sodium ~50.5 mg (2.2 mEq) per cefotaxime 1 g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 500 mg, 1 g, 2 g, 10 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Claforan&reg;: 500 mg, 1 g, 2 g, 10 g [contains sodium ~50.5 mg (2.2 mEq) per cefotaxime 1 g]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F147456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Powder",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F147476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Can be administered IVP over at least 3-5 minutes or I.V. intermittent infusion over 15-30 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F147547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in peritoneal dialysis solutions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, alprostadil, amifostine, aztreonam, bivalirudin, caffeine citrate, cyclophosphamide, cyclosporine, dexmedetomidine, diltiazem, docetaxel, etoposide phosphate, famotidine, fenoldopam, fentanyl, fludarabine, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydromorphone, levofloxacin, lorazepam, magnesium sulfate, melphalan, meperidine, milrinone, morphine, ondansetron, oxytocin, propofol, remifentanil, sargramostim, teniposide, thiotepa, tigecycline, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, azithromycin, filgrastim, fluconazole, gemcitabine, hetastarch in NS, pantoprazole, pemetrexed, pentamidine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Anakinra, cisatracurium, midazolam, vancomycin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Caffeine citrate, dimenhydrinate, heparin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Doxapram, pantoprazole.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F147475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of susceptible organisms in lower respiratory tract, skin and skin structure, bone and joint, urinary tract, intra-abdominal, gynecologic as well as bacteremia/septicemia, and documented or suspected central nervous system infections (eg, meningitis). Active against most gram-negative bacilli (not",
"     <i>",
"      Pseudomonas",
"     </i>",
"     spp) and gram-positive cocci (not enterococcus). Active against many penicillin-resistant pneumococci.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14470552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute bacterial rhinosinusitis (ABRS)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F147549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cefotaxime may be confused with cefOXitin, cefuroxime",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Spectrocef [Italy] may be confused with Spectracef brand name for cefditoren [U.S., Great Britain, Mexico, Portugal, Spain]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F147540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Colitis, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Pain at injection site",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Agranulocytosis, alkaline phosphatase increased, ALT increased, anaphylaxis, arrhythmia (after rapid I.V. injection via central catheter), AST increased, bilirubin increased, BUN increased, candidiasis, cholestasis, Coombs test (direct) positive, creatinine increased, encephalopathy, eosinophilia, erythema multiforme, fever, GGT increased, headache, hemolytic anemia, hepatitis, interstitial nephritis, jaundice, LDH increased, leukopenia, moniliasis, neutropenia, phlebitis, pseudomembranous colitis, Stevens-Johnson syndrome, thrombocytopenia, toxic epidermal necrolysis, transaminases increased, urticaria, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Reactions reported with other cephalosporins: Aplastic anemia, hemorrhage, pancytopenia, renal dysfunction, seizure, superinfection, toxic nephropathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F147479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cefotaxime, any component of the formulation, or other cephalosporins",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F147460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmia: A potentially life-threatening arrhythmia has been reported in patients who received a rapid (&lt;1 minute) bolus injection via central venous catheter.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Granulocytopenia: Granulocytopenia and more rarely agranulocytosis may develop during prolonged treatment (&gt;10 days).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Penicillin allergy: Use with caution in patients with a history of penicillin allergy, especially IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tissue inflammation: Minimize tissue inflammation by changing infusion sites when needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; modify dosage in severe impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F147465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Cephalosporins (3rd Generation) may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cefotaxime. Management: Avoid cefotaxime doses greater than 6 g/day with concurrent probenecid.  Any patients receiving this combination should be monitored closely for evidence of cefotaxime toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F147468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5951413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. Cefotaxime crosses the human placenta and can be found in fetal tissue. An increase in most types of birth defects was not found following first trimester exposure to cephalosporins. During pregnancy, peak cefotaxime serum concentrations are decreased and the serum half-life is shorter. Cefotaxime is approved for use in women undergoing cesarean section (consult current guidelines for appropriate use).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F147504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F147481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Low concentrations of cefotaxime are found in breast milk. The manufacturer recommends that caution be exercised when administering cefotaxime to nursing women. Nondose-related effects could include modification of bowel flora. The pregnancy-related changes in cefotaxime pharmacokinetics continue into the early postpartum period.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F147482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323047\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Claforan in D5W Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 gm/50 mL (50 mL): $12.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 gm/50 mL (50 mL): $21.43",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Cefotaxime Sodium Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (1): $6.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 g (1): $13.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 g (1): $65.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (1): $6.38",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Claforan Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (1): $1.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 g (1): $4.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 g (1): $22.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (1): $1.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Claforan Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (1): $3.89",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 g (1): $7.02",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F147470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Observe for signs and symptoms of anaphylaxis during first dose; CBC with differential (especially with long courses); renal function",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F147483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Benaxima (MX);",
"     </li>",
"     <li>",
"      Biosint (MX);",
"     </li>",
"     <li>",
"      Biotax (IN);",
"     </li>",
"     <li>",
"      Cefacolin (AR);",
"     </li>",
"     <li>",
"      Cefalekol (HU);",
"     </li>",
"     <li>",
"      Cefirad (KP);",
"     </li>",
"     <li>",
"      Cefocam (PY);",
"     </li>",
"     <li>",
"      Cefot (DO);",
"     </li>",
"     <li>",
"      Cefotaksim (HR);",
"     </li>",
"     <li>",
"      Cefotax (AE, BH, CY, EG, IQ, IR, JO, JP, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Cefotaxim (DE, NO);",
"     </li>",
"     <li>",
"      Cefotrial (PE);",
"     </li>",
"     <li>",
"      Cefox (PH);",
"     </li>",
"     <li>",
"      Cefoxim (KP);",
"     </li>",
"     <li>",
"      Cefpiran (KP);",
"     </li>",
"     <li>",
"      Cetax (TW);",
"     </li>",
"     <li>",
"      Clacef (ID);",
"     </li>",
"     <li>",
"      Cladex (PH);",
"     </li>",
"     <li>",
"      Claforan (AE, AT, AU, BB, BE, BF, BG, BH, BJ, BM, BR, BS, BZ, CH, CI, CR, CY, DK, EE, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, GT, GY, HK, HN, HR, HU, ID, IE, IL, IN, IQ, IR, IT, JM, JO, KE, KP, KW, LB, LR, LU, LY, MA, ML, MR, MT, MU, MW, MY, NE, NG, NI, NL, NZ, OM, PA, PH, PK, PY, QA, RU, SA, SC, SD, SE, SG, SK, SL, SN, SR, SV, SY, TH, TN, TR, TT, TW, TZ, UG, VE, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Claraxim (TH);",
"     </li>",
"     <li>",
"      Clatax (ID);",
"     </li>",
"     <li>",
"      Clavox (TW);",
"     </li>",
"     <li>",
"      Efotax (ID);",
"     </li>",
"     <li>",
"      Fot-Amsa (MX);",
"     </li>",
"     <li>",
"      Fotexina (CO, EC, MX);",
"     </li>",
"     <li>",
"      Grifotaxima (CN);",
"     </li>",
"     <li>",
"      Haxim (PH);",
"     </li>",
"     <li>",
"      Kalfoxim (ID);",
"     </li>",
"     <li>",
"      Lancef (ID);",
"     </li>",
"     <li>",
"      Lapixime (ID);",
"     </li>",
"     <li>",
"      Lyforan (IN);",
"     </li>",
"     <li>",
"      Makrocef (HR);",
"     </li>",
"     <li>",
"      Molelant (GR);",
"     </li>",
"     <li>",
"      Necaxime (TH);",
"     </li>",
"     <li>",
"      Newtaxime (KP);",
"     </li>",
"     <li>",
"      Omnatax (IN);",
"     </li>",
"     <li>",
"      Oritaxim (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Pantaxin (PH);",
"     </li>",
"     <li>",
"      Policef (BR);",
"     </li>",
"     <li>",
"      Procefa (ID);",
"     </li>",
"     <li>",
"      Ralopar (PT);",
"     </li>",
"     <li>",
"      Reftax (ZA);",
"     </li>",
"     <li>",
"      Rekaxime (MY);",
"     </li>",
"     <li>",
"      Saifulong (CL);",
"     </li>",
"     <li>",
"      Sefotak (AE, BH, CY, CZ, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Soclaf (ID);",
"     </li>",
"     <li>",
"      Spirosine (GR);",
"     </li>",
"     <li>",
"      Stoparen (GR);",
"     </li>",
"     <li>",
"      Talcef (PE);",
"     </li>",
"     <li>",
"      Taporin (MX);",
"     </li>",
"     <li>",
"      Taxim (PH);",
"     </li>",
"     <li>",
"      Taximax (ID);",
"     </li>",
"     <li>",
"      Taxime (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Tebruxim (MX);",
"     </li>",
"     <li>",
"      Tirdicef (ID);",
"     </li>",
"     <li>",
"      Tirotax (MX, PL);",
"     </li>",
"     <li>",
"      Ultracef (UY);",
"     </li>",
"     <li>",
"      Unitax (TW);",
"     </li>",
"     <li>",
"      Valoran (EE);",
"     </li>",
"     <li>",
"      Viken (MX);",
"     </li>",
"     <li>",
"      Xedin (MX);",
"     </li>",
"     <li>",
"      Zariviz (IT);",
"     </li>",
"     <li>",
"      Zefocent (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F147459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F147478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Widely to body tissues and fluids including aqueous humor, ascitic and prostatic fluids, bone; penetrates CSF best when meninges are inflamed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Partially hepatic to active metabolite, desacetylcefotaxime",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cefotaxime: Infants &le;1500 g: 4.6 hours; Infants &gt;1500 g: 3.4 hours; Adults: 1-1.5 hours; prolonged with renal and/or hepatic impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Desacetylcefotaxime: 1.5-1.9 hours; prolonged with renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: I.M.: Within 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~60% as unchanged drug and metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 55, 149.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al.  &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bratzler DW, Dellinger EP, Olsen KM, et al, &ldquo;Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2013, 70(3):195-283.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/23327981/pubmed\" id=\"23327981\" target=\"_blank\">",
"        23327981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brogden RN and Spencer CM, &ldquo;Cefotaxime. A Reappraisal of Its Antibacterial Activity and Pharmacokinetic Properties, and a Review of Its Therapeutic Efficacy When Administered Twice Daily for the Treatment of Mild-to-Moderate Infections,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1997, 53(3):483-510.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/9074846/pubmed\" id=\"9074846\" target=\"_blank\">",
"        9074846",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections&rdquo;,",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2012, 61(31):590-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/22874837/pubmed\" id=\"22874837\" target=\"_blank\">",
"        22874837",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chow AW, Benninger MS, Brook I, et al, &ldquo;IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(8):e72-112.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/22438350/pubmed\" id=\"22438350\" target=\"_blank\">",
"        22438350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Deeter RG, Weinstein MP, Swanson KA, et al, &ldquo;Crossover Assessment of Serum Bactericidal Activity and Pharmacokinetics of Five Broad-Spectrum Cephalosporins in the Elderly,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1990, 34(6):1007-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/2393258/pubmed\" id=\"2393258\" target=\"_blank\">",
"        2393258",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gilbert DN, Moellering RC, Eliopoulos GM, et al, eds,",
"      <i>",
"       The Sanford Guide To Antimicrobial Therapy",
"      </i>",
"      , 41st ed, Sperryville, VA: Antimicrobial Therapy, Inc, 2011, 55.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Halperin JJ, Shapiro ED, Logigian E, et al, &ldquo;Practice Parameter: Treatment of Nervous System Lyme Disease (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2007, 69(1):91-102.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/17522387/pubmed\" id=\"17522387\" target=\"_blank\">",
"        17522387",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heintz BH, Matzke GR, Dager WE, &ldquo;Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(5):562-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/19397464/pubmed\" id=\"19397464\" target=\"_blank\">",
"        19397464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Klein NC and Cunha BA, &ldquo;Third-Generation Cephalosporins,&rdquo;",
"      <i>",
"       Med Clin North Am",
"      </i>",
"      , 1995, 79(4):705-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/7791418/pubmed\" id=\"7791418\" target=\"_blank\">",
"        7791418",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ludwig E, Sz&eacute;kely &Eacute;, Csiba A, et al, &ldquo;Pharmacokinetics of Cefotaxime and Desacetylcefotaxime in Elderly Patients,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1988, 35(Suppl 2):51-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/3396489/pubmed\" id=\"3396489\" target=\"_blank\">",
"        3396489",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marshall WF and Blair JE, &ldquo;The Cephalosporins,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1999, 74(2):187-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/10069359/pubmed\" id=\"10069359\" target=\"_blank\">",
"        10069359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Runyon BA, &ldquo;Management of Adult Patients With Ascites Due to Cirrhosis: An Update,&rdquo;",
"      <i>",
"       Hepatology",
"      </i>",
"      , 2009, 49(6):2087-107.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/19475696/pubmed\" id=\"19475696\" target=\"_blank\">",
"        19475696",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Solomkin JS, Mazuski JE, Bradley JS, et al, &ldquo;Diagnosis and Management of Complicated Intra-Abdominal Infections in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      ,  2010, 50(2):133-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/20034345/pubmed\" id=\"20034345\" target=\"_blank\">",
"        20034345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Spritzer R, Kamp HJ, Dzoljic G, et al, &ldquo;Five Years of Cefotaxime Use in a Neonatal Intensive Care Unit,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1990, 9(2):92-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/2179846/pubmed\" id=\"2179846\" target=\"_blank\">",
"        2179846",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stevens DL, Bisno AL, Chambers HF, et al, &ldquo;Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005; 41(10):1373&ndash;406.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/16231249/pubmed\" id=\"16231249\" target=\"_blank\">",
"        16231249",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al, \"Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(8):1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al, &ldquo;Practice Guidelines for the Management of Bacterial Meningitis,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(9):1267-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/15494903/pubmed\" id=\"15494903\" target=\"_blank\">",
"        15494903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wormser GP, Dattwyler RJ, Shapiro ED, et al, &ldquo;The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2006, 43(9):1089-134.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/57/35735/abstract-text/17029130/pubmed\" id=\"17029130\" target=\"_blank\">",
"        17029130",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9221 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.211.0.116-F84AD05CA0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35735=[""].join("\n");
var outline_f34_57_35735=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147493\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147494\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147542\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147497\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147520\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147498\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147499\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147500\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147472\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147456\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147476\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147547\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147475\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14470552\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147549\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147540\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147479\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147460\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298990\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147465\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147468\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5951413\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147504\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147481\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147482\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323047\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147470\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147483\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147459\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147478\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9221\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9221|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/61/34771?source=related_link\">",
"      Cefotaxime: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/23/40310?source=related_link\">",
"      Cefotaxime: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_57_35736="Clinical manifestations and diagnosis of blastomycosis";
var content_f34_57_35736=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of blastomycosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/57/35736/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35736/contributors\">",
"     Robert W Bradsher, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/57/35736/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35736/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/57/35736/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/57/35736/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/57/35736/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blastomycosis is a systemic pyogranulomatous infection that arises after inhalation of the conidia of the thermally dimorphic fungus, Blastomyces dermatitidis. Most cases of blastomycosis have been reported in North America. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/79?source=see_link\">",
"     \"Mycology, pathogenesis, and epidemiology of blastomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of blastomycosis are varied and include asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ]. Although B. dermatitidis has been reported to involve almost every organ, the lungs are the most common site of infection, followed by the skin, bones, and genitourinary system. Extrapulmonary disease results from hematogenous spread from a primary pulmonary infection.",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of blastomycosis will be reviewed here. The mycology, pathogenesis, epidemiology, and treatment of blastomycosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/79?source=see_link\">",
"     \"Mycology, pathogenesis, and epidemiology of blastomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29912?source=see_link\">",
"     \"Treatment of blastomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SITES OF INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lungs are the most common site of infection, followed by the skin, bones, and genitourinary tract. Studies performed prior to the availability of effective therapy indicated that approximately two-thirds of patients with blastomycosis had multiorgan involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], and the disease was progressive with reported mortality rates of up to 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/4\">",
"     4",
"    </a>",
"    ]. Additionally, most of these earlier studies were autopsy-based; thus, multiorgan disease was probably over represented. In contrast, more recent clinical experience in Arkansas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/5\">",
"     5",
"    </a>",
"    ], Wisconsin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/6\">",
"     6",
"    </a>",
"    ], Mississippi [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/7\">",
"     7",
"    </a>",
"    ], and Manitoba, Canada [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/8\">",
"     8",
"    </a>",
"    ] has indicated a lower frequency of extrapulmonary disease.",
"   </p>",
"   <p>",
"    In a study of 326 patients with blastomycosis, the following distribution of organ involvement was observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pulmonary &mdash; 91 percent",
"     </li>",
"     <li>",
"      Skin &mdash; 18 percent",
"     </li>",
"     <li>",
"      Bone &mdash; 4 percent",
"     </li>",
"     <li>",
"      Genitourinary &mdash; 2 percent",
"     </li>",
"     <li>",
"      Central nervous system &mdash; 1 percent",
"     </li>",
"     <li>",
"      Other (laryngeal involvement, soft tissue, lymphatic, esophageal, joint, and tracheal involvement) &mdash; 3 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the same study, 56 patients (17 percent) had multiorgan involvement, primarily involving either the lungs (95 percent)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    skin (77 percent) and other organs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both acute and chronic blastomycosis may mimic other diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/9\">",
"     9",
"    </a>",
"    ]. This is due to the variability of the presentation of blastomycosis and its relative rarity. As an example, acute pulmonary blastomycosis may be initially diagnosed as community-acquired bacterial or viral pneumonia, whereas chronic pulmonary blastomycosis is often initially thought to be malignancy or tuberculosis. Skin lesions are frequently misdiagnosed as pyoderma gangrenosum or keratoacanthoma. Involvement of the larynx, brain, lymph nodes, skin, or other organs may be thought to be carcinoma.",
"   </p>",
"   <p>",
"    Thus, a high index of suspicion and aggressive collection of samples for microbiology and histologic evaluation should be performed when the diagnosis is uncertain and patients live in or have traveled to areas endemic for blastomycosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PULMONARY INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lungs are the usual portal of entry for blastomycosis. Patients may present with either acute or chronic pneumonia, although chronic pneumonia is more common. As defined in point source outbreaks, up to 50 percent of B. dermatitidis infections are asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. The incubation period from exposure until the onset of pulmonary symptoms is approximately three to six weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/11\">",
"     11",
"    </a>",
"    ]. The incubation period from exposure to the onset of extrapulmonary symptoms is highly variable.",
"   </p>",
"   <p>",
"    In a study that included 326 patients with blastomycosis, the following presenting symptoms were observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cough &mdash; 73 percent",
"     </li>",
"     <li>",
"      Fever &mdash; 54 percent",
"     </li>",
"     <li>",
"      Sputum production &mdash; 50 percent",
"     </li>",
"     <li>",
"      Chest pain &mdash; 41 percent",
"     </li>",
"     <li>",
"      Shortness of breath &mdash; 38 percent",
"     </li>",
"     <li>",
"      Weight loss of at least 5 percent &mdash; 37 percent",
"     </li>",
"     <li>",
"      Night sweats &mdash; 31 percent",
"     </li>",
"     <li>",
"      Chills &mdash; 28 percent",
"     </li>",
"     <li>",
"      Hemoptysis &mdash; 23 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other symptoms may include arthralgias, myalgias, and pleuritic chest pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute infection is frequently unrecognized unless related to a cluster of cases. The signs and symptoms of acute pulmonary blastomycosis usually begin abruptly and may be indistinguishable from viral or bacterial pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cough is initially nonproductive, but often becomes productive of purulent sputum as the disease progresses. Patients may also experience fever, shortness of breath, weight loss, night sweats,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other pulmonary or constitutional signs and symptoms. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Pulmonary involvement'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Chest radiography most commonly reveals alveolar infiltrates or a mass lesion, although miliary or reticulonodular patterns can also occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Chest computed tomography (CT) scanning may show nodules, consolidation with or without cavitation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tree-in-bud opacities (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83713 \" href=\"mobipreview.htm?12/18/12577\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef83714 \" href=\"mobipreview.htm?27/39/28279\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/17\">",
"     17",
"    </a>",
"    ]. Small pleural effusions are frequent. The lack of significant hilar adenopathy may be helpful in distinguishing blastomycosis from histoplasmosis, in which adenopathy is common. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42376?source=see_link\">",
"     \"Pathogenesis and clinical features of pulmonary histoplasmosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spontaneous resolution of acute pulmonary blastomycosis has been reported, but its frequency is unknown; patients with extrapulmonary manifestation often describe prior lung infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/14,18\">",
"     14,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients diagnosed with blastomycosis may have a chronic pneumonia that is clinically similar to tuberculosis, other fungal infections (eg, histoplasmosis), or bronchogenic carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ]. Diagnosis is often delayed for more than one month, even when patients seek medical attention within seven days of onset of illness, allowing patients to transition from acute to chronic pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/7\">",
"     7",
"    </a>",
"    ]. Many of these patients received multiple rounds of antibiotics before the diagnosis was established. Additionally, some patients are initially asymptomatic, but progress over time into the chronic form of blastomycosis. Symptoms may include low-grade fever, productive cough, hemoptysis, chest pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    weight loss.",
"   </p>",
"   <p>",
"    The radiographic findings are varied. Alveolar infiltrates with or without cavitation, mass lesions, and fibronodular infiltrates are most common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. Infiltrates are more frequently reported in the upper lobes. Small pleural effusions and pleural thickening have been reported, but large pleural effusions are uncommon. Significant pleural involvement was associated with a poor outcome in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Acute respiratory distress syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, patients may present with diffuse pneumonitis associated with acute respiratory distress syndrome (ARDS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1,20-22\">",
"     1,20-22",
"    </a>",
"    ]. In small case series, the mortality rate associated with ARDS due to blastomycosis was over 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/20,21\">",
"     20,21",
"    </a>",
"    ], and most deaths occurred during the first few days of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EXTRAPULMONARY BLASTOMYCOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although extrapulmonary disease has been reported in over 50 percent of patients with chronic blastomycosis, most of these studies were autopsy-based or were published prior to the availability of effective therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/2,3,23-27\">",
"     2,3,23-27",
"    </a>",
"    ]. In contrast, more recent studies have documented multiorgan disease in approximately 20 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Extrapulmonary disease is usually seen in conjunction with active pulmonary infection. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Sites of involvement'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Skin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin disease is the second most common manifestation of blastomycosis after pneumonia. The characteristic cutaneous finding is a verrucous lesion, with irregular borders (",
"    <a class=\"graphic graphic_picture graphicRef83716 \" href=\"mobipreview.htm?17/55/18295\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef83720 \" href=\"mobipreview.htm?19/53/20306\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef83721 \" href=\"mobipreview.htm?25/43/26289\">",
"     picture 4",
"    </a>",
"    ). The color may range from gray to violet. This lesion may mimic squamous cell carcinoma. Microabscesses form at the periphery of verrucous lesions and biopsies taken from the margins usually reveal broad-based budding organisms on microscopy. Ulcerative lesions that bleed easily and have well-demarcated, heaped-up borders may also occur (",
"    <a class=\"graphic graphic_picture graphicRef83717 \" href=\"mobipreview.htm?22/55/23414\">",
"     picture 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef83718 \" href=\"mobipreview.htm?3/55/3959\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subcutaneous nodules are cold abscesses that can be seen in patients with disseminated disease (",
"    <a class=\"graphic graphic_picture graphicRef83719 \" href=\"mobipreview.htm?35/24/36230\">",
"     picture 7",
"    </a>",
"    ). Microscopic examination from these lesions reveals broad-based budding yeasts typical of Blastomyces dermatitidis (",
"    <a class=\"graphic graphic_picture graphicRef63105 \" href=\"mobipreview.htm?27/35/28209\">",
"     picture 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef66379 \" href=\"mobipreview.htm?3/47/3839\">",
"     picture 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients with cutaneous disease resulting from dissemination of lung disease have little or no regional lymphadenopathy. In contrast, lymphadenitis is a prominent finding in patients with inoculation blastomycosis due to a dog bite or inoculation of pathology staff by autopsy accident [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. There is a report of transmission of blastomycosis after a bite wound from a kinkajou, an exotic pet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/31\">",
"     31",
"    </a>",
"    ]. &nbsp;However, the vast majority of cutaneous lesions are from hematogenous spread and not from direct inoculation. Patients with blastomycosis often have a history of pet dogs that died from blastomycosis. This suggests that both humans and their pets have become infected by aerosol inhalation from the environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bone and joint",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis is the next most common extrapulmonary manifestation of blastomycosis after cutaneous involvement, occurring in up to one-quarter of cases of patients with multiorgan disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/32\">",
"     32",
"    </a>",
"    ]. A retrospective study of 45 patients hospitalized with blastomycosis of bones or joints revealed that cutaneous disease was present in 33 (73 percent) and pulmonary disease in 29 (64 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/33\">",
"     33",
"    </a>",
"    ]. This study is consistent with results from the University of Mississippi Medical Center, in which patients with isolated skin disease were at risk for infection in other non pulmonary sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/7\">",
"     7",
"    </a>",
"    ]. Any bone may be involved, although the most common are the vertebrae, pelvis, and sacrum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients often present with soft tissue swelling or a chronic draining sinus tract adjacent to the focus of osteomyelitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ]. There is usually little or no bone pain associated with osteomyelitis due to blastomycosis.",
"   </p>",
"   <p>",
"    A well-circumscribed, osteolytic lesion is the most common radiographic finding. Vertebral disease can be radiographically similar to tuberculosis, with anterior involvement of the vertebral body and destruction of the disc interspace [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/34\">",
"     34",
"    </a>",
"    ]. Paravertebral abscesses are also commonly associated with vertebral blastomycosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/35\">",
"     35",
"    </a>",
"    ]. Biopsy of bone lesions caused by Blastomyces dermatitidis may reveal granuloma formation, suppuration,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Arthritis due to blastomycosis usually results from direct extension from osteomyelitis and may be acute or chronic in its presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Genitourinary system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrapulmonary blastomycosis occurs most commonly in men; genitourinary system involvement presents as prostatitis and epididymoorchitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Some patients have asymptomatic pyuria. Urine cultures are more likely to be positive if specimens are obtained after prostatic massage and the sediment is cultured after centrifugation.",
"   </p>",
"   <p>",
"    Rare cases of tuboovarian abscess or endometritis have been reported in women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/38\">",
"     38",
"    </a>",
"    ]. In one case report, a woman acquired blastomycosis by sexual transmission from a man who had disseminated disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Central nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blastomycosis of the central nervous system (CNS) is uncommon in immunocompetent hosts, and has been reported in fewer than 5 percent of cases. CNS infection may present as meningitis, epidural abscess, or intracranial abscesses, particularly in the cerebellum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/39\">",
"     39",
"    </a>",
"    ]. CNS involvement may occur in immunocompromised patients, especially those with AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/40\">",
"     40",
"    </a>",
"    ]. In a retrospective study of HIV-infected patients with blastomycosis, 6 of 15 had CNS involvement, usually manifested as single or multiple brain abscesses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/40\">",
"     40",
"    </a>",
"    ]. In one review, 10 of 22 patients with CNS blastomycosis were not considered to be immunosuppressed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/39\">",
"     39",
"    </a>",
"    ]. Of note, 17 of the 22 patients had evidence of blastomycosis in other organs as well.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;B. dermatitidis has been reported to involve almost every organ, including lymph nodes, liver, spleen, breast, adrenal gland, thyroid, and eye [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ]. Blastomycosis has also been reported in the mucosa of the nose, mouth, and larynx.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SPECIAL POPULATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;An estimated 10 percent of patients reported with blastomycosis are children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/8,10,41\">",
"     8,10,41",
"    </a>",
"    ]. The clinical spectrum in pediatric disease is similar to that in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pregnancy and perinatal transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blastomycosis has been reported, albeit infrequently, during pregnancy. Pregnant women are more likely to have disseminated disease than nonpregnant individuals; this may be related to the depressed cellular immunity associated with pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Perinatal transmission has been documented. Infection may result from aspiration of infected vaginal secretions during childbirth, an ascending vaginal infection associated with premature rupture of the membranes, or transplacental infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Immunocompromised hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;B. dermatitidis can behave as an opportunistic pathogen, especially in patients with advanced AIDS, transplant recipients, those who are prescribed TNF-alpha inhibitors, and other immunocompromised patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1,9,43,44\">",
"     1,9,43,44",
"    </a>",
"    ]. Pulmonary disease tends to be more severe in immunocompromised hosts, including findings of diffuse pulmonary infiltrates, large pleural effusions,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    respiratory failure. Additionally, disseminated disease is more common in immunocompromised patients, the clinical course is more aggressive, and there is a higher mortality rate (up to 40 percent) than in immunocompetent patients.",
"   </p>",
"   <p>",
"    Frequent relapses have been reported in patients with AIDS and in patients who remain on immunosuppressive therapy. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29912?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment of blastomycosis\", section on 'Immunocompromised hosts'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive diagnosis requires growth of the organism from a clinical specimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ]. Unlike Candida and Aspergillus spp, colonization or contamination with B. dermatitidis does not occur, which means that visualizing the organism on histology or obtaining a positive culture confirms the diagnosis of blastomycosis. Presumptive diagnosis of blastomycosis may be made by visualization of the characteristic yeast form in clinical specimens, such as sputum, tissue, or purulent material. In the appropriate clinical situation, visualization may justify beginning empirical antifungal therapy. Serology is not useful for the diagnosis of blastomycosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identification of B. dermatitidis by culture depends upon growth of the organism in the mycelial phase and conversion of the mycelial phase to the yeast phase, or use of a commercially available DNA probe that allows the rapid identification of a mold that has grown in culture as being B. dermatitidis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/45\">",
"     45",
"    </a>",
"    ]. The mold form of the organism is not difficult to culture from most clinical specimens using Sabouraud dextrose agar without cycloheximide at 25 to 30&ordm;C; it typically grows within one to four weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"     1",
"    </a>",
"    ]. The mycelial phase produces spherical, oval, or pyriform conidia from aerial hyphae. At 37&ordm;C, B. dermatitidis colonies are wrinkled, pasty, and moist. The yeast cell, whether in vitro or in tissue, is thick-walled and spherical, producing single buds with a broad base of attachment between the bud and parent cell (",
"    <a class=\"graphic graphic_picture graphicRef66379 \" href=\"mobipreview.htm?3/47/3839\">",
"     picture 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63105 \" href=\"mobipreview.htm?27/35/28209\">",
"     picture 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In adult patients with pulmonary blastomycosis, sputum culture has a high yield (75 percent per single sample, 86 percent per patient) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/46\">",
"     46",
"    </a>",
"    ]. Specimens obtained for culture by bronchoscopy yield a positive diagnosis in 92 percent of patients. Specimens are frequently contaminated with bacteria that inhibit fungal growth, and should thus also be cultured on medium containing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Direct examination of clinical specimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although wet preparations have a relatively low diagnostic yield (36 percent for a single specimen and 46 percent for multiple specimens) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/46\">",
"     46",
"    </a>",
"    ], the simplicity and low cost of the procedure, as well as its potential for rapid diagnosis, justify a wet preparation on all clinical specimens.",
"   </p>",
"   <p>",
"    Fresh wet preparations of sputum, pleural fluid, bronchoalveolar lavage fluid, cerebrospinal fluid, urine, purulent material, skin scrapings, or tissue impression smears may be examined directly with calcofluor white, 10 percent potassium hydroxide (KOH), or both. KOH has been recommended to aid in finding yeast and fungal elements, but most laboratories have supplanted this with calcofluor white, which causes the yeast cell wall to fluoresce. Calcofluor white staining requires use of a fluorescence microscope but is easy, rapid, and particularly useful when organisms are sparse.",
"   </p>",
"   <p>",
"    It is useful to concentrate clinical specimens, such as sputum, urine, pleural fluid, and cerebrospinal fluid by centrifugation. It is also helpful to digest sputum samples with trypsin and smear the centrifuged sediment.",
"   </p>",
"   <p>",
"    When visualized, the yeast cells are easily differentiated from others on the basis of their size (8 to 15 microns in diameter), refractile cell wall, and single, broad-based buds (",
"    <a class=\"graphic graphic_picture graphicRef66379 \" href=\"mobipreview.htm?3/47/3839\">",
"     picture 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63105 \" href=\"mobipreview.htm?27/35/28209\">",
"     picture 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef62300 \" href=\"mobipreview.htm?6/60/7104\">",
"     picture 10",
"    </a>",
"    ). Occasionally, the endospores of Coccidioides species may resemble single yeast cells, but the presence of broad-based budding yeasts can be used to distinguish B. dermatitidis. Paracoccidioides brasiliensis, rarely seen in the United States, is distinguished from B. dermatitidis by the presence of multiple, narrow-based buds arranged around the periphery of the mother cell. B. dermatitidis may sometimes be as small as Cryptococcus neoformans, although the capsule and narrow-based bud of the latter aid in differentiation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13751?source=see_link\">",
"     \"Laboratory diagnosis of coccidioidomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/4/36935?source=see_link\">",
"     \"Clinical manifestations and diagnosis of chronic paracoccidioidomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/24/37254?source=see_link\">",
"     \"Microbiology and epidemiology of cryptococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients who are not producing sputum or in whom lung imaging indicates the possibility of malignancy, bronchoscopy is particularly useful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/46\">",
"     46",
"    </a>",
"    ]. In addition to fungal staining and culture, bronchial washings, bronchoalveolar lavage fluid, and post-bronchoscopy sputum samples should be evaluated using cytology because the organism is often visualized on Papanicolaou preparations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pyogranulomatous tissue response is frequently seen in blastomycosis and should signal the possibility of this fungus. Yeast forms can be difficult to visualize with routine hematoxylin and eosin stains, and special stains, such as the methenamine silver stain or the periodic acid-Schiff (PAS) stain, are particularly useful for examining tissue for the presence of fungal elements (",
"    <a class=\"graphic graphic_picture graphicRef83714 \" href=\"mobipreview.htm?27/39/28279\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Serologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is not useful for the diagnosis of blastomycosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/48\">",
"     48",
"    </a>",
"    ], owing to the high degree of cross-reactivity shared by the endemic mycoses, most notably Histoplasma capsulatum. Immunodiffusion assays that measure antibody to Blastomyces dermatitidis A antigen are relatively specific, but sensitivity is only 28 to 64 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Complement fixation tests perform even less well, with sensitivities of 9 to 43 percent and poor specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Enzyme immunoassays employing A antigen are the least reliable, with greater sensitivity but lower specificity compared with other methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/49-52\">",
"     49-52",
"    </a>",
"    ]. A serologic assay employing the BAD1 recombinant protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/53\">",
"     53",
"    </a>",
"    ] or yeast phase lysates from multiple sources of B. dermatitidis have been explored for IgM and IgG antibody detection in an effort to improve immunodiagnostic testing for blastomycosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Although these tests are promising, they have not been validated using human specimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Nucleic acid detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular identification of B. dermatitidis has been accomplished by a variety of techniques, including polymerase chain reaction (PCR) assays for ribosomal genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/56,57\">",
"     56,57",
"    </a>",
"    ], the ITS-region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/56\">",
"     56",
"    </a>",
"    ], repetitive sequences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/57\">",
"     57",
"    </a>",
"    ], and species- or genus-specific genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Real-time PCR assays have been developed that can identify B. dermatitidis in culture specimens, as well as in various clinical specimens (eg, bronchial washings, bronchoalveolar fluid, pleural fluid, sputum, blood) and paraffin-embedded tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. PCR techniques, although promising, are labor-intensive, are not routinely available, and their utility has not been confirmed in large prospective studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Antigen detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The detection of fungal antigens in serum and urine has proven useful in the diagnosis and treatment of patients with certain invasive mycoses, such as histoplasmosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/48\">",
"     48",
"    </a>",
"    ]. An antigen detection assay for blastomycosis is currently available for clinical use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/62\">",
"     62",
"    </a>",
"    ]. The sensitivity of this assay is 89 percent in disseminated blastomycosis and 93 percent overall. Sensitivity is higher in urine than in serum. However, specificity is modest, 79 percent overall, and due to cross-reactive antigens present in specimens obtained from patients with histoplasmosis, paracoccidioidomycosis, and penicilliosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/63\">",
"     63",
"    </a>",
"    ]. Cross-reactivity was less than 5 percent for patients with aspergillosis or cryptococcosis and less than 2 percent in healthy adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antigen levels appear to decline with successful treatment and increase with recurrence of illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. In a more recent review, 23 of 27 patients (85 percent) with recently diagnosed blastomycosis had antigenuria detected while none of 50 control subjects had B. dermatitidis antigenuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/57/35736/abstract/66\">",
"     66",
"    </a>",
"    ]. Despite the benefits of antigen detection, its utility is limited given the ease of diagnosis by conventional methods and the modest specificity provided by these assays.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical manifestations of blastomycosis are varied and include asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease. Although B. dermatitidis has been reported to involve almost every organ, the lungs are the most common site. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both acute and chronic blastomycosis often mimic other diseases. Acute pulmonary blastomycosis may be initially diagnosed as community-acquired bacterial or viral pneumonia, whereas chronic pulmonary blastomycosis is most often thought to be malignancy or tuberculosis. Acute infection is frequently unrecognized unless related to a cluster of cases. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Acute pneumonia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients present with chronic pneumonia. Skin disease is the second most common manifestation, and is characterized by verrucous lesions (",
"      <a class=\"graphic graphic_picture graphicRef83716 \" href=\"mobipreview.htm?17/55/18295\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef83720 \" href=\"mobipreview.htm?19/53/20306\">",
"       picture 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef83721 \" href=\"mobipreview.htm?25/43/26289\">",
"       picture 4",
"      </a>",
"      ), ulcerative lesions (",
"      <a class=\"graphic graphic_picture graphicRef83717 \" href=\"mobipreview.htm?22/55/23414\">",
"       picture 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef83718 \" href=\"mobipreview.htm?3/55/3959\">",
"       picture 6",
"      </a>",
"      ), or subcutaneous nodules (",
"      <a class=\"graphic graphic_picture graphicRef83719 \" href=\"mobipreview.htm?35/24/36230\">",
"       picture 7",
"      </a>",
"      ). Osteomyelitis is the next most common extrapulmonary manifestation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chronic pneumonia'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Skin'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Bone and joint'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary disease tends to be more severe in immunocompromised hosts. There is a higher mortality rate (up to 40 percent) than in immunocompetent patients. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Immunocompromised hosts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Definitive diagnosis requires culturing the organism from clinical specimens, but a presumptive diagnosis of blastomycosis may be made by visualization of the characteristic yeast form in clinical specimens such as sputum, tissue, or purulent material. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/1\">",
"      Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010; 23:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/2\">",
"      KAPLAN W, CLIFFORD MK. BLASTOMYCOSIS. I. A REVIEW OF 198 COLLECTED CASES IN VETERANS ADMINISTRATION HOSPITALS. Am Rev Respir Dis 1964; 89:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/3\">",
"      Witorsch P, Utz JP. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 1968; 47:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/4\">",
"      Martin, DS, Smith, DT. Blastomycosis I: A review of the literature. Am Rev Tuberc 1939; 39:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/5\">",
"      Bradsher RW, Rice DC, Abernathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985; 103:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/6\">",
"      Baumgardner DJ, Buggy BP, Mattson BJ, et al. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis 1992; 15:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/7\">",
"      Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997; 12:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/8\">",
"      Crampton TL, Light RB, Berg GM, et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis 2002; 34:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/9\">",
"      Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am 2003; 17:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/10\">",
"      Klein BS, Vergeront JM, DiSalvo AF, et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987; 136:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/11\">",
"      Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect 1986; 1:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/12\">",
"      Proctor ME, Klein BS, Jones JM, Davis JP. Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation. Mycopathologia 2002; 153:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/13\">",
"      Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/14\">",
"      Vaaler AK, Bradsher RW, Davies SF. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med 1990; 89:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/15\">",
"      Sheflin JR, Campbell JA, Thompson GP. Pulmonary blastomycosis: findings on chest radiographs in 63 patients. AJR Am J Roentgenol 1990; 154:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/16\">",
"      Brown LR, Swensen SJ, Van Scoy RE, et al. Roentgenologic features of pulmonary blastomycosis. Mayo Clin Proc 1991; 66:29.",
"     </a>",
"    </li>",
"    <li>",
"     Fungal and parasitic infection. In: Imaging of Pulmonary Infections, Muller NL, Franquet T, Soo Lee K.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/18\">",
"      Sarosi GA, Davies SF, Phillips JR. Self-limited blastomycosis: a report of 39 cases. Semin Respir Infect 1986; 1:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/19\">",
"      Kinasewitz GT, Penn RL, George RB. The spectrum and significance of pleural disease in blastomycosis. Chest 1984; 86:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/20\">",
"      Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993; 329:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/21\">",
"      Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001; 5:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/22\">",
"      Lahm T, Neese S, Thornburg AT, et al. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. Chest 2008; 133:1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/23\">",
"      CHERNISS EI, WAISBREN BA. North American blastomycosis: a clinical study of 40 cases. Ann Intern Med 1956; 44:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/24\">",
"      ABERNATHY RS. Clinical manifestations of pulmonary blastomycosis. Ann Intern Med 1959; 51:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/25\">",
"      Lockwood WR, Allison F Jr, Batson BE, Busey JF. The treatment of North American blastomycosis. Ten years' experience. Am Rev Respir Dis 1969; 100:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/26\">",
"      Duttera MJ Jr, Osterhout S. North American blastomycosis: a survey of 63 cases. South Med J 1969; 62:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/27\">",
"      Busey JF. Blastomycosis. 3. A comparative study of 2-hydroxystilbamidine and amphotericin B therapy. Am Rev Respir Dis 1972; 105:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/28\">",
"      Gnann JW Jr, Bressler GS, Bodet CA 3rd, Avent CK. Human blastomycosis after a dog bite. Ann Intern Med 1983; 98:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/29\">",
"      Larson DM, Eckman MR, Alber RL, Goldschmidt VG. Primary cutaneous (inoculation) blastomycosis: an occupational hazard to pathologists. Am J Clin Pathol 1983; 79:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/30\">",
"      Gray NA, Baddour LM. Cutaneous inoculation blastomycosis. Clin Infect Dis 2002; 34:E44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/31\">",
"      Harris JR, Blaney DD, Lindsley MD, et al. Blastomycosis in man after kinkajou bite. Emerg Infect Dis 2011; 17:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/32\">",
"      Moore RM, Green NE. Blastomycosis of bone. A report of six cases. J Bone Joint Surg Am 1982; 64:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/33\">",
"      Oppenheimer M, Embil JM, Black B, et al. Blastomycosis of bones and joints. South Med J 2007; 100:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/34\">",
"      G&uuml;ler N, Palanduz A, Ones U, et al. Progressive vertebral blastomycosis mimicking tuberculosis. Pediatr Infect Dis J 1995; 14:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/35\">",
"      Saccente M, Abernathy RS, Pappas PG, et al. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature. Clin Infect Dis 1998; 26:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/36\">",
"      Inoshita T, Youngberg GA, Boelen LJ, Langston J. Blastomycosis presenting with prostatic involvement: report of 2 cases and review of the literature. J Urol 1983; 130:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/37\">",
"      Seo R, Oyasu R, Schaeffer A. Blastomycosis of the epididymis and prostate. Urology 1997; 50:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/38\">",
"      Amin M, Lich R Jr. Blastomycosis of the genitourinary tract. J Urol 1975; 113:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/39\">",
"      Bariola JR, Perry P, Pappas PG, et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010; 50:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/40\">",
"      Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/41\">",
"      Dworkin MS, Duckro AN, Proia L, et al. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005; 41:e107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/42\">",
"      Lemos LB, Soofi M, Amir E. Blastomycosis and pregnancy. Ann Diagn Pathol 2002; 6:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/43\">",
"      Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/44\">",
"      Serody JS, Mill MR, Detterbeck FC, et al. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis 1993; 16:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/45\">",
"      Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol 1993; 31:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/46\">",
"      Martynowicz MA, Prakash UB. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 2002; 121:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/47\">",
"      Lemos LB, Baliga M, Taylor BD, et al. Bronchoalveolar lavage for diagnosis of fungal disease. Five years' experience in a southern United States rural area with many blastomycosis cases. Acta Cytol 1995; 39:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/48\">",
"      Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 2006; 8:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/49\">",
"      Klein BS, Kuritsky JN, Chappell WA, et al. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis. Am Rev Respir Dis 1986; 133:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/50\">",
"      Klein BS, Vergeront JM, Kaufman L, et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 1987; 155:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/51\">",
"      Bradsher RW, Pappas PG. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J 1995; 88:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/52\">",
"      Sekhon AS, Kaufman L, Kobayashi GS, et al. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol 1995; 33:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/53\">",
"      Soufleris AJ, Klein BS, Courtney BT, et al. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis 1994; 19:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/54\">",
"      Abuodeh RO, Chester EM, Scalarone GM. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources. Mycoses 2004; 47:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/55\">",
"      Sestero CM, Scalarone GM. Detection of IgG and IgM in sera from canines with blastomycosis using eight blastomyces dermatitidis yeast phase lysate antigens. Mycopathologia 2006; 162:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/56\">",
"      Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33:2913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/57\">",
"      Bialek R, Cirera AC, Herrmann T, et al. Nested PCR assays for detection of Blastomyces dermatitidis DNA in paraffin-embedded canine tissue. J Clin Microbiol 2003; 41:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/58\">",
"      Hayden RT, Qian X, Roberts GD, Lloyd RV. In situ hybridization for the identification of yeastlike organisms in tissue section. Diagn Mol Pathol 2001; 10:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/59\">",
"      Abbott JJ, Hamacher KL, Ahmed I. In situ hybridization in cutaneous deep fungal infections: a valuable diagnostic adjunct to fungal morphology and tissue cultures. J Cutan Pathol 2006; 33:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/60\">",
"      Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol 2012; 50:1783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/61\">",
"      Babady NE, Buckwalter SP, Hall L, et al. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol 2011; 49:3204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/62\">",
"      Durkin M, Witt J, Lemonte A, et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42:4873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/63\">",
"      Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997; 24:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/64\">",
"      Tarr M, Marcinak J, Mongkolrattanothai K, et al. Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent. Infect Dis Obstet Gynecol 2007; 2007:89059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/65\">",
"      Mongkolrattanothai K, Peev M, Wheat LJ, Marcinak J. Urine antigen detection of blastomycosis in pediatric patients. Pediatr Infect Dis J 2006; 25:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/57/35736/abstract/66\">",
"      Bariola JR, Hage CA, Durkin M. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis 2011.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2437 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.146-E8BDD971E0-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35736=[""].join("\n");
var outline_f34_57_35736=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SITES OF INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PULMONARY INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EXTRAPULMONARY BLASTOMYCOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bone and joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Genitourinary system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Central nervous system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other sites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SPECIAL POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pregnancy and perinatal transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Direct examination of clinical specimens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Serologic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Nucleic acid detection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Antigen detection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2437\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2437|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?12/18/12577\" title=\"diagnostic image 1\">",
"      Blastomycosis chest CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2437|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/39/28279\" title=\"picture 1\">",
"      Blastomycosis chest CT and histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/55/18295\" title=\"picture 2\">",
"      Verrucous skin lesion in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/53/20306\" title=\"picture 3\">",
"      Verrucous skin lesions in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/43/26289\" title=\"picture 4\">",
"      Skin lesion in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/55/23414\" title=\"picture 5\">",
"      Ulcerative breast lesion in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/55/3959\" title=\"picture 6\">",
"      Ulcerative lesion in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/24/36230\" title=\"picture 7\">",
"      Subcutaneous nodules in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/35/28209\" title=\"picture 8\">",
"      Budding of yeast phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/47/3839\" title=\"picture 9\">",
"      B dermatitidis wet mount",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/60/7104\" title=\"picture 10\">",
"      Refractile cell wall in yeast",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/4/36935?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic paracoccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13751?source=related_link\">",
"      Laboratory diagnosis of coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/24/37254?source=related_link\">",
"      Microbiology and epidemiology of cryptococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/79?source=related_link\">",
"      Mycology, pathogenesis, and epidemiology of blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42376?source=related_link\">",
"      Pathogenesis and clinical features of pulmonary histoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29912?source=related_link\">",
"      Treatment of blastomycosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_57_35737="Spindle cell carcinoma Light";
var content_f34_57_35737=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58508&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58508&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Spindle cell carcinoma of the head and neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of a spindle cell carcinoma (left panel). The growth pattern is one of interlacing fascicles or pinwheel (storiform) arrangements. These tumors need to be distinguished from sarcomas and melanomas, and immunostains for cytokeratin (right panel) are useful in this regard.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of G Kenneth Haines, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35737=[""].join("\n");
var outline_f34_57_35737=null;
var title_f34_57_35738="M-mode echo peripartum CM I";
var content_f34_57_35738=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75329%7ECARD%2F54340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75329%7ECARD%2F54340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peripartum cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    M-mode echocardiogram of a patient with peripartum cardiomyopathy (38 weeks gestation) shows left ventricular dilatation and severely reduced left ventricular function.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Recovered peripartum cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    M-mode echocardiogram obtained two weeks after delivery shows clinical recovery from the cardiomyopathy. Left ventricular dimensions are normal and left ventricular dysfunction has resolved.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35738=[""].join("\n");
var outline_f34_57_35738=null;
var title_f34_57_35739="Pregnancy rate and cost per cycle for treatment";
var content_f34_57_35739=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61307&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61307&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated pregnancy rate and cost per cycle for treatment of unexplained infertility",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pregnancy rate per cycle",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cost per cycle in US dollars",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Expectant management",
"       </td>",
"       <td class=\"centered\">",
"        1 to 3",
"       </td>",
"       <td class=\"centered\">",
"        Less than 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IUI",
"       </td>",
"       <td class=\"centered\">",
"        4 to 6",
"       </td>",
"       <td class=\"centered\">",
"        300",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clomiphene citrate",
"       </td>",
"       <td class=\"centered\">",
"        4 to 6",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clomiphene plus IUI",
"       </td>",
"       <td class=\"centered\">",
"        7 to 9",
"       </td>",
"       <td class=\"centered\">",
"        400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gonadotropin injection",
"       </td>",
"       <td class=\"centered\">",
"        4 to 10",
"       </td>",
"       <td class=\"centered\">",
"        2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gonadotropin injection plus IUI",
"       </td>",
"       <td class=\"centered\">",
"        9 to 16",
"       </td>",
"       <td class=\"centered\">",
"        2300",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In vitro fertilization",
"       </td>",
"       <td class=\"centered\">",
"        20 to 40",
"       </td>",
"       <td class=\"centered\">",
"        12,000",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IUI: intrauterine insemination.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35739=[""].join("\n");
var outline_f34_57_35739=null;
var title_f34_57_35740="General management of patients with complicated PUD";
var content_f34_57_35740=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F65479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F65479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    General management of patients with complicated peptic ulcer disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Initial management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Monitor blood pressure, electrocardiogram, and oxygen saturation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Provide supplemental oxygen, if oxygen saturation is reduced.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Patient should take nothing by mouth.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Ensure adequate intravenous access.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Elective/urgent endotracheal intubation for patients with ongoing hematemesis, respiratory failure, or altered mental status.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Fluid resuscitation, plus blood transfusions, as needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Give intravenous, full dose PPI.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Obtain gastroenterology consultation for consideration of upper endoscopy, unless perforation is suspected.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Obtain surgical consultation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Once patient is tolerating oral intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Switch to full dose oral PPI twice daily.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Treat for",
"        <em>",
"         H. pylori",
"        </em>",
"        if tests are positive*.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Ensure non-aspirin NSAIDs are stopped, if at all possible. Otherwise, switch to celecoxib plus PPI and monitor closely, including periodic endoscopy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Stop aspirin, including low-dose aspirin, if possible.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. For gastric ulcers, at 4 to 6 weeks, perform upper endoscopy to evaluate healing and exclude neoplasia (unless there is confidence that the stomach and duodenum were adequately evaluated endoscopically or surgically during hospitalization). Giant duodenal ulcers also warrant follow-up endoscopy to ensure healing and exclude rare malignancy or other etiologies.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        6. If initial tests for",
"        <em>",
"         H. pylori",
"        </em>",
"        are negative, at roughly 4 weeks (or later for large ulcers):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Switch to full dose H2 receptor antagonists and continue for two weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. If an upper endoscopy will be performed, biopsy for",
"        <em>",
"         H. pylori",
"        </em>",
"        urease testing and histology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. If upper endoscopy will not be performed, obtain an",
"        <em>",
"         H. pylori",
"        </em>",
"        breath test or stool antigen test",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PPI: proton pump inhibitor;",
"     <em>",
"      H. pylori",
"     </em>",
"     :",
"     <em>",
"      Helicobacter pylori",
"     </em>",
"     ; NSAID: nonsteroidal antiinflammatory drug.",
"     <br>",
"      * With an established ulcer,",
"      <em>",
"       H. pylori",
"      </em>",
"      is only ruled out when two tests obtained while the patient is off of antibiotics, PPIs, and bismuth are negative.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35740=[""].join("\n");
var outline_f34_57_35740=null;
var title_f34_57_35741="Opioid intoxication in children and adolescents - Rapid overview";
var content_f34_57_35741=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69375&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69375&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Opioid intoxication in children and adolescents: Rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span style=\"color: #ff0000;\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depressed mental status ranging from lethargy to coma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miotic pupils (often pinpoint)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depressed respirations including apnea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bradycardia and hypotension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased to absent bowel sounds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Track marks (adolescents with IV drug abuse)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Ancillary studies",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blood glucose and pulse oximetry in patients with coma and depressed respirations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum ethanol level, especially in adolescents with recreational or suicidal overdose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum acetaminophen if suicidal intent or ingestion of combination medications (eg, acetaminophen with oxycodone)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrocardiogram in patients intoxicated with methadone (prolonged QTc) or propoxyphene (prolonged QRS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest radiograph in patients with persistent respiratory findings that suggest pulmonary aspiration or noncardiogenic pulmonary edema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinalysis, serum electrolytes, blood urea nitrogen, creatinine, and creatine kinase in patients with prolonged immobilization or muscular rigidity at risk for rhabdomyolysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rapid urine pregnancy test in postmenarchal girls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rapid urine testing for opioids in young children and infants with coma from unknown cause or in whom intentional poisoning by a caretaker is suspected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Support airway and breathing using bag-mask ventilation with 100 percent inspired oxygen until naloxone is administered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Give naloxone for deep coma and respiratory depression as follows",
"        <sup>",
"         &sect;",
"        </sup>",
"        :",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        - Children &lt;20 kg: 0.1 mg/kg IV or IO (maximum 2 mg per dose)",
"        <strong>",
"         except neonates",
"        </strong>",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        - Children over 20 kg: 2 mg IV or IO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        - Adolescents suspected of opioid addiction: 0.04 to 0.4 mg per dose repeated every 3-5 minutes and titrated to patient response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        - If no effect, repeat the naloxone dose every one to two minutes to a maximum total dose of 10 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         - Patients with recurrent toxicity may receive additional bolus doses or a continuous naloxone infusion. Begin the infusion rate at 2/3 of the total dose of naloxone needed to restore breathing, delivered every hour.",
"        </p>",
"        <ul>",
"         <li>",
"          If the patient develops respiratory depression despite the naloxone infusion (this may happen 20 to 30 minutes after starting infusion) administer a naloxone bolus (using half the original effetive bolus dose) and repeat if necessary until adequate ventilation returns, then increase the infusion rate",
"         </li>",
"         <li>",
"          If the patient develops signs of opioid withdrawal, stop the infusion. If respiratory depression returns, start the infusion at half the original rate.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Give activated charcoal (1 gram/kg orally or by nasogastric tube, maximum dose 50 grams) to alert young children and adolescents who present within one hour of oral overdose",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In cases of suspected child abuse, consult an experienced children protection team (if available) and report suspicion to the appropriate governmental agency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Consult psychiatry for patients with substance abuse or suicidal intent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IO: intraosseous; AC: activated charcoal; ET: endotracheal tube; IM: intramuscular.",
"     <br>",
"      * The diagnosis of opioid intoxication is based upon clinical features and response to antidotal therapy.",
"      <br>",
"       &Delta; Small pupils are not always present in children and adolescents with opioid intoxication.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        Other ancillary studies may be indicated in selected patients in whom trauma, infection, or other etiologies besides poisoning are suspected. (See \"Evaluation of stupor and coma in children\" and \"Approach to the child with occult toxic exposure\").",
"        <br>",
"         &sect; Naloxone may also be given intramuscularly or intratracheally via endotracheal tube (ET) in children or adolescents with poor IV access. If an endotracheal tube is present, ET administration is preferred over intramuscular, if IV and IO routes not available. ET dose is approximately two to three times IV dose.",
"         <br>",
"          &yen; Naloxone administration is not recommended as part of initial resuscitation of neonates in the delivery room. Refer to UpToDate topics on neonatal resuscitation.",
"          <br>",
"           &Dagger; AC should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first or naloxone therapy is effective in maintaining an alert state. Endotracheal intubation should not be performed solely for the purpose of giving AC.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35741=[""].join("\n");
var outline_f34_57_35741=null;
var title_f34_57_35742="Serum prolactin and suckling";
var content_f34_57_35742=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F59612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F59612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Serum prolacin and suckling",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 300px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Serum prolactin concentrations basally and in response to suckling as a function of time after delivery. Within the first week after delivery, the basal value is high relative to the nonpregnant state, and there may be a further increase in response to suckling. Several weeks after delivery, the basal value is close to that of the nonpregnant state, but there is still a pronounced increase in response to suckling. Three months after delivery, the basal value is similar to that of the nonpregnant state, and there is a minimal response to suckling, if any.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Tyson, JE, Ito, P, Guyda, H, et al, Am J Obstet Gynecol 1972; 113:14.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35742=[""].join("\n");
var outline_f34_57_35742=null;
var title_f34_57_35743="Renal angiomyolipoma CT";
var content_f34_57_35743=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan showing renal angiomyolipoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 328px; height: 288px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEgAUgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5sxRiiigAxRiiigAxRiil7UAJigCiloATFGKWigBMUYoooAMUYoooAMUYoooAMUYoooAMUYoooAMUYoooAMUYoooAMUYoooAMUYoooAMUYopaAExRilpKADFGKKKADFGKKKADFGKKKADFGKKKADFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAC0lLSUAFFFLQAlFLRQAYopaKAEooooASilooASiloxQAlLRijFACUUuD6UYNACUUuDRg0AJRS4NGKAEopcUYoAKSlxRigAopKKACiiigBcUYpwooAbirTafcLb+cUGMbioOXVf7xXqF6cn1FQEZU8j0xXWXniSF7a8e1DW7XdhHYXFuHZjKVCfvGbGNuYwQvagDkce9G33pxpO9ACbfejb7040tADNtLtHrTh1wASfQdasizkA3SlIR/tnk/QUAVNo96Noq8IbaMncZZfxCino8anKQRgA/xfN/OgDOwM/wD16NvTrWkZWJGNo7cKKQTyD+M/QUAZ+32NKEP90/kaviaQZIdufenfa5wf9Y59OaAM3C56igbT6VqC5mGCX568gUNcPIwZkjbae6jmgDMwKMVpmVW4aG3/AATH8qZ+5wc28efXmgDOpausITnEIz7NTQIs/wCoXI/2jQBUoq2xX+GJQM0hcg8cD6UAVQCegJp4hkI+4ce9TbiepNIQW6mgCPyW77QfdqPJAPMqAevJp5H0xSdDQAwxrjO8/gKPLTuzflSnofWlxQAnlx+r/lSGNOzn8RS0UAN8o4yrKfx5pjIVxuGM1IaUMw6HFAEFFTHa33htOeo/wqNkK89R6jpQA2kPTNLSHpQAlLSUUAFFFFAD6KKKADnBOOPWu0t/7Ph09dxW5sZdMbeo3rHbXe04LHo0mQCB0+YelcX/ACoNABS/jSd6fGjOyqgLMegHegBKsRWpKh5m8pD0z1P0FTokVsR92Wf1/hQ+3qaiZizFnO5vXqTQBIkqxgLbgRnpvPLH8f8ACmliclmyffmmjI5wDTgCT0oAMBsYOD2oK569aeEYrnGQfSpNjc4XI9cUAQFT6YFBBzn3/OpSMcHIFIwxjjHuDQBGR34z0pRj8fSnYPTAyeuaAOx60AMUE+wpfbvSrnvj0pzKcnIAHWgBuCOOgpCe3anAdyRTSB3/AP10ANwecnFK3QfSlHQ55P0pwHWgBmPWgj3z2zin455/I004z/h3oAjxkfSlAyCMU7Bx+tKARzntQBHjOc0n86kCjtz+FKIXPCqfyoAgx7Uc1ZS2kJHynJ6DHarDadJHGGKk7qAM/Hp3pNufU1fgt90mwjntXS6L4cjvHCyTIuVLZxnPtQBxJBo2+ld9qHgG7MZlsCs8acNt6r9a469025tGxPG6fUYoAokGkDFfcHqOxp5z0pp7mgBGQMNyfivpUR6VMCRgg4PrTZQGXeuB6j0oAhooooAKKKKAH0UUUAFGKKUc8Y56UAORGd1VQSzHAFXBi3DImGc/ff19h7UhT7KrRkDzm4c/3fYU1QeMZ+lACHHAI4pVyOcZ/rThyMLkU5UJIGCSemKABEL/AHRx6YrW0/Rp7pC6xkovVsH8q6H4aeGIde1+GPUGki09CTNKvr2XPvXvkXhrRNK04z+SrRQyYWMHAOPU9aAPn06BJYR7ry3kCyplPkIz74Paqv8AZrINxi2R9snr+FdZ4w1++1bWp5IV2WkWVTC8Mo7D2xXM2Ejy33m3LhiCMKTgCgCCTRJHw0SEg9vUVVk8P3QxsQsvTPavRLSJLjBSQM6AMFXvUq4PmRyoz4BK5XJB9KAPNDodxg/IeuCcd6qS6dcI21o3znPQ1639lBj/AHp6LyD2aqN0BIqxi3jZud2G5NAHlv2aRTtMZwfamvGwPK4A716lDp8RIE6KSxzlRx9Ko3tjpkIxNDgA84OA1AHm5XGOOfQ00rnnHWur1RtGgBWFJJHOcBWwFrAe5jB/dQqpz35NAFVVbcMZPXtTgpyflxtG4j2/z2qU3DE5AQEdsdqEuZQTyoPrigCDa2OFPvxSJG7HhST9OlTefJycgEe1S2+oypJkqh9Pl70APg0m6lYBEySM/Sr9l4fkmUs5VSoz07VJba+sbDfbjGMMAetaf/CQ2UjghJIsDouMCgBLXw9CkZaRHkfGdq9ee9aaaJaRo58pnKjjJwMf1p1t4h0w8KzhuTlv4SetLHrllyolOS3c9v8ACgCt/ZcSXo3wbUXkjHI96ypbgb50CqxRio9CPU1svcw6hL+6nKnG0hjwR2qvD4YaRWmEp2Hv/e+lAHFOG85mTO4nPFXTLfqgZPMDDqRXWLodrZktIrbQcMzHNR6hqNvCvlRiNVxgZ7UAReEvHFzpFxGLksyE4cMMhwfX6V3mqW1j4ntPOjWLeRhWYdPwHWvK55ba7BSfbwQAyjHHtWrpOpXGlxi7tJ1eAZUgrkHjigDF8XeG59IuB8reW4JVtpAYe1cw1eqa34pttf0mKyuI/LZFyshIyWPYegrzW+gMMzDBHNAFQ5zxTJPu81IaZIPkoAipKKKACiiigB9L3pBS0AFW7RPKQXB+9kiMe/c1BbxedKE3BR1LHsKszP5kny8IBhR6CgCPBPU596cvsMHrSZH+e9SIvfPNAD1A9OvNdNonhy5uVikZQomO1ST90d80nhvRWmCXM0ZeMnbGgPLN/hXtGg6K9nbI7AecFLyF/m2LQAmh6Z/ZGkLb2EBECsQWY8lvr3qtrV/LcB0Xa7bQqRqTjHqferWsam2ox22n2czQ2VuC+QcYOeW465p9jpRwH8tdpwFcN29TQByz6d5xO9lYY3MuTjGf8arQ+GI55iyKqrk4cn8s+tdXPFavcuQGkhgYbynBJHX61bi1TTbXEfnW6txkMuSo+nGPTP8AhQByQ8P39sD5UUfmgDaQTznnNZd3a6yZSPIePd3zxmvQj4p0yNyq3BkkxjaBkt7A1mz+NNPDSiM+ZOOCGGfoB70AcHFNqVlE6zQqxU9Sf85rHvfE1yGZI4liYjDY6/Wug1+9l1SCSWK1dWHygZxtHc81x8sdq4kyzrsOMgZoASTxBfMuzzcK3UKKqXEtxdyBZJN2OhJ6UlykUS5Eu7jIIGKWwu7ETr5m8dAcjrQBt6H4QutVO5CAvTJ65PT6D3rrLP4VSyk+bOqKo5yDVzwp4q07TEjiu5NoUYwq9fqe9dgnjzw15AYakSRyVaNsj2x3oA4dvhVIGBS4jeIjk5wc1nT/AA4uFJWMF29Ac5rsb34l6RDMfsi3M4Axwm0H61z198Q9RuHePS7XbvyFyORmgDnLvwJeQRO7phE6tnpXL3GnRxSbRJkkkc9q6zUDq+ouX1Kd2AwpCvwvHtVddPhMBeGSNVTG4MNzE0AcwmmyvnywDg8Z4zTfsNy33UL+u3np2rq7dJvM2i182JRguq4xV2yistKklkWKcSTHcUboFz70AefmGRSQYyD6YqSG1dioZljJ4JJxXpGoXEuo2DmxFsr7gA0mMr6msq/s7WRFNwY3ZQBITkE47j60AcnNbzwDcMmI8AjvVi18Q6hbqI452wuAFPatzV5rO305fsLZiLEBSctHx6elchcOskuQCD14oA073XbmSLEshwByPU9qwbm+mnOWbj2qaK0ub6UxWyGSTrtBq3/YqRKBdzOsp6BACPzPWgDNtLgpIA+Sh6+1btjfm03CMFraT/Wxt0Ye3vWLq1mtjfPAjtIqgEMy7TyPSpVuUZFYyBZMYKkcZoA6KaCBQs8RDwt8ynqV9jUF5bG9gO0DK/dJOAaztLuFjvAGY/Z3PzBTXVQ6ddEMY7eSSA/OGAySPpQBwMilWZSOnBqKX7proNet4mxc24wG4YE96wJRwT3HagCCkpTSUAFFFFADxSikqWBBJIoJwvUn2oAnTEVtjHzyfMfZewpBjtnikZyzFiMZ7UowT0IoAeq4PQ/n1rY8P6XLqd9HHGpI6tz2rLRCWA5YH09a9Z+G+nW1teWiTDdLMQz9tncDFAHt/wAKPhrb2uiw6hq8TLd3CKUhOCsaduPXFM+KEEGixGOA+R9oHlop/j49a7TSvEdvZaNdahrF3Ba6dbqPndsBcDoO5+leNav4nl+I3if7ZDGLfQbPKWbPkNOT1JB6UAVvD2m+bL5k4+UfMCG4NdRNHbxRN9nLRE8sp5Xj+VQwxRKpESlCpwV9PX/9dN1VV+wTb/uSREAqcn6ZoA4bxNrziR4Y5I41OSTEOT7e9YMg+3Q5utr/AC7jJ3x6Gkug5mACCRclT5hwAP8AGordAju1pdkAcGJzn5vQe1AGU9u1lYXN7DMQMbFJ6oD2rj1vPLnYFiR1DZ5zXojSW11BLbXC+XO0R+ZjgFsnFcheaDeL5QltGUuOXQbgffNAGxpGox6jYvb3e1YIELmQMdx9j61gShIt7wsUiZuAepq/4c0+7hMwXiNvlbeMfhWRNYXE915Sbmk3nCE4/KgC1ayRSobe6c7HxtAHT6VgzKFmkUdAxAFdrpehpFHc3WqyeUIYi8aY6vjhfzrlYbGSSU+fmMZyeOT9KANHw4sV0JIb2ZkVcFD3z6V1UMfhy2gDSzyz3gySgXcuPSuTCQphYQ54x9K6DQ9Pjlj850kCDoVGeaALKwR3rbhajYSAu04rZsrWK0i5MRVuFXHU/Wr9nLFCuwW1v5RAIzyT65NZ+pXTRuoPleQVwpODkfSgClquowQxSeWVWT7u7GB6Z4703wn4fk1tzcXLSJbKw+cH7xrCu9QUyDASUA4JZa9U8CyB9BheFvvnG3Hyj2oA0LDS4LdFjRjFg52EZyPXNWryytpYgHtUMeP9Y3Vx7elTCZWX5owkSnGO3T1qKadNu91MihuhyMCgDjNS8NWcKSz6YbiEFck/eB9cDrXAava3UJdgrhP7zdf/AK1ew7bmK0lbUrhHk3Fo5Eg8s7OeCMkFvcYrzfX9TkmldbeMnc2WDDlqAOH+z3MshKpJI3X5RUTxyRH5kIJ6ZNa+tRyafdqIJyrld3yH7oPY1W86OS1HmAyXDMMOx5WgBdFLwSs33CVIJPp6VPcs8r7xGJcHA3H+VRxMEKsxBz1OMjHvWpJZ+eyz2kqyMMZi7/UUAYNxazm5M9wnnRMmDluR6VlXNu0LAkHY3Kn1Fdlb6bM080NxFcKByVZeB/n1rJvbEtGRPIFRCVUZyfyoAxLR9jg9s9K+yP2cRZSeCTczyQzPgI28AlOvy8/hXxywVGwmcA9T3r0/4H/ERfBWvGHVIhPol4VW4BJPkHPEgHfHcdSKAPQvjx8PLGzjPiTwzCG0+5kK3kMIBSJ8cSeoB5yOxx61846lbPayvG/bpjuK+5pm04Wsto7RXXhzWoiI7hWDIQw6+mRn/OK+P/GmlLZXd5ZhjJNZs0ZcLwQP/rUAcSaDRRQAUUUUAPqaMbYj6vx+AqFQWIA6k4qdzzt7LwKABR9KkThsEcVGKngXJUDJye3NAHS+D9KF1cfam+7E3yq3G5v/AK1dzZz3J1qAlWjVCVdsDIGOTnuav/CTwbPr+9MMtpbAPKVG5S56KfQ4pvxVtl8ISPZWQ2y3ik+uwdOAe9AGZqF3dePPElvolhcSrpVucneeGxwzkD9K9RsrG2tLaC0SEQxxLgALxx3Bri/hDpMFnpBvroMk91yCBwEyePxr0WMv5RCZeMKQSSDx6YoAiNu6EyFW553Fd1RPAG+ZcZckOGAIA7cVZV4GmRg7RRjB2p0+ue1LJuXIaMsj/fZSD9KAPNtfsZdNnme4hzayPlJozkp7EVgykqYpCiSRh+JBycHjPvXsNxarcQ4yjRkFPLwCR/8AWryXxfYXmiXJFucWhO8Rk8UAULw+YNisnyvnLc8egqGfVriJVhtZx5bfLtccIfasyTWUMeJYyMEfdIHPr9KpXF79qUl9u7gg8DigC1DqEi3pabggYKE8VkXDPJK7qzLIpzu7D2pXkLyGRSDjHBPJqaAPNvCIWBGSAOAfegDotZuJF0ezgQb5HUNLIBn5cDArBkS4um3IGOBj7vpW34el1G4H2SC13oM7iw4xXX6dpGobopHjMduDj5wP0FAHnEKmJGJgdpFHUKcD61PbvqkjkQCU98KOP8K9v0+xglQJcwJOIuQJEwG+oHU1Y/se02k2sAgYc8Lx9KAOG8FeHNQ1GB5L0FYjkYcdaseNvh/DDppurC/ma4VfuHo49K62a9TSljNx54gK5cx4GffFNj8QWmsO0GmESqEOY9uCTnqDQB4UNDvjDJLJbyRRR8PIQQK6z4e61FalNKupBErvujkY8Z9D7Vf8V+ZBdva6lvRH+dFQcH61y+uaYbYQXVur7SA3C9PrQB7Ejps2b1YAZPOQfTFIG+ZkKsGwcZUkfp/+uuZ8N6iz6bD5jK+5AwDZJ611VtKuGeQpnPJHc0Acn401MWOitJudpnIQKRgfUD2rzuK5lazkJJMh56YOPrXU/EeK4ub6IRCRo15Abg8fyrmNxGlyPcrsDn5Ao647fSgDAu0mmhupQpPkxvJlj/dUn+ldvD4QttPuL+3upFuWtb25sjJ5ZUSGKZ49wXJIyFzjJx61iQ2xufD2rSujLFHaTMmF6ERtXp9zGx1bxA6YQJrWpFmzzn7XN0oA5NLK2jkWJLZQeu1kHOD0/wD10+ey0+SFxCv2e46nyuCp+lM16xubVo51YLEwyWLY3fhWPHdNGG8t1ORjLA8n2oAh1tdXtLRx9pa4gOMuOwrBsbWe/kIjGCwwSRXoVtGZJAkrKPNADk88Y6VS06wht8vDbq4Ugqd2CvPegDibnQLuPdlCXBwBjg1lSKYTskQrICc57V6dLdQFnjcgF88qeF+vvXG+I7aPDSRhQd38PORQB0/w98e6hpmmS6I0pltM+ZDDI2UVs849PwrP8S3U15fXt/I4DXSNvA7Hb/WuMgZ4po3XcpBBz7V6poXhebxLBerZESxx2jzBv9oITj07UAeMjoKWjsPpRQAhooooAmh6lv7opw9qEGIh/tHNKPc0AOHWtbQbX7VqUSAqBySScAAVlR/e6Z+ldH4PjjbUcuQPlIBbgUAfavwg0WPS/AlllB5l5/pUhxgndyPyGK+e/wBoi7i1f4ojTrI/NbhIXIX+NsZFfVelGK08P2ZJ2ww2qHPooQV8ZadjWvidf3d0rt5t7LPwecljtz+lAHreigWlhBbxwjZFGse1wR0HJB9atGSESMQCrYAUFMjk+vaqkAm2J5TCQoCBk8kVYaSbEJliQA/KTjnHvQBZ8xsLJhHVflG4d6aJmY+VGPKYdQeG/PpUKJ5jMyGZRkAgAetPPl7GLhxJkrvQcY9x3oAcyqi4uVeIj+JSABzWXrFgt3FJFIPNDZADAfMO1a6R+a7FZlYqMjd6gVFLLD5YDsrMOyr+uO1AHgHivSHsLtkAKkknH8qwEiLDnBz7V7P460xGVpMRyJtOBnJz/SuH8J+HDqWrMkshSKIhm44/OgDK0PwzeavOiwr+5zywHQd69g0/w5p1nbwQQIk9oB8+R8wb1zVyGwisbAKcxQIODA3Tn1rTt8yQKrSB4zyDtz19aAKmn6TDasXtoFZpMgAnpxV6a3laAqfLDjorDA/A1NbLF5ezdwoxgrhgPakuYXuVUZBi6jPGP/14oAz4Y44JgHkcTnjDfyq9ELiRB5MIVecu3UkdeKbCsHBebzB/EhXGwegPrUwdhwjYi6necMPoaAMK/is7e1kuLtimTyDlifoK5nR9ZjtL8XYjHkO2zYgy4PsBXYafcS6pLLNbwu8cZMY8xQufx71Xi8LMmoS3m5Y/OXG2MZFAHNeMJ114xyWsbDyzgmT5SBWPcW5s/s0crPNDOPm2qcjnpmuvvfCV5OSBesko5VmGc4rE1Hw34igeG42peRBsK4+9/wB8mgBdFtXtZyrKVtCQygr09Oa6uOEmNXtkHBxkdPeuM03U7zT7qS31K1uIoN+Nxi4Ppz3H0rq4byKaOPe7xRv1VcDPv9KAMbWLMzOT5Ill3bnXO4ADpXCeJ9NJeS4+RAOPLX+D8K9UmMRH7hCYz97nr9fr6Vg+JNJIs5GVQJCONpyFX0OaAOejjEXw91orvTfYTHEmAW/dtyB6V1czoNV13oAutalvZieP9Ml6D8a4XUZQfC+qJJOG22UoCseVPlt0/rXY30TXGr6+NxXZrWo4I4/5fJj+NAFHX2t2hjQCOSVsknJOF65rBNhMU3MwQEYAxyBj9K6S9u7a0ibzJUXK5UnhgfXPrXIXfisxSOlkGZ8YMsgwGP0oAS+AtbYNBI5A+XceOT6ZrkNX1OeO4aJPlK8E9z9avnU5bnUI1uSMjHHbHqKoavZSXN9PMMMmeCo+8P8AGgB2k38kq7WUYjO8EDGKbf3UcymNSS/OSD1P0qnYzG0mdI2DlyBjHeptZtJLdEn8tYg7bSAaAM3+8Dkdq+l/2UbyPUrPW9MmwZo4PlBHJRuP64r5shV5ELBNwB5wK9P/AGdvEX/CN/ES1lnlEdjeKbS4yOzcqc9sMB+GaAPI5V2Oy+hx+VMqa8x9rnxyPMbkfU1DQAUUUUAT/wAKD0UUopqkYX6U4UAPQ9wD+ddD4TkK6gCV3AKSeM4rnQa3vCyg3bM3THr0oA+l9a8dPq3gmwsNNd1ZoljuHZtuCMAj6cV5d4CiK+JNTdTkBivGM9+tMslK+UZASm4dWxTfh1On9valuUtAXJZsZ4yelAHpIAZVWO3dmb5TtIUg9T3qWEsImQfP/CRJyc/h6Usm1l3xoSqrkE8HjpxToETkNKVcgbAOnP8AKgBI2xkGNlY+jZHpVg3DRtGIwwJ+UrjP4jPWqxVnnP2flc7cHnPHp6UjADH7tlj7MTyDnmgCdGLoFdzkkkDaMke+OKldZcFfLiO37y9cjHH1qBH2wqpYpEBhgQMflSArCyufnjzuDA8qKAKGt2sctm8ixElTjjkL9Kp+F7RraxuCI/MMhLF2HPHbHattnIiZoWJRuQrHr71gXusW9ijpdJKMnKnOCSe/FAF28cx/JFMpBAJRl+UVpaYUKOY4zwB84Hyg+1cJL4siZmhMKl5OfMfJUD0rrvDd7He2y/ZlbLDG0fKpI7+1AGzLDE8gaWMSk56HH9akk5BWT944GQgB4HtQtgyIDcxFOf4JM5/yKuxrIC7AJJHjj+8cdzQBmrbsE+9GgJJK4yfUZqu0IuJ1izgjk7+30NaSCBpMzMOucBcHn+lc94r1saRewxnyxvGGJBKjuOlAHWWuIxHBBEAFwAjd/f8A+vT3m+zsW+82TtwRg+uK4L7drupgfYpoBB/y0fBI/CtXRr5G1H+zZ13TOm8Kx6gdwe1AHTxNFPH8rICv8W7BB/rVaWHzdytLIzdCUPGPxrRS2t1AIQkkcRDp9c1i65Fd21u81rCMocGInlh7GgB7WsL7hIyttHKscg/UVmzaDbyyf6HG0a5yS5/kfSksdcXPl3ANpNtHDLyR3xzSahq0FvC8y7zDLhUMjY3e+O1AFO70yRg7W1yiwAgbVOMkdeaoTWcMkf2d55G2ncArZ5B6H2rB8R+MN+5LaRVjbgckFueTWFY+LYbfUonll3xZIZQpG0f1oA19O8M2GseLk0DUr+5s49RiltBLCq4jmYZQnIOQQHXHByy81J8b7E+FvF0sOjaheXEkk9xqN6GKiOJriVpEjUAZyAWJJJ4Zelc/4v1WO4u7e/0x5IbuFldJDxsZWDI49SCAR9Kpy63N4i1XUdS1dlS/1GUyTFeVXPARc9AqhVBPZRQBy1zqEl1gT5K5z15zUSpuUHOSeq5xxV3V9Ka1lJXfMM/eA2ioba2mfAjjKg8ZIoApR/u50KDame/J/Crt5PKsO2JSytzjmoNTtXtoVJOWY8EHgUunXxgAbfjHJBGaAK1haGS52pGcsc/N2+lb9zpcdxHHEJvN2kKSD0qpPfwzzeTbfKpOCcYOT1rqtAt42jQSFx2wBgMfr6UAZp0Vo7AFXjAAH7tCCW981neHrdYb64iaPeNhIDdQfavQLyKKC1ZnSGLZkZPcevvXB2bj+3XaMkA5GQcd+tAHBt1P1P8AOinSDDt/vH+dNoAKKKKAJY/uinimR/dFPoAUdetdX4NTIuW8oSEDoTjFcqOtdB4cuVgWVXH3+OT0FAHoFqMLs3RFxgEMcHcaq+ACIfFN7GyhX3MpQDnOegrZ8AWQ1fxNpFgUkEdzMMhlwNoBPf6V1vxF8N2/hr4tWk9mkUdpqcPmAEbdkg4IBHc4H50AaG9Yo/mSMsflAfnBp7MZGwJU4IAUcimRIjJ8zoeT0Xv9aSXKIQjGRhyARxx6igBTCgzlWDA4BVjwaVWXYxZSMZOw8GkLyyy/vmwXGSSMY/pTNo38CNx2LjkDuTigCWTfK7onloqr91V/rTkhTzCkWWbo/oTS72DkGNAAQC4OBx7dqkmQSK37xHbHyupI3exoAhkjglcGbduJyAilgCPpXM+KdjvtjdSzH+6AMe2ea62WdlhDFAjAYyMYHpzXG+I7tF+9FC445zz07UAef6jD5TkYdR2I/wAK7z4SXVrhYPtUf2rcTsfJIGK4K/S5uZGMSSBWH3QDgD610/gTwVqU91HcrIYSDxjgn8aAPZrmQCFXOAjcckggj09KryEkrIr7lHzKqD19TVe78LahdQfNrM0RYYZUUFQe1cvrPhvxlo9qx0/UG1Ec5CoFZfQe9AHQajqcFmrSXciOh6K3Dcf0rz3U3k17xEWtSwtgFOHOV+me1cJqN5qN3etHfyTvcGTa0b5BVumMV6x4TspvKs9OsFMl9L8m3ZkFsckn29+OKANO1zZww8mMZCpbjoR7etc/qEo07xbY6g75IYoFQ8bSD+Ve2eFvhtY6bN9t1eZtR1FhhixIjX2C9/8APFdamhaRGcppdgpxjIt0H9KAPMYdRsriDzLK6jZmADfNuAFYGueIrK2WdIp1kijHzbMkLXqXiLwBoes2csKW39nzOOJrL90wP0HBrx8+EpvAmsyw37G6hueILllz5gHt0B55FAHF3XjOwFy0k1u53MdrsudnoBWleXqalbWzxKfIKnbjG0t6n0NcH45mM2tSRRwhY1kJU4ALZ74rpdN0+RPDsaqu2Ug7g/Tg9cf1oA4jUA/2uVGBdQ2Sq5A+v61RnQBgQyrnoAa39SiVZJPtMjK6nA8teD/hWZNb+dA5ijO9ec45IoAkt2WezQKCzxt80b8g0Wlh5gZmIcg4BU5A+orKcMvHDe3QVPHfzRSK0bbVbg4FAF2Rp2keN22hB1Jzj6Cp7Ai5uoLaINLKWHBbqc9aoi7WQ72TLqTnceoPerHh4bNTimLlEDAkqO31oA9gbwTo02kJaXNuvmMM74jkgnqQfavHfHPg+78KXSSFDPYSZCT7cDOejehxj8694ju18qPYj+UACHXr7cU/ULPT9YsZ4Z4xMsi7Gjc5B9x7+hoA+X4pQrGWPCsOGXFdNoWrFjGHmcRIc7c8ZrP8aeHJ/DmqmHLvbSZkglYY3Lnp9RWDHKyH5XKn26GgD0vU9VX+zs5HmBSpU/MpHt6Vm+E9N1C5N1qkULtY2xUSzsPlU5HH1rjWvZXQJIxI9j2r68+F3hmGz+AMkd1CyS3trPdyZHzc7iv6AUAfGFyMXMo/22/maip8xBlcjoWJH50ygAooooAkj+7TxTI+h+tPGPwoActbPhkoL/8AeIZPlJAHXPrWKKu6ZL5V5GzEqoPJXg0Ae+fCu/gi8b6ADku04hXJ7lGGT6V3n7TUckFr4Z1KLINtdOrMB0BUH/2X9a8T8OajFYa9pmqRMx+xXUc3yjK7Qen619N/G/SYta+Gup7kDSQKtxC3dSCOfyJoA8igulmiEqOJARudgPXtkVdjlUrv3mRlyDgfLj+tcb4F1P7TpzwHYrQYBGzORz+VdNbSKq7AVyTnIJ4z6/nQBfS5IXcdxUjB2clqVXkYBPO8tfuYkXk+lQxSfLt3yshyScDP0FRRs8sTA5R+6g/d/OgDT3lU5VpBjJKqDn60glWFSSWVGGTmPn6AVVjyjbgCuD1YdPfNSJPKrmRnMpzkOoztH9KAFuLnNrI6sAJf4cDoPUVz50k6nNHlwVHQIOF98mtoL9rvQCheNPm4G0Z966OC0hZfnjXa3GF7H2oAw9K8OwWxPmOXTqA44BruLG2iaKNGAVB1ZBgCoUhgEMishLNjoM4+la/hu3e6MxUl0TAIxjBxxQBWvL8W0i26eZu3Yy4Hzfl2qRhhtzCSN36BUOH9s+tal7pcAjaVAA6Z3kds+9Y7XTSAxrI22Ic+5+tAHjfxV0qz/wCEjhvot8dwYneXII3EY259xXpP7OPhz7L4cl1y+EjX127Rx+Zn93ED2B9T1+lec+MtQbVvGM9rGQ0NjCoc7fmySOPwr6R8JWjWPhvT7dyGZYgcgY6nP9aANeiiigArK8TaJbeINHnsLtQQ4OxiOUfHDCtWigD4h8c6Lc6BrUsN4gaS1uPLdychx1B/GunbxNaXWkwttMvPlsNuOK6X9o60RdUvZo40EzxxMxx8x4xn9MV4lol/Ja38Mro8qrwUzwR6GgD0jUtPhuLaKUoiJFywAGXz05rkpXtYspaxCNyMbpDnn0x3rt9La7vxNO9pOlvn90EiAzxXJ+K4PJl8u208RSsN7d+/P0+lAHK31pNJMxbqO5XGaorCQSGJ2g454x71tySXl5Z3G6RiAPmI43e1ZLwtHh25U9vSgCER7XLK25DxnHNd94W8PpdaG10tyY5mYhAVJz7Vyek6bc39yYbRCxzksR8o+pr0a5sLvRtHt7e0m8z5fneLOAfTnpQBS8NatdeZHp8yzOHcoHB+4eoAPcV6fbvJBGuC3J4Y8Yql8K7WP+zXnv4IWuRzGidcf41pa6saTDYpjLndjrgn1oA4n4y6UupeEpb1TmSzbzFz/dJG7Hr1r58Pyt0FfTfjAC48I6kpGSLVu20dOlfNVr9k/tG1bUUL2CzxmdQxUtGGBcZHI4yM0ALp0Aur6GA/KJXVD9CwH9a+9fiDImgfC3V1tyFW209oIucZ+XYoH6V8+eK/gjf+CNbh1nR1n1vw/FKsrqozcW6hgTvUD514+8oz6qBzXX/HH4labquiWekaLcJPFc7Li5kjIZNg6KD65wfwoA+UL1Ql5OqjAWQgD8agq1qbrJqV06Y2tKxGOmM1VoAKKKKAJYh+7LY6NinCktfmLp3YcfUUo6cUAKKcpwepplOFAFy1u3hfqSDx+FfUPhP4oJrnwo1PTrsgaxaW62yhyAZlIwHz/OvlMcdK0tHvJra+SSH5iOPmGaAOnhuH0TXxPn93Kfn6njPIr1qMefapIkyOHQEBMYP1PavLZCmswOkojhuM7wSuBmrvhbXbjR2NncOyxf3Tzgj0oA9QyXQ4wjNgEgdhUkaI/wAryTqjtn5sAkjpg+lVbW6823RonaRuhYgcZ/qM1b8t12rMh2qeGU5OT6UAMWBDMS0LjGQGJxj3xmnhmQAvGDgnZsfJHvinPIDtA3bxywEf3jnjAqnLKvksQQWCksWG1QPpQBsaTE7sWQ7nbqB1YE9PQV08cckUKKEfB5BOMsfSuf8ADDxtGkm44IySDjJrpnZZLXYomCH5jsznH1oAmstMuL6PYC8JX5jt7e1a2lSzafbyJlCW+fai5LfhWTZX11ZwSNbQB+4WU/r16VqaZqE0dkzXXkfaH6DGB9QBQBlya1JfLJGVSMA4wB055+Uf1qpe3UNvYy3Uh2iFCxyOgHfFSzQyrK8oiYo/zFo8KD+A5rzP4z6+UsIdGgY/a7kfvUQ42pnocetAHAwX0+tavq980gRppNylh2zwAB7Cvs7QpFl0XT5EJZWt4yCRgn5RXxnojy6akVjbyxpd3DbndxwnHAr6u+FNxPdfD7Rpbtg03lshYdwrso/QCgDrKK5vxx4mHhrT0mWHzZpCQu77qgY5PfuOK8X1r4lavNdAJfyxFgRtUbAnuAOv50AfRlFeE+GfiVq1rcImoyNcwbsMJFx+Tdf517hZ3Ed3aQ3EJJjlQOueuCM0AeJ/tGaelw9u4CCSS2YAk8kqcj69a+ePCVtHceIrO2mXcryBSrE8ivcv2oLq4g1fRkVXEbQOyMh4JB5B/MV4PFLNDfRX9kCHicOB6EHNAH1JsS1t4ooYvKiXhRuB5rjvGnhy41DTpbmwhWO9A2llbIYd+DWn4Z16HxBo8N3a7Ul6OcYKsOoK/wBa1YbiSCRXMhZl+bkjBPsKAPnCxVkmns79jHndkFTkMP1FMntZ5wC65VRtDg5UjtXv9xDavKk1xYjf5nzFwDuP17U+7sdKmtnFxZWyxleET1/DpQB5Homo2ulaYnlyyxueGYEMr89MHpXoOkJb3VlujZmRvmxztNUNL8L6PMY/Mj3NEWY8Eg+mT/jW7Bbi3UxxNGEjIYBUxj/PpQBNYIbL5I9sKf3FweP6UtzJKhZ1UYPGSMt/nmrcIdvviGM9WwvJyfWrD26xY3ruPcu3HH8qAOR8cuI/COqqZS2LcgIo6E9/pzXzQyebJ5YGQ3H1r3z4xayLXRH02GRPtN+R8qrkhAfXtk8YryeLT10y2NzdylLg4CxlOc/0oA+iNf8AjRPoPw+8JDSEtbnXLrT4pLo3IZkh2rsbIBBLF1bHPRTnqK+bPGOuXXiHXJ9UvY7WG4n5kW0hEKMf7xUdWPqeT3qBEIikkkYgElgPUk5NZUrFmJzn3NAFaT75+tNp0n3zTaACiiigB0bbHVgMlSCKsTDDkgfKw3D8aqirMZ8yDb/FHz9R/wDWoAbS59cUlANADgcYqa1KrOpYnGeg71Bn2p8blXB9DmgDpbiVms4yQUA6FjnIrorVV1ewt+c3IXClV5J6YrlrSWK/iEc8mG7DGAPei2mm025DRZZFbg4PGKAO6f8At3wdNF/a8E0NtPgqxOQ2ewP9K67StftL9VW3uhG2MEMB+leqfCjxRpPxO8EPputW9tLeWo8q6tWHBH8Mig84I7joc14r8XPhPqfgq4k1DQ1ub7QSM+YOZLbno+OSOnzYoA6gTIVcmcykfe2nH4Z/wrE17VrSC08s+VuHKc7zn/H3ry2x8SXdo2DJtGMYPNVbzVGuTlXJxngnpQB7T4C8SwO6RMD5igAs44znsPWvVbZ2kiIQmLceCB39DXyHpeoy2dyJTI2QQcKa9k8L/Eu3hgjS7VkUDa5YFifegD1poGXAaWUu67igHyj8ahkclzEXcgnJ2nt6CuBm+KOmsv8AoVjd35BHESE/jms+88bazdl4rTT49PiIO6SSQM4B/kaAOz8Q63BpsTRoXkvXB8tQxBAHcivMjambUp7th5lzKxaWQt9wUsnnRs00spuCcZA+b8SfxrU0qS4ht7mGa3twsh3A5+b2GaAJND8LaffahDNcIUVyDuQgk8+lfS+j2lvY6ZbWtmAIIkCLivjq/u9esNVhledoYRIGDKQEAz3x14r648HHf4Z06TbtMkQc++ec/j1oAq+N/DMfiXTRD5giuI8mNyMjkcg+3T8q+ades5vDmpy2GoQhJk+UJuBU+h3e9fW0sazRPHIMo6lWHqDXz3+0N4HSytoNa0mKZlLCGVFO4jJOOvOP/r0AU/hn4bm8S6q32m5EdvGcuS4LZ/uoPp/j7V9H28KW8EcMQxHGoRR6ADArzz4N+Cbfw/4bsLydGbUZ4hKSzZ2blHA98GvR6APJPj9C13ptpBLab4VJeOYdVbuPYdK8F00QXFw1i4Mcu0lCQMD1wa90/aIi1Gay0dNPnkijLyGUK2MgAda8ZTT4C25mY3IXqPugnvQAaZLceG9SMlioAcDzYkyQ/uPQ16JpGvWGqYVH8uccmF1wSfavPdNjn08iO6nWdmJJkdSUA/xplzdWc1yyNiOcfMkkII79zQB63cJKxR1k2BySwI+97iopbZnTDBieNvQHBH+Ned6b4i1exB8i7W6DkL5Tglj+NdEfE+tW9n52peEtU+zLkieNC65/L8aANddMltSN8auu7GN2Cp+velntxCCy9S2CTw3/ANeuVn+KGjwQ4e0uDN1MciFMfXNY998VbZGP2LTTLwMeZLwP0oA9Da68ne04Kryxfso7ZPavPvFHxLWz8yLSQlzKePPYEqv/AMUa888UeMNZ8RzLFJKyQkYFvDkKee/r+Neufs8/CxNRvV8Q68jPbWkg8iB1BWWQDqfUD+eKAO7+C3w7eGKPxd4yUXGtXK+ZbwzAFbOMjI4PRiD+A96+ePibrMfiXx3rVzp5RrJrphEy8bkX5Q344zXsX7QXxegNve+EPDEvmySAwX95GxAjGfmiQjqSMhj0AOOvT57hl+wwbpEX0w/FAC3SlLfG4bVGM1zz9TVy/vDcMQvC5zjNUjx/OgCGT75ptOf71NoAKKKKAAdafFIY3DL1Hb1HpTB1ooAtSoBtZCDG4yuP5fWo6dbzKmUlBaFuo9D6ilmiMTYJDKeVYHgigBv1pQRTc9KX+VAEsMrxMGQ8+ldDp2qQvEYrhQ49K5qnKcYx1oA6/SNV1Pw3q0Gs6BcNa3MLZRlO4FT1Vh0Kn0NfS3gP49+HvEUQsvFMSaNeONh8077eXjn5iPlz6N+dfI1rfz242o2YyclW5Bq4Ps94uUzHI3YkYJoA9++LXwe0sW8niHwo6HTH/eSxW+JFjB53Jg/d5/CvEToMay4S53x5wHCk8+mKSx1TVdLhkgsdSu7eJ1KNGshCMp6jHSmWmpXlp86uRlv4e3vQB1vw+8J6HqeuC28Q6pLpluR8soT77ehJ+7X0Ho/gj4V+HomvHn0y5CLuaW8vFlxjnOM4/SvC9Hs0urVJ5nkmjK5Ybup+ner91ZW91bx27pCkDDH3BuHvQB7NrXxJ8MaRphPhC30+5kcYj8mMRo3HYAc14Zf32qanrKXd/DCqztgRwYBx36elZM3hueydprHUdqp8xySuPcV0+mlXjQlmkkxlcjapOO57UAW44Iifs80wUMPu7jyO2QKfEqxgxmLaccAggNjp1pIXkDKbZgGCnJHHTtkjmpyNzlw2CPlUyOSue/FADkgS4hkT7PGNgBLN82cgnH0r2Tw58R9Iu9Ito7FXnmt41imSNSqxsABjJFeUWbRkFk2g5AIVSxGOOP1NJp9p9jmubi3kMbT44ztGT6j1oA9g1Px+IrcGxsvMmIzhnyAPwHNVbzWoPGmnxaeiRwvgzy734G0djj3rgJLoiyCiZUVVJ37ep/rW34P8H6nqmmTX8mLQvGwi3Z3uT0xk4A96AOig8f21pb2lhZQq7QRCN2L7gu0YA4+lWZvHzokBNrCpJIfLk5+mBx+Oa8sl02/0m6C6hDNb3AG7G4L8pPP61Ebpp8xiT5gfm5DZ9eaAOl+IXipfFEVtbWNpIptnLuHPD5GCBXmd7FGrsojaJ1O1lUn5Ceh610UiKFMqMwz1+YkAeue1ZN4JEiK/KSesuMke49aAKfksEJa3k8lRydxIBHtWfeorNKttGYAQCkrZODWuIZoiAGV+7bAcY9/emsoVRnKnOcgcHPt3oA5aC9vodTRJYZIXiGRLDkr9cV6p4Q+N99YRrZ6pp02qRRkJ58RCuo9SMc1wl7Kltt3RiNuV2jqx9/amWVlHY7im2Mzn51J4Hvn+lAHvEnxB8EXdot3c6WJZHBJV7JWb3yTXgvxL1DS9c1g3OmaFbaRaJ1EahTJ23EADH5VLG4jUMtxEGDc5POPX0Ncd4v8AEP2mWW0tGSRCwLSquCfbPpQBBcTadp5YwHdIV4yOhrq7j4xa0ngqLwx4fhWwj2lZr5HImcHrt7Jn16+mK8wSAgh7h8ADO09adc3oOVt0MYPfPJoAk8yK1QncHmPY9qoTzPM26Rs0wkk85/Gmk+1ABzTWp1NNAET/AHqSlfr2pD1oAKKKKANHw/aWF9q0Nvq+pjS7Jwd92YGmCYBI+ReTk4FXfGXhm68LastncTQXVvNEtxaXlud0VzC33ZFP4EEdiCKz9EsBqmq21kby0shM237RduUij92bBwK6j4oalptzdaJpej3P26DRNPXT2vVG1Lhw7OzIOu0FiAT1xmgDkZbYrBDMkkciyAkqrZZCDjDDt0yPrRBPsQxSAtCTkgdQfUGoM9+49KcXJPzjPv3oAsywFUEsbB4j/EO3sahFLbyvBJvgfB6EEdfYjvVlRFdHCYgnP8DH5WPse1AFegUssbxSMkilWBwQabQA+lDY5FMFLnHUUAXoL5gAso3r781owXUDHkMRnkHj8qwQdx4p6nB6cdsUAeiaBq/2WKNJJGjtsn5iAQn0FdPDOzSGWMFlYjawXgg9gK8osdSWMqLhDIgAGAcV1Wg6vaANElztDEYSVcr74PagDsllkR41nClN+Pu7voamXKzN8pMa8ZOCOew/xqlFNGyssHlDDcNtwuD6YP61P9o+zbWZSZAcBlA/yKANaPLKquMqpywxgewAqZS4VoYI+ANzfN8oPf8AxrMW58txJCNxZeoXOD9DVlNQSVArF0AH3WUAgj6etAFqOdUmI3FZAQWYZCtxyTmrErIyCNtphVcrsY4bPp3qiHCxeWxDDfu57e49aDcpjcDJk9CR0/x+lADJ5N+p28kt+sNrtKkHozD8elel+HPjP4XtdMgtdSupEnhUICseQwHHXNfOvirWFW4eF4hlFIUN2BPH41xctyzyZyQc8L2oA+g/iH4+0PxPrsN1ZXNwqQxGGNWTAJJPJ/WsyGeBo7eK2V1Td+6IPzMO+72rxOG8aCbenPOMY4rstF8TRElroquECrGowM+uf6UAd9HLLJG+1WCZIxwoPPbviqrqJgC8ibshgd5JJB6YrGttf05pRmUBiBhnFST+I9Niw1q7TyhtoREyQT/FnvQBtzSReWWEiCNvU459T61U3gjasg2R4YIOTj1wfxrIbUptRLRC38qI5yWA3MO/0q7Lt8tVwwRANqhslRjg/wCelAENwkXyiRy+MnkZKg9j+dMkaONHGXmjUbmxwSf9nNZ17rNppxxLKzOx3MFIORjpXJ6r4onnZlsw0UQ4G7rigDY1i9FxHsE0cEJPIxhsDtXJ3N9FEzJaJ0P33XmqUk8kzs0rlj15qDdxj+dAEksskzFpCST3qMkY9aQnPrSZFAAaSnIjSMFjVmPoBmtK00W5nIDgxkkAJjLH8KAMvvU4tyI/Mnbyo+wI+ZvYCtWYWGmOVL+ZMB0TDEHPc9B+tZF5fSXMhbAQH05P50AQXLB5AVjEagYA7/U1DQaKADvRRRQAUtJRQAetH40UUAH0pdxIwTTaUdaAJjczmMI0zlB0BOcVHvY87jTaWgBdzepo3N/eNJ/KigB29v7xpQ75zuNMooAf5j/3jR5j5+8aZmloA0LTWNRtF2219PGvorcVNH4j1mMsU1O5G7k/N1rJooA1f+Eg1fH/ACErn/vqnp4k1pCNuqXQI4GHrHozQBtv4p11xhtWvCOnL0yfxHrNwu2bVbxl9DIayM0UATyXM7nLzSMT3Zs0wSyDo7D8ajzSZoAlMrnq5oE0gPDsPxqPNGaAJhdTgYE0mPrUttqV7ayeZbXc0T4xuRsHFU6KANT+39XwB/ad3gdP3hqK51jUrknz7+6kzwd0h5qhSZoAkMshzmRz9TSGR+7t+dMooAXe394/nRub1P502loAXcfU0bm/vGkooAmiuriL/VTyp/uuRTnvbt4fJe6naHuhkJB/Cq1LQAlL2pKU0AIelFBpKAFopKKADNGaSigBc0ZpKKAFzQDSUUALn2ozSUUALmlB5ptL7UAKDRmkzRQAuaM0lFAC5oziikoAdmgGkpKAHZozTaWgBc0ZpM0ZoAXNGaTNFAC5pM0lFAC5ozSUtABmjNJRmgBc0ZptFADs80mfakoNAC5NGaSigBc0Z7UlFAC5ozSCigBc0UlFAH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single axial CT scan demonstrates a mass in the left kidney (arrow). The presence of fat within this mass is suggested by an attenuation similar to that of perirenal fat (arrowhead).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_57_35743=[""].join("\n");
var outline_f34_57_35743=null;
